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Summary 
This thesis sheds light on the mode of action of membrane proteins and their 
ligands. Two model systems were chosen: the membrane protein was the human 
voltage dependent anion channel (HVDAC) and the membrane protein targeting toxin 
was Conkunitzin-S1.  
HVDAC is located in the outer mitochondrial membrane. It is primarily 
responsible for metabolite flux of the mitochondria. The structure of HVDAC was 
determined conjointly by NMR-spectroscopy and X-ray crystallography. This is the 
first time that these methods were united to solve a de novo protein structure. It is the 
first structure of a human, mitochondrial ion channel. HVDAC adopts a β-barrel fold 
composed of 18 β-strands and it has an N-terminal α-helix. The N-terminal part, 
which is known to contain the voltage-sensing domain, shows in solution an increased 
flexibility. The C-terminal part is mainly responsible for binding of interaction 
partners. The pro-apoptotic protein Bid and the anti-apoptotic protein Bcl-xL as well 
as the lanthanide Gadolinium compete for this site. The antidepressant fluoxetine 
interacts mainly with the C-terminal loop, while interaction sites of nucleotides are 
distributed over the whole sequence. 
Conkunitzin-S1 (Conk-S1) is a 60-residue neurotoxin from the venom of the 
cone snail Conus striatus that interacts with voltage-gated potassium channels. Conk-
S1 shares sequence homology with Kunitz type proteins but contains only two out of 
the three highly conserved cysteine bridges, which are typically found in these small, 
basic protein modules. In this study the three-dimensional structure of Conk-S1 has 
been solved by multidimensional NMR spectroscopy. The solution structure of 
recombinant Conk-S1 shows that a Kunitz fold is present, even though one of the 
highly conserved disulfide crosslinks is missing. Introduction of a third, homologous 
disulfide bond into Conk-S1 results in a functional toxin with similar affinity for 
Shaker K+ channels. Scanning mutagenesis revealed, that Conk-S1 adopts a different 
mode of binding than the structurally homologous dendrotoxins from snake venom. 
The affinity of Conk-S1 can be enhanced by a pore mutation within the Shaker 




Diese Doktorarbeit gibt Aufschluss über die Wechselwirkungen von 
Membranproteinen und ihren Liganden. Hierfür wurden zwei Modell-Systeme 
gewählt: als Membran Protein wurde der menschliche spannungsabhängige Anionen 
Kanal (HVDAC) gewählt, als Membran Protein Ligand das Toxin Conkunitzin-S1.  
HVDAC sitzt in der äußeren mitochondrialen Membran. Er ist hauptsächlich 
für den Metabolitenaustausch der Mitochondrien verantwortlich. Die Struktur des 
HVDAC wurde gemeinschaftlich mittels der NMR-Spektroskopie und der 
Röntgenstrukturanalyse aufgeklärt. Dies ist das erste mal, das beide Methoden vereint 
wurden um eine de novo Protein Struktur zu lösen. Es ist die erste Struktur eines 
menschlichen, mitochondrialen Ionenkanals. HVDAC liegt als β-Fass vor, das aus 18 
β-Strängen aufgebaut ist. Außerdem hat es eine N-terminale α-Helix. Der N-
terminale Teil, der bekannterweise für die Spannungsabhängigkeit verantwortlich ist, 
zeigt in Lösung eine gesteigerte Flexibilität. Der C-terminale Teil ist hauptsächlich 
für die Bindung von Interaktionspartnern verantwortlich. Das pro-apoptotische 
Protein Bid und das anti-apoptotische Protein Bcl-xL wie auch das Lanthanid 
Gadolinium konkurrieren um dieses Bindungsstelle. Das Antidepressivum Fluoxetin 
interagiert hauptsächlich mit der C-terminalen Schleife, während Interaktionsstellen 
von Nukleotiden über die ganze Sequenz verteilt sind. 
Conkunitzin-S1 (Conk-S1) ist ein 60-Reste großes Neurotoxin aus dem Gift 
der Kegelschnecke Conus striatus, das mit spannungsabhängigen Kaliumionen 
Kanälen interagiert. Conk-S1 hat Sequenzhomologien zu Kunitz-artigen Proteinen, 
besitzt aber nur zwei von den drei hochgradig konservierten Cysteinbrücken, die 
typischerweise in dieses kleinen, basischen Proteinen gefunden werden. In dieser 
Studie wurde die drei-dimensionale Struktur des Conk-S1 mit multidimensionaler 
NMR-Spektroskopie gelöst. Rekombinantes Conk-S1 zeigt eine Kunitz-Faltung, 
obwohl eine der drei hochkonservierten Disulfid-Quervernetzungen fehlt. Die 
Einführung der dritten, homologen Disulfidbrücke ergibt ein funktionales Toxin, mit 
gleicher Affinität zu dem Shaker K+ Kanal. Mutagenesestudien ergaben, dass Conk-
S1 auf unterschiedlich Weise an Kaliumkanäle bindet als die strukturell homologen 
Dendrotoxine aus Schlangengiften. Die Affinität von Conk-S1 kann mit einer 
Mutation innerhalb der Shaker Kanalpore gesteigert werden. Dies zeigt die 
Interaktion des Conk-S1 mit dem Vestibulum des Kaliumkanals an. 
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1.1 Structure determination of Membrane proteins 
 Membrane proteins can be either integral or peripheral to the 
membrane. Peripheral membrane proteins are to some degree water-soluble and tether 
to the membrane by an anchoring group. Integral membrane proteins (IMPs) contain 
several transmembrane segments and are therefore insoluble in water. IMPs are 
essential for cellular transport processes and intercellular signalling. They constitute 
roughly 20-30% of the eukaryotic genomes[1]. Despite their wide abundance and 
physiological importance, out of the over 35.000 protein structures deposited in the 
Protein Data Bank (pdb), there are only 250[2] (state 27.03.07) coordinate files of 
membrane proteins. This under-representation of membrane proteins in the pdb has 
two major reasons. First it stems from their complex expression behaviour[3]. 
Secondly it results from the difficulty to obtain high-quality crystals suitable for X-
ray diffraction. This is due to the fact, that IMP’s are highly hydrophobic. Thus they 
have to be solubilised for example in detergent micelles, which are inherently 
resistant to forming ordered crystal lattices[4]. Therefore solution nuclear magnetic 
resonance (NMR) spectroscopy could be a viable alternative to X-ray diffraction. 
However, out of the 250 deposited coordinate files, only 5 were investigated by NMR 
spectroscopy. The major problem for solution NMR is the size limit. As molecular 
masses increase, NMR spectra become increasingly difficult to interpret because of 
spectral crowding and line broadening due to fast transverse relaxation[5]. Since the 
IMPs form a complex with the detergent micelles the overall molecular weight of the 
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studied particle is significantly increased. Membrane proteins with masses in the same 
order as those of the micelles will determine the size of the complex. Therefore the 
complex size cannot be minimized simply by choosing a detergent known to form 
small micelles[6].  
Nevertheless, several recent developments make structure determination of 
IMP’s by solution NMR feasible[7]. Transverse relaxation-optimised spectroscopy 
(TROSY) -based methods[8] provide a substantial improvement of 15N-nuclei 
relaxation behaviour, especially at high field strengths (900 MHz)[7]. Full deuteration 
of side chains further improves the relaxation behaviour[9], while partial protonation 
yields additional distance constraints[10]. Especially cell free expression systems 
provide the opportunity for advanced labelling schemes. The stereo-array isotope 
labelling (SAIL)[5] optimises the samples with respect to spectral quality and 
information content. Another approach, the combinatorial selective labelling scheme 
(CSL)[11], is able to speed up the assignment process dramatically. Long range 
distance constraints can be obtained from residual dipolar couplings (RDCs)[12] and 
from strategically placed paramagnetic spin labels[13].  
 
1.2 Membrane proteins as drug targets 
 Due to their physiological relevance membrane proteins constitute 60% of all 
drug targets[14]. Out of these are at least 40% integral membrane proteins, of which 
66% are rhodopsin like G-protein-coupled receptors (GPCRs), 20% are ligand-gated 
and 14% voltage-gated ion channels. Under the top 20 prescription drugs based on 
total sales 16 act against IMPs (Med Ad News, May 2005, drug target location from 
DrugBank[15]). This clearly points out the immense potential of membrane protein 
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targeting compounds. One combinatorial library of compounds interacting with IMPs 
is provided by nature. These are the conotoxins that form the venome of cone snails.  
 
1.3 Cone Snails and Conotoxins  
 Cone snails are a genus of toxic, carnivorous gastropodes, which consists of 
approximately 500 species[16]. They thrive in tropical, marine habitats. Each Conus 
species has evolved its own large molecular repertoire of venom components, 
different from that of every other Conus species. A general rationale for this can be 
found in the complete web of biological interactions present in marine 
communities[17]. All these species use a similar strategy for hunting. They carry a 
hollow, harpoon-shaped tooth, with which they inject a highly potent venom into their 
prey[18] (see Fig. 1).  
 
 
Fig. 1[18] Conus purpurascens rapidly catching a clown fish.  
 
Each Conus species developed probably over 100 different venom components. This 
leads to an estimate of over 50.000 different pharmacologically active components[19]. 
These components, the conotoxins, are small, peptidic toxins. The majority binds with 
high affinity and specificity to various ligand- or voltage-gated ion channels but also 
some conotoxins are known, that interact with GPCRs (reviewed in [20]). Since only a 
minuscule fraction of the total conotoxin diversity has so far been characterised in 
detail[20] and since conotoxins interact with essential drug targets (see 1.2) there is a 
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high interest from the pharmacological point of view to continue investigating this 
combinatorial library provided by nature.  
 
1.4 Rationale and Outline 
 The aim of this thesis is to shed light on the mode of action of membrane 
proteins and their ligands. Two model systems were chosen: a membrane protein and 
a membrane protein targeting conotoxin. The membrane protein is the human voltage 
dependent anion channel (HVDAC) from the mitochondrial outer membrane. The 
conotoxin is Conkunitzin-S1 (Conk-S1), a Kunitz-type protein from Conus striatus. 
Both proteins shall structurally and functionally be analysed. NMR-spectroscopy is 
chosen as a major tool for these investigations. This is done because only NMR-
spectroscopy is able to investigate proteins in solution, ergo in their physiological 
relevant form. Additionally it allows for the determination of dynamics, which are 
prerequisite for protein/protein interactions. The HVDAC will also be investigated by 
X-ray crystallography in the framework of the thesis of Thomas Meins. The aim is to 
solve the structure conjointly by NMR-spectroscopy and X-ray crystallography, 
because the complex behaviour of HVDAC pushes both methods at their limits. 
Functional investigations for the HVDAC will solely be done by NMR-
spectroscopy; Conk-S1 will functionally be investigated by electrophysiology.  
 The following work is divided in 3 chapters. Chapter 2 describes the materials 
and the general methods that have been used during this thesis, Chapter 3 and 4 
include experimental details, structure elucidation and functional analysis of HVDAC 
and Conk-S1, respectively.  
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2 
Materials and Methods 
 
2.1 General Materials  
2.1.1 Chemicals and enzymes 
All chemicals and enzymes used during this work are summarised in Table 1.  
 
Table 1 Chemicals and enzymes 
Chemicals/Enzymes  Company  
Agar, DNase I, IPTG  AppliChem, Darmstadt, Germany  
ammonium chloride (>98 % 15N)  Cambridge Isotope Laboratories, Andover, USA  
13C6-D-glucose (>98 % 13C)  Spectra Stable Isotopes, Columbia, USA  
BamHI, CIAP, _HindIII, NcoI, NdeI, _X174DNA/BsuRI(HaeIII), T4-
DNA ligase  Fermentas, St. Leon-Rot, Germany  
ammonium molybdate tetrahydrate, ascorbic acid, Coomassie Bril-lant 
Blue R-250, copper chloride dihydrate, iron (II) sulfate hep-tahydrate  Fluka, Neu-Ulm, Germany  
DTT  Gerbu, Gaiberg, Germany  
agarose, kanamycin sulphate  GibcoBRL, Karlsruhe, Germany  
Ficoll 400  ICN Biomedicals Inc, Costa Mesa, USA  
Bench Mark protein ladder  Invitrogen, Karlsruhe, Germany  
acetic acid, α-D(+)-glucose monohydrate, ammonium acetate, am-
monium chloride, ammonium hydrocarbonate, boric acid, disodium 
hydrogen phosphate, ethanol, glycerol, glycine, hydrochloric acid, 
manganese chloride dihydrate, magnesium sulfate heptahydrate, sodium 
chloride, sodium dihydrogen phosphate, sodium hydroxide, TFA, 
thiaminechloride hydrochloride, Tris, urea  
Merck, Darmstadt, Germany  
BSA   New England Biolabs, Ipswich, USA  
Hot Star Taq, Ni-NTA Agarose, QIAGEN Plasmid Midi Kit, QI-Aprep 
Spin Miniprep Kit,  Qiagen, Hilden, Germany  
cobalt chloride hexahydrate   Riedel-de Haëen, Seelze, Germany  
CompleteT M protease inhibitors, CompleteT M 
EDTA-free, elastase, protease K, trypsin  
protease inhibitors  Roche Diagnostics, Mannheim, Germany  
acetonitrile, ampicillin sodium salt, APS, dipotassium hydrogen 
phosphate, ethidium bromide, EDTA, HEPES, imidazole, magne-sium 
chloride hexahydrate, MES, MOPS, potassium dihydrogen phosphate, 
Rotiphorese Gel 30, sodium acetate, TEMED, tryptone, yeast extract 
Roth, Karlsruhe, Germany  
SDS   Serva, Heidelberg, Germany  
Turbo Pfu DNA polymerase, dNTP   Stratagene, La Jolla, USA  
MTSL                                                     Toronto Research Chemicals, Toronto, Canada  
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2.1.2 Bacterial strains 
Bacterial strains used in this work are summarized in Table 2 
 
Table 2 Bacterial strains 
Strain Genotype References 
BL21(DE3)  F−, ompT, hsdSB,(rB−, mB−), dcm, gal, λ(DE3) [21] 
XL1-Blue recA1 endA1 gyrA96 thi-1 hsdR17 supE44 relA1 lac [F’proAB lacIqZΔM15Tn10 
(Tetr)] 
Stratagene 
XL2-Blue recA1 endA1 gyrA96 thi-1 hsdR17 supE44 relA1 lac [F’proAB lacIqZΔM15Tn10 
(Tetr) Amy Camr] 
Stratagene 
XL10-Gold® TetR Δ(mcrA)183 Δ(mcrCB-hsdSMR-mrr)173 endA1 supE44 thi-1 recA1 gyrA96 
relA1 lac Hte[F’ proAB lacIqZΔM15 Tn10 (TetR) Amy CamR] 
Stratagene 
 
Plasmids containing the desired gene were transformed into the Escherichia coli (E. 
coli ) expression strain BL21(DE3). Plasmids modified with the QuikChange® site-
directed mutagenesis kit (Stratagene) were transformed into either E. coli XL1-Blue, 
XL2-Blue or XL10-Gold. 
 
2.1.3 Oligonucleotide primers for mutagenesis of Conk-S1 
 All primers used for the mutagenesis of Conk-S1 were ordered from 
Invitrogen (Karlsruhe, Germany). They are summarised in Table 3. Bases that differ 
from the wild type sequence are shown in bold. 
 
Table 3 Oligonucleotide primers for the mutagenesis of Conk-S1 
Name Sequence 5’ - 3’ Mutation 
ConS6 GAGAATTTACTACAATAGCGCTGCAAAACAGTGTTTAAGGTTCGAT R29A (5’-3’) 
ConS7 ATCGAACCTTAAACACTGTTTTGCAGCGCTATTGTAGTAAATTCTC R29A (3’-5’) 
ConS8 GAATTTACTACAATAGCGCTAGAGCACAGTGTTTAAGGTTCGATTAC K30A (5’-3’) 
ConS9 GTAATCGAACCTTAAACACTGTGCTCTAGCGCTATTGTAGTAAATTC K30A (3’-5’) 
ConS10 GTGGGTCGGGCACAGCGGCTGAGAAGAGAAT K18A (5’-3’) 
ConS11 ATTCTCTTCTCAGCCGCTGTGCCCGACCCAC K18A (3’-5’) 
ConS12 GTGTTTAAGGTTCGATGCCACAGGACAAGGAGGCAAC Y37A (5’-3’) 
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Name Sequence 5’ - 3’ Mutation 
ConS13 GTTGCCTCCTTGTCCTGTGGCATCGAACCTTAAACAC Y37A (3’-5’) 
ConS14 GACAGTGGGTCGTGCACAAAGGCTGAG G16C (5’-3’) 
ConS15 GGTTCGATTACACAGGATGCGGAGGCAACGAAAAC Q40C (5’-3’) 
ConS16 GAGAATTTACTACAATAGCGCTAAAAGACAGTGTTTAAGGTTCGATTACAC R29KK30R (5’-3’) 
ConS17 GTGTAATCGAACCTTAAACACTGTCTTTTAGCGCTATTGTAGTAAATTCTC R29KK30R (3’-5’) 
ConS18 CAAAGGCTGAGAAGAGAATTGCCTACAATAGCGCTAGAAAAC Y24A (5’-3’) 
ConS19 GTTTTCTAGCGCTATTGTAGGCAATTCTCTTCTCAGCCTTTG Y24A (3’-5’) 
ConS20 TAGAAAACAGTGTTTAAGGGCCGATTACACAGGACAAGGAG F35A (5’-3’) 
ConS21 CTCCTTGTCCTGTGTAATCGGCCCTTAAACACTGTTTTCTA F35A (3’-5’) 
ConS22 CGGGCACAAAGGCTGAGGCGAGAATTTACTACAATAGC K21A (5’-3’) 
ConS23 GCTATTGTAGTAAATTCTCGCCTCAGCCTTTGTGCCCG K21A (3’-5’) 
ConS24 GGGCACAAAGGCTGAGAAGGCAATTTACTACAATAGCGC R22A (5’-3’) 
ConS25 GCGCTATTGTAGTAAATTGCCTTCTCAGCCTTTGTGCCC R22A (3’-5’) 
ConS26 ATTCCTCGAGGAAGGATGCACCGAGTCTATGCGATCT R3A (5’-3’) 
ConS27 AGATCGCATAGACTCGGTGCATCCTTCCTCGAGGAAT R3A (3’-5’) 
ConS28 CGCTAGAAAACAGTGTTTAGCGTTCGATTACACAGGACAAG R34A (5’-3’) 
ConS29 CTTGTCCTGTGTAATCGAACGCTAAACACTGTTTTCTAGCG R34A (3’-5’) 
ConS30 GGCAACGAAAACAATTTTGCCCGTACTTACGATTGCCAAC R48A (5’-3’) 
ConS31 GTTGGCAATCGTAAGTACGGGCAAAATTGTTTTCGTTGCC R48A (3’-5’) 
ConS32 GCAACGAAAACAATTTTCGCGCTACTTACGATTGCCAACG R49A (5’-3’) 
ConS33 CGTTGGCAATCGTAAGTAGCGCGAAAATTGTTTTCGTTGC R49A (3’-5’) 
ConS34 AACAATTTTCGCCGTACTGCCGATTGCCAACGAACGTG Y51A (5’-3’) 
ConS35 CACGTTCGTTGGCAATCGGCAGTACGGCGAAAATTGTT Y51A (3’-5’) 
ConS36 GCCGTACTTACGATTGCCAAGCAACGTGTCTGTATACATG R55A (5’-3’) 
ConS37 CATGTATACAGACACGTTGCTTGGCAATCGTAAGTACGGC R55A (3’-5’) 
 
2.1.4 Equipment 







Table 4 Instruments and consumables 
Common Name  Identifier/Company  
Balances  Sartorius B 3100 S, Sartorius, Göttingen, Germany  Sartorius AC 210 S, Sartorius, Göttingen, Germany  
 Beckmann-Coulter Avanti J-20 and J-301, rotors: JLA 8.100, JLA 9.100, JLA 16.250,  
 JA 25.50 Ti, JA 30.50 Ti, Krefeld, Germany  
Centrifuges  Eppendorf Centrifuge 5415D, Wesseling-Berzdorf, Germany  
 Eppendorf Centrifuge 5804, Wesseling-Berzdorf, Germany  
 Heraeus Biofuge primo, Kendro, Hanau, Germany  
 Microcon, YM-3 and YM-10, Amicon, Bedford, USA  
Concentrators  Centricon, YM-3 and YM-10, Amicon, Bedford, USA Centriplus, YM-3 and YM-10, Amicon, Bedford, USA  
 Vivaspin 2 ml MWCO 10.000 PES, Vivascience, Hannover, Germany  
Desalting  
NAPT M -10, Amersham Pharmacia Biotech, Freiburg, Germany  
PDT M -10, Amersham Pharmacia Biotech, Freiburg, Germany  
 Slide-A-Lyzer Dialysis Cassettes, MWCO 3500, 0.1-0.5 ml Capacity, Pierce Biotechnology, Inc., Rockford, IL, USA 
Dialysis  Slide-A-Lyzer Dialysis Cassettes, MWCO 10000, 0.1-0.5 ml Capacity, Pierce Biotechnology, Inc., Rockford, IL, USA  
 Spectra Por membranes, MWCO 10000, Roth, Karlsruhe, Germany  
 Spectra Por membranes, MWCO 3500, Roth, Karlsruhe, Germany  
 Kodak Electrophoresis documentation and analysis system 120, Eastman Kodak Co., New York, NY, USA 
Electrophoresis  Power Pac 300, BioRad, M¬unchen, Germany Polyacrylamide gel electrophoresis: Mini-PROTEAN 3 Cell, BioRad, München, Germany  
 Agarose gel electrophoresis: Mini-Sub Cell GT, BioRad, München, Germany  
-80 °C freezer  MDF-U71V Ultra-low temperature freezer, SANYO Electric Co., Ltd, Osaka, Japan  
Filtering  sterile filter 0,20 µm, Sartorius, Göttingen, Germany  
Äkta prime, Amersham Pharmacia Biotech, Freiburg, Germany  
Äkta basic, Amersham Pharmacia Biotech, Freiburg, Germany  FPLC 
HiTrapTM SP XL, Amersham Pharmacia Biotech, Freiburg, Germany  
 system 1: UV-975, PU-980, LG-980-02, DG-980-50, AS-2055Plus, CO-200, JASCO International, Groß-Umstadt, Germany 
 system 2: MD-910, PU-980, LG-1580-04, DG-1580-54, AS-950-10, CO-200, JASCO International, Groß-Umstadt, Germany  
HPLC  system 3: MD-2010Plus, PU-2080Plus, LG-2080-04, DG-2080-54, AS-2055Plus, CO-200,  
 JASCO International, Groß-Umstadt, Germany  
 Vydac C18 10x250 mm, Hesperia, CA, USA  
 Vydac C18 4.6x250 mm, Hesperia, CA, USA  
Incubator  Infors Multitron HT, Einsbach, Germany Certomat R, B. Braun Biotech International, Melsungen, Germany  
Lyophylisation  Christ Alpha 2-4, B. Braun Biotech International, Melsungen, Germany  
 AVANCE 400, Bruker, Karlsruhe, Germany  
 AVANCE 600, Bruker, Karlsruhe, Germany  
 DRX 600, Bruker, Karlsruhe, Germany  
NMR  AVANCE 700, Bruker, Karlsruhe, Germany  DRX 800, Bruker, Karlsruhe, Germany  
 AVANCE 900, Bruker, Karlsruhe, Germany  
 Quality NMR Sample Tubes 5 mm, Norell, Inc., Landisville, NJ, USA  




2.2 General Methods 
2.2.1 Molecular biology methods 
2.2.1.1 Agarose gel electrophoresis 
All solutions used for Agarose gel electrophoresis are summarized in Table 5. 
DNA fragments were separated on horizontal agarose gels. These gels were prepared 
by melting 1 % (w/v) agarose in 1 x TBE buffer and adding 25 µl ethidium bromide/l 
1 % agarose. Each DNA sample was mixed with 1/5 volumes of 5 x DNA-loading 
buffer. Gels were run at a constant voltage of 100 V, imaged under UV-light and 
digitized for documentation. 
 
Table 5 Solutions for Agarose gel electrophoresis 
Application Solution name Substance Amount 
Ficoll 400 12.5 g 
EDTA pH 8 2.5 ml, 0.5M 
SDS 0.5 g 
bromphenol blue 25 mg 
xylene cyanol FF 25 mg 
5 x DNA loading buffer 
H2O up to 50 ml 
Tris 108 g 
boric acid 55 g 
Agarose gel 
10 x TBE buffer 
EDTA pH 40 ml, 0.5M 
 
 
2.2.1.2 Isolation of DNA 
10 ml E. coli XL2-blue overnight cultures were used for purification of up to 
20 µg plasmid DNA with the help of the QIAprep Spin Miniprep Kit. Plasmid DNA 
was isolated from the cell pellets according to the producer’s instructions. For 
removal of enzymes, salts and buffers, columns with a silica gel membrane 
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(QIAquick spin columns) were used according to the producer’s instructions. 
 
2.2.1.3 Site-directed mutagenesis 
Single site amino acid changes were generated using the QuikChange® site-
directed mutagenesis kit (Stratagene). Primers used for mutagenesis were designed 
according to the instruction manual and are included in Table 3. The 50 µl PCR 
reaction mixtures contained 125 ng of each primer, 10 ng plasmid DNA template, 
6.25 µmol dNTPs and 2.5 units Turbo Pfu DNA polymerase in Cloned Pfu buffer. 
The cycling after an initial step at 95 °C for 30 s was performed as follows: 1.) 
denaturing for 30 s at 95 °C, 2.) annealing for 1 min at 55 °C and 3.) elongation for 
1 min per kb of plasmid length at 68 °C. For creating single nucleotide changes and 
for creating double or triple nucleotide changes the number of cycles was 12 and 16, 
respectively.  
Multiple site amino acid changes were generated using the QuikChange® 
multi-site-directed mutagenesis kit. The 25 µl PCR reaction mixtures contained 
100 ng of each primer, 100 ng plasmid DNA template, 6.25 µmol dNTPs and 1 µl 
QuickChange® Multi enzyme blend. The cycling after an initial step at 95 °C for 
1 min was performed as follows: 1.) denaturing for 1 min at 95 °C, 2.) annealing for 
1 min at 55 °C and 3.) elongation for 2 min per kb of plasmid length at 65 °C. 
Following temperature cycling, 10 units of Dpn I restriction enzyme were 
directly added to each PCR reaction mixture and incubated for 1 h at 37 °C. 1 µl of 
the reaction mix was transformed into E. coli XL1-blue or E. coli XL2-blue for single 
site-, and into E. coli XL10-gold for multiple site directed mutagenesis (see 2.1.2). 
The plasmid DNA was isolated (see 2.2.1.2) and the desired mutation was confirmed 
by DNA sequencing (see 2.2.1.4). 
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2.2.1.4 DNA sequencing 
Sequencing of purified plasmid DNA was performed via the extended Hot 
Shot DNA sequencing service of Seqlab (Göttingen, Germany). 200 µl PCR tubes 
with a flat lid were loaded with a total volume of 7 µl containing 20 pmol of primer 
and 0.6-0.7 µg plasmid DNA in water. 
 
2.2.1.5 Determination of DNA concentration and purity 
The absorption at 260 nm (A260) was measured to determine the DNA 
concentration. An A260 of 1 equals 50 µg/ml dsDNA[22]. The ratio of A260/A280 was 
calculated. A ratio between 1.8 and 2 indicates reasonably pure DNA, suitable for 
DNA sequencing.  
 
2.2.1.6 Transformation of E. coli 
1 µl plasmid DNA was added to 50 µl competent cells and incubated for 
30 min on ice. Cells were subjected to a heat shock of 42 °C for 45 s and 
subsequently cooled for 2 min on ice. Afterwards the cells were supplemented with 
0.5 ml of 2 x YT medium and incubated for 1 h at 37 °C. Finally the cells were plated 
onto LB-agar plates containing ampicillin. 
 
2.2.2 Methods for protein expression 
 All solutions used for cultivation, storage and lysis of E. coli cells are 
summarised in Table 5. The culture media utilised in the expression of Conk-S1 
(Table 6) were sterilised by autoclaving. Prior to usage 100µg/l ampicillin was added 
to each medium. Agar plates where prepared by adding 15g agar to 1 l of medium. 
The ampicillin- and IPTG-stock solutions where sterile filtrated and stored at -20°C.  
 28 
Table 6 Culture media for expression of Conk-S1 
Application Solution name Substance Amount 
tryptone 16 g 
yeast extract 10g 
NaCl 10g 
2 x YT 
H2O up to 1 l 
tryptone 10 g 
yeast extract 5 g 
NaCl 10 g 
LB 
H2O up to 1 l 
Na2HPO4 6.8 g 
KH2PO4 3.0 g 
NaCl 0.5 g 
NH4Cl or 15NH4Cl 1.0 g 
glucose or 13C6-glucose 4.0 g 
MgSO4 2ml, 1M 
CaCl2 50µl, 2M 
thiaminechloride•HCl 0.03 g 
trace elements 10 ml 
Culture medium for 
bacteria 
M9 minimal medium 
H2O Up to 1 l 
FeSO4•7 H2O 0.6 g 
MnCl2•2 H2O 0.094 g 
CoCl2•6 H2O 0.08 g 
ZnSO4•7 H2O 0.07 g 
CuCl2•2H2O 0.03 g 
H3BO3 0.002 g 
(NH4)6Mo7O24•4H2O 0.025 g 
H2O up to 100 ml, stir 10 min 
Trace elements for M9 
minimal medium 
trace elements stock 
solution 




ampicillin sodium salt 100 mg/ml 
Inductor for 
transcription 
IPTG stock solution IPTG 1M 
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Application Solution name Substance Amount 
Tris/HCl pH 8.5 20 mM 
NaCl 500 mM 
PMSF 0.5 mM 
Cell lysis lysis buffer 
EDTA 1 mM 
 
2.2.2.1 Cultivation of E. coli 
Conk-S1 and its mutants were expressed in the E. coli strain BL21(DE3). All 
cells were grown at 37° C in media containing the antibiotic ampicillin (100 µg/l). 
The pre- and expression-culture were shaken vigorously. In order to start the 
cultivation from a single colony cells were grown overnight on an agar plate made of 
LB medium. From this plate a single colony was picked to inoculate a 2 ml 2 x YT 
overday preculture. Of this preculture 30µl were added to a 30 ml LB overnight 
preculture. The expression culture for protein expression was prepared by inoculating 
1 l LB medium with 20 ml of the overnight preculture. For the preparation of 15N and 
13C isotopic labelled samples the 2 x YT medium and the LB medium were replaced 
by LB and M9 minimal medium, respectively. The M9 minimal medium utilises 
NH4Cl and glucose as sole nitrogen and carbon sources, which can be used 15N and 
13C labelled, as required. The optical density of the expression culture was measured 
regularly at 600 nm (OD600), in order to follow the cell growth. Protein expression 
was induced at an OD600 of 0.6-0.7 by addition of IPTG, to a final concentration of 
1 mM. The cells were harvested at an OD600 of 1.7-1.9 by centrifugation at 10153 x g 






2.2.2.2 Storage of E. coli 
Cell pellets were stored at -80°C. For long term storage of the E. coli strains a 
part of the LB preculture was mixed with sterile 50 % glycerol at a ratio of 2.33:1 
(v/v). This mixture was also stored at -80°C. 
 
2.2.2.3 Cell lysis 
 Cell pellets from 1 l culture were resuspended on ice in maximal 70 ml lysis 
buffer. The cells were lysed by ultrasonication for 5 x 20 s. In between each stroke the 
suspension was cooled on ice for 2-5 min. Inclusion bodies were pelleted by 
centrifugation at 75000 x g at 4°C for 40 min.  
 
2.2.3 Protein purification and investigation 
 All solutions used for refolding and purification of Conk-S1 are summarised 
in Table 7.  
 
Table 7 Purification and refolding of Conk-S1 
Application Solution name Substance Amount 
guanidine/HCl 6 M 
denaturing buffer 
β-mercaptoethanol 50 mM 
Tris/HCl pH 8.0 50 mM 
guanidine/HCl 3 M 
reduced glutathione 2 mM 
oxidised glutathione 0.2 mM 
refolding buffer 1 
EDTA 2 mM 
Tris/HCl pH 8.0 50 mM 
reduced glutathione 2 mM 
oxidised glutathione 0.2 mM 
Protein refolding 
refolding buffer 2 
EDTA 2 mM 
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Application Solution name Substance Amount 
Tris/HCl pH 6.5 20 mM 
NaCl 0.5 M 
EDTA 1 mM 
intein cleavage buffer 
PMSF 0.5 mM 
cation exchange buffer A Hepes pH 7 50 mM 
Hepes pH 7 50 mM 
cation exchange buffer B 
NaCl 1 M 
H2O 99.9 % 
HPLC buffer A 
TFA 0.1 % 
acetonitrile 99 % 
Protein purification 
HPLC buffer B 
TFA 0.1 % 
H2O 90 % 
APS stock solution 
APS 10 % (w/v) 
H2O 90 % 
destaining solution 
acetic acid 10 % 
SDS 1.7 g 
Tris/HCl pH 6.8 7.5 ml, 1M 
glycerol 23 ml 
bromphenol blue 50 mg 
β-mercaptoethanol 0.5 ml 
4 x protein loading 
buffer 
H2O up to 50 ml 
SDS 1g 
Tris 3.03 g 
glycine 14.4 g 
running buffer 
H2O up to 1 l 
Comassie Brilliant blue 
G250 
2.2 g 
acetic acid 100 ml 
isopropanol 250 ml 
SDS-PAGE 
staining solution 





Application Solution name Substance Amount 
Rotiphorese Gel 30 250µl 
Tris/HCl 2M, 313µl 
10% SDS 25 µl 
10% APS 25 µl 
TEMED 2 µl 
stacking gel (3 %) 
H2O 1.88 µl 
Rotiphorese Gel 30 250µl 
Tris/HCl 2M, 313µl 
10 % SDS 25 µl 
10 % APS 25 µl 
TEMED 2 µl 
SDS-PAGE 
seperating gel (12.5 %) 
H2O 1.88 µl 
 
 
2.2.3.1 Protein refolding 
 The inclusion body pellet was dissolved in 20 ml denaturing buffer (Table 7). 
Insoluble debris was removed by centrifugation at 75000 x g at 4°C for 1 h. The 
supernatant was successively dialysed against 1 l of refolding buffer 1 and 2 for each 
16 h at 4 °C. Precipitant was removed by centrifugation at 75000 x g at 4° C for 
20 min. 
 
2.2.3.2 CBD-Ssp DnaB intein tag cleavage[23] 
 The cleavage of the CBD-Ssp DnaB intein tag from the peptide was induced 
by a pH jump from pH 8 to pH 6.5 (see 4.3.1). This was performed by dialysis of the 
protein solution against the intein cleavage buffer (Table 7) for 5h at 4 °C, followed 




2.2.3.3 Cation exchange chromatography 
 Cation exchange chromatography was conducted on an Äkta prime low 
pressure liquid chromatography system on a 1 ml HiTrapTM SP XL column. The 
column was successively equilibrated with 10 bed volumes of cation exchange buffer 
A (Table 7), 10 bed volumes of cation exchange buffer B (Table 7) and again 10 bed 
volumes of cation exchange buffer A. The flow rate for equilibration was 1 ml/min. 
The sample was loaded at a flow rate of 1 ml/min. After sample loading the column 
was washed with 10 to 20 bed volumes of buffer A, to remove unbound impurities. 
The peptide was eluted with a 30 ml linear gradient to buffer B at a flow rate of 
0.5 ml/min. Fractions of 0.5 ml size were collected.  
 
2.2.3.4 Reversed phase - high performance liquid chromatography (RP-HPLC) 
 RP-HPLC was conducted on JASCO systems on an analytical or a semi-
preparative VYDAC C18 reversed phase column. The column was pre-equilibrated 
with RP-HPLC buffer A (Table 7). The elution was performed at a flow rate of 
1 ml/min for the analytical column and 3  ml/min for the semi-preparative column. A 
linear gradient of 0-60 % RP-HPLC buffer B in 30 min was applied. 
 
2.2.3.5 Sodium dodecyl sulphate – polyacrylamide gel electrophoresis (SDS-
PAGE)[24] 
 The discontinuous Tris-glycine buffer system as described by Laemmli[24] was 
used to separate proteins by molecular weight. All gels had a stacking gel with an 
acrylamide concentration of 3 % and a separating gel with 12.5 % acrylamide. The 
solutions for the stacking and separating gel are given in Table 7. Since Conk-S1 has 
a molecular weight smaller than 10 kDa, 2 M Tris/HCl pH 8.8 was used as the 
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stacking/separation gel buffer instead of the usually utilised 1 M buffer[25]. Protein 
samples were mixed with 4 x protein loading buffer and were denatured at 100 °C for 
5 min before loading. The gels were run at 25 mA. Staining of the gels was done with 
Coomassie blue R-250 by heating the gel in staining solution for 90 s in the 
microwave. Afterwards staining solution was removed, the gels were washed with 
water and incubated in destaining solution in the microwave for 2 times 90 s. Finally, 
the SDS-gels were imaged and digitized for documentation. 
 
2.2.3.6 Determination of protein concentration 
The concentration of proteins in solution was determined, according to the Lambert-
Beer law, by measuring the absorption at 280 nm (A280). 
Aλ = ελ · c · d                                                   (1) 
Aλ : absorption at wavelength λ  
ελ : molar extinction coefficient at wavelength λ in M
−1cm−1 
c: protein concentration (M) 
d: thickness of the cuvette (cm) 
 
2.2.3.7 Elecrospray Quadrupole Mass spectrometry 
For Elecrospray Quadrupole Mass spectrometry the source capillary was set to 
2.94 kV. Scans were acquired in positive-ion mode at m/z 500-2500. It was 
performed after RP-HPLC (see 2.2.3.4). 
 
2.2.3.8 Site-directed spin-labeling (SDSL) 
 SDSL is a technique to introduce a paramagnetic spin label into a protein. It is 
based on a specific reaction between the spin label and an amino acid. In the most 
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common procedure, a unique sulfhydryl group of a cysteine is selectively modified 
with a paramagnetic nitroxide reagent[26]. Single cysteine mutants of HVDAC for the 
attachment of a spin label were prepared by Thomas Meins. They were modified 
with the thiol-specific nitroxide spin label reagent (1-oxy-2,2,5,5-tetramethyl-3-
pyrroline-3-methyl)-methanethiosulfonate (MTSL). 100 µg/µl MTSL in cold acetone 
was added to the protein solution at a 3 to 5-fold molar excess and incubated for at 
least 1.5 h at room temperature. Excess spin label was removed by dialysis. Complete 
labeling with MTSL was verified by ESI-MS (see 2.2.3.7). 
 
2.2.4 Electrophysiological methods 
 All solutions used for the electrophysiological investigation of Conk-S1 are 
summarised in Table 8. 
Table 8 Electrophysiological investigation of Conk-S1 
Application Solution name Substance Amount 
collagenase type 2 200 mg 
collagenase solution 
Ca2+-free Barth medium 200 ml 
NaCl 84 mM 
KCl 10 mM 
NaHCO3 2.5 mM 
Digestion of follicular 
layer 
Ca2+-free Barth medium 
Tris/HCl pH 7.4 7.5 mM 
NaCl 84 mM 
KCl 10 mM 
NaHCO3 2.5 mM 
Ca(NO3)2 6.5 mM 
CaCl2 0.6 mM 
Tris/HCl pH 7.4 7.5 mM 
Barth medium 
antibiotic solution 2 % (v/v) 
cefuxorixim / zinacef 750 4 mg/l 
Washing and incubation 
of oocytes 
antibiotic solution 
penicillin /streptomycin 100U/ml 
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K-aspartate 200 mM 
KCl 20 mM 
MgCl2 1 mM 




HEPES pH 7.4 10 mM 
NaCl 115 mM 
KCl 2.5 mM 
CaCl2 1.8 mM 
Measuring solution normal frog Ringer 
HEPES pH 7.2 10 mM 
tricaine 2.5 g Anesthetic for Xenopus 
laevis 
anaesthetic solution 
H2O 1 l 
 
 
2.2.4.1 Xenopus oocyte handling 
 Female Xenopus laevis (Fig. 2a) were incubated in anaesthetic solution at 0° C 
for 30 min. Afterwards the ovarian tissue containing oocytes at different stages of 
maturation was surgically removed.  
 
 
Fig. 2 a) Xenopus laevis[27] b) Xenopus laevis oocytes[28] 
 
This tissue was incubated for 2-3 hours in collagenase solution at 17°C in order to 
remove the follicular cell layer partially by digestion. The surgery and the following 
digestion was done by technicians of the molecular and cellular neuropharmacology 
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group of Heinrich Terlau at the Max-Planck-Institute for experimental medicine in 
Göttingen. The enzymatic reaction was stopped by washing the oocytes extensively in 
Barth medium. For further investigation oocytes between stage IV and VI (Fig. 2b) 
were selected and stored in Barth medium at 17°C. Into each of these oocytes approx. 
50 nl of a 0.25 µg/µl cRNA solution of the corresponding Shaker K+ channel were 
injected. Afterwards they were incubated in Barth medium at 17°C for 1-3 days in 
order to allow the expression of the ion channels. Then the oocytes were incubated in 
the hypertonic skinning solution for approx. 3 min at room temperature, which 
induces a shrinking of the oocytes. The outer vitelline membrane of the oocytes was 
then removed mechanically with fine tweezers. For the electrophysiological 
measurements the oocytes were washed once with normal frog Ringers (NFR). 
Finally each of them was placed in a measuring chamber containing NFR.  
 
2.2.4.2 Electrophysiological measurements 
Whole-cell currents were recorded under two-electrode voltage-clamp control 
using a Turbo-Tec amplifier (npi electronic, Tamm, Germany). The intracellular 
electrodes were filled with 2 M KCl and had a resistance between 0.4 and 1 MΩ. 
Current records were low-pass filtered at 1 KHz (-3 db) and sampled at 4 kHz. The 
bath solution was NFR containing 115 mM NaCl, 2.5 mM KCl, 1.8 mM CaCl2 and 
10 mM Hepes (pH 7.2) (NaOH). All electrophysiological experiments were 
performed at room temperature (19-22 °C). Toxin-containing solutions were applied 
continuously during the whole experiment from a reservoir through a silicon tube 
directly into the bath chamber. Whole-cell currents at a test potential of 0 mV were 
measured every 15 s during toxin application. 
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The IC50 values of Conk-S1 and its mutants were calculated from the reduction of 
whole-cell currents at a test potential of 0 mV obtained from oocytes expressing 
Shaker K according to the relationship IC50 = fc/(1-fc)[Tx], where fc is the fractional 
current and [Tx] is the toxin concentration. Data are given as means ± the standard 
deviation (rmsd). 
 The kon and koff values were obtained by an exponential fit [y = y0+A*exp(-
k*x)] to the experimental data during decrease and increase of the current, obtained 
during the wash-in and wash-out of the peptide. This is possible because the “on” 
reaction is pseudo first order, due to the constant toxin concentration, and the “off” 
reaction is first order. 
 
2.2.5 NMR spectroscopy 
 NMR sample preparation for HVDAC is described in the doctoral thesis of 
Thomas Meins[29] and is repeated here in chapter 3.2.1.5 The sample preparation of 
Conk-S1 is described in chapter 4.2. The chemical shift assignment strategy for the 
32 kDa membrane protein HVDAC is given in chapter 3.3.1, for the 7 kDa soluble 
protein Conk-S1 in chapter 4.2.3. For the HVDAC, all spectra were measured in a 
TROSY version, with exception of the NOESY-HMQC.  
 
2.2.5.1 Secondary Structure determination 
 Relative to random coil chemical shifts CA and C’ resonances tend to shift 
upfield in β-strands and extended sheets and downfield in helices. The opposite trend 
holds for CB resonances[30]. Therefore secondary structure elements can be identified 
by subtracting the random coil (δCcoil) from the experimental chemical shift (δCexp). 
Tabulated random coil values were used. The secondary chemical shift (ΔδC) is 
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defined as the difference between δCexp and δCcoil. To derive secondary structure 
information, the secondary chemical shifts were combined using the following 
formula: 
Δδ(CA CB C’) = ΔδCA − ΔδCB + ΔδC’                               (2). 
 
If CB chemical shifts were not available ΔδCA and ΔδC’ were added. In this notation 
negative secondary chemical shifts indicate β-strands and positive values indicate α-
helices.  
 
2.2.5.2 Mapping of interaction sites 
Chemical shifts depend on the local electronical environment of a nucleus. If 
effectors bind to a protein, this environment changes at the interaction site. This 
causes perturbations of the chemical shifts. These perturbations can be followed in 
every NMR-spectrum. 15N-1H-HSQC or 15N-1H-TROSY-HSQC spectra have a high 
sensitivity. Therefore chemical shift values can be easily followed in the 15N-1H-
HSQC spectrum during a titration. The titration was done by a stepwise addition of 
the effector to the desired protein NMR-sample and subsequent recording of a 15N-
1H-HSQC spectrum. During the titration the pH of the NMR-sample was held 
constant. The chemical shift perturbations upon receptor addition are commonly 












                                       (3) 
ΔδHN:   average amide chemical shift perturbation 
ΔδN:     amide nitrogen chemical shift changes 
ΔδH:     amide proton chemical shift changes 
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Residues with the largest 15N and 1H chemical shift changes upon the NMR titration 
define the binding interface. 
 
2.2.5.3 Solvent exchange experiments 
 To investigate the solvent accessibility D2O exchange experiments were 
carried out. Amide protons, which are involved in tight hydrogen bonds or which are 
buried in the hydrophobic core of a protein, will exchange much slower with the D2O 
than protons, which are exposed to the solvent. Therefore the peak intensity for 
solvent exposed residues will be reduced in D2O. For the D2O exchange the desired 
NMR-sample was lyophilised and subsequently redissolved in D2O. Afterwards 
consecutive TROSY-HSQC spectra were recorded. The first spectrum was recorded 
1 h after dissolving the sample in D2O and ran for 3 h and 13 min. Residues, which 
did show a peak in this spectrum, were considered to be in secondary structure 
elements. Residues, which did not show a peak in this spectrum, were considered to 
be in loops or flexible secondary structure elements.  
 
2.2.5.4. Residual dipolar couplings (RDCs) 
2.2.5.4.1 Alignment media 
 Under isotropic solution condition dipolar couplings average exactly to zero as 
a result of Brownian rotational diffusion, which is many orders of magnitude faster 
than the recording of a NMR-signal[32]. Therefore anisotropic alignment media[12, 33, 
34], which induce a slightly preferred orientation of the molecule, are needed to 
observe RDCs. Conk-S1 was partially aligned in a non-ionic liquid crystalline 
medium based on a mixture of n-alkyl-poly(ethylene glycol) and n-alkyl alcohol[35] 
(see 4.2.2). For the alignment of HVDAC charged copolymer gels were tested, which 
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were especially optimised for integral membrane proteins[36]. The composition of the 
charged gels was varied extensively, but in most gels no NMR signal of the 15N, 2H- 
HVDAC was observed. This is due to the restriction of rotational diffusion of the 
protein in the gel[36]. Signal was observed in a positively charged 5% gel composed of 
acrylamide and (3-acrylamidopropyl)-trimethylammonium chloride in a 1:1 ratio, 
both containing N.N’-methylenebisacrylamide in a 37.5:1 ratio. However, the signal 
to noise ratio was too low to record a 2D TROSY-HSQC.  
 
2.2.5.4.2 RDC measurements 
 1DN-H, 1DCA-HA, 1DN-C and 1DC-CA were measured in the quantitative J 
correlation manner as described in chapter 4.2.3. 
 
2.2.5.4.3 Evaluation of the residual dipolar couplings with PALES[37] 
 The magnitude (normalized to 1DN-H) and rhombicity of the alignment tensor 
were determined from the histogram of dipolar couplings by the program PALES[37].  
 In order to determine the agreement between experimentally observed RDCs 
and crystal- or NMR-structures the RDCs were back calculated based on the 
respective structures. This was done using singular value decomposition (SVD) as 
implemented in PALES. The correlation coefficient of the back calculated and 
experimental RDCs were used to describe the consistency between the structure and 






2.2.5.5 Estimation of the molecular weight from T1ρ 
 The rotational correlation time (τc) is proportional to the effective 
hydrodynamic radius (rH) of a molecule. For approximately spherical globular 










                                                   (4) 
in which !
w
 is the viscosity of  the solvent, k is the Boltzmann constant and T is the 
temperature. The hydrodynamic radius can be very roughly estimated from the 
molecular weight (MW) of a protein by assuming that the specific volume of a protein 
is V = 0.73 cm3/g and that a hydration layer of rw = 1.6 to 3.2 Å (corresponding to 

















                                             (5) 
For 20°C in water solution the combination of equation (3) and (4) gives roughly: 
!
c
ns[ ]  ∼ 0.5MW kDa[ ]                                             (6) 




















                                               (7) 
where rAB is the distance between atom A and B, γA/B is the magnetogyric ratio of 
atom A or B, h is the Planck constant and µ0 is the magnetic permeability of the 







                                                  (8) 
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The T1ρ time of the amide nitrogen was measured with a spin-lock power of 2.5 kHz. 
Two 1D experiments with different spin-lock pulse durations were recorded (pulse-
sequence is given in Appendix D). The first had a 2 ms (ΔA) spin-lock pulse, the 
second a spin lock pulse which length (ΔB) corresponds to approx. 1.3 times the 
theoretical relaxation time, estimated from the hypothetical MW. The two spectra 
were overlaid with X-WINNMR 3.5 and their intensity ratio (IB/IA) was determined. 











                                               (9). 
 
2.2.5.6 Steady state heteronuclear 15N{1H}-nuclear Overhauser effects (NOEs) 
 Steady state heteronuclear 15N{1H}-NOEs were obtained from two spectra, 
which were recorded in an interleaved manner (pulse-sequence is given in Appendix 
D). One spectrum was with, the other without proton presaturation during the 5 s 
relaxation delay. The 15N{1H}-NOEs for each residue were calculated from the 
intensity ration of similar 15N/1H crosspeaks from both spectra.  
 
2.2.5.7 Paramagnetic relaxation enhancement (PRE) 
 Enhanced relaxation of the nuclear spins surrounding a paramagnetic centre 
constituted of one or several unpaired electrons presents one of the most obvious 
manifestations of paramagnetism[39]. The relaxation enhancement strongly depends on 
the distance between the nuclear and the electron spin. Since this effect is visible for 
significantly longer distances than internuclear interactions long range information 
can be gained for a molecule with a paramagnetic centre[40].  
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 For the PRE measurement two TROSY-HSQC spectra were recorded, one 
with and one without the paramagnetic MTSL-tag (see 2.2.3.8). The peak intensities 
ratio (Ipara/Idia) of corresponding 15N/1H crosspeaks can be converted in the 
paramagnetic transverse relaxation rate enhancement ( R
2
para )[13] by estimating the 
additional relaxation needed to reduce the peak intensity in the diamagnetic case to 
the intensity observed in the paramagnetic case. Paramagnetic induced R1 relaxation 
during t1 is neglected because it is typically insignificant compared to R2 effects[41]. 
Additionally R1 and R2 relaxation effects of the spinlabel on 15N nuclei were 
considered to be negligible compared to 1H, because of the lower magnetogyric ratio 
of 15N (see eq 12)[13]. R
2
para  can be calculated from the intensity ratio of a particular 
















                                                (10) 
where R2 is the intrinsic transverse relaxation rate and tinept is the total inept evolution 
time (∼10.5 ms). R
2
para  is inversely proportional to the distance between the electron 
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where τc is the correlation time for this electron-nuclear interaction, ωH is the Lamor 




S S +1( )! 2g2"2                                          (12) 
 in which γ is the nuclear magnetogyric ratio, g is the electronic g factor and β is the 
Bohr magneton. Overall K is 1.23 x 10-32cm6s-2 [42]. For distance calculations τc is 
assumed to be equal to the global correlation time of the protein. Because of low 
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spectral quality no exact distances were calculated. The residues were rather grouped 
in two classes. Broadening effects of the MTSL can be observed up to 20-25 Å[13]. 
Therefore one group contained peaks, which in the paramagnetic case were broadened 
beyond detection, indicating that the amide proton was closer than 25 Å to the 
unpaired electron. The second group contained peaks, which in the paramagnetic case 
were still detectable, indicating that the amide proton was further than 25 Å away 
from the unpaired electron. 
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3  
Structural and functional investigation 
of HVDAC – the first structure of a 
human, mitochondrial ion channel 
 
3.1 Introduction 
 The voltage dependent anion channel (VDAC) is a 283 residue protein located 
in the mitochondrial outer membrane (MOM). It is an aqueous pore and known to be 
primarily responsible for metabolite flux across the MOM[43]. In its open state, at low 
potentials, it is permeable for anions like ATP and ADP. Upon channel closure, at 
high potentials, it undergoes a selectivity change and small cations like Ca2+ can 
pass[44]. Therefore it has a regulatory role in the energy metabolism of the 
mitochondria and is involved in Ca-signalling. Additionally there is substantial 
evidence that VDAC plays an essential role in apoptosis, because it interacts with 
different pro- and anti-apoptotic proteins, like tBid[45] or Bcl-xL[46-48].  
Mitochondria-dependent apoptosis involves the permeabilisation of both 
mitochondrial membranes. This leads to release of proapototic effectors, like 
cytochrome c, apoptosis inducing factor (AIF) and endonuclease G[49]. VDAC has a 
size exclusion limit of approx. 5 kDa and is therefore not permeable to 
cytochrome c[50]. Nevertheless there are strong indications that VDAC is involved in 
the process of mitochondrial membrane permeabilisation. This has been demonstrated 
by preventing the Ca2+-induced permeabilisation of the mitochondrial membrane with 
two polyclonal, specific anti-VDAC antibodies[51]. Theses antibodies recognise 
different VDAC epitopes and inhibit their activity in liposomes. Therefore there are 
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several models, which try to explain the role of VDAC in apoptosis. Several studies 
propose a Ca2+-induced formation of a permeability transition pore (PTP), which is 
big enough to release cytochrome c[48, 52, 53]. It is thought, that VDAC is a key 
component of the PTP[48, 53-55]. Another model proposes, that the OMM becomes 
impermeable to small metabolites in early stages of apoptosis[56]. This would lead to 
accumulation of metabolites in the inter-membrane space of the mitochondrion 
resulting in osmotic swelling and disrupture of the outer membrane. This hypothesis 
is based on the fact that VDAC closes upon binding to the proapoptotic protein 
tBid[45]. Additionally, Bcl-xL, an antiapoptotic protein, stabilises the open 
conformation of VDAC[46]. Nevertheless, this model disagrees with the fact, that upon 
VDAC inhibition mitochondrial membrane permeabilisation is inhibited[51]. If 
osmotic swelling would induce apoptosis, VDAC inhibition should then rather lead to 
membrane permeabilisation. A third model proposes, that apoptosis is mediated by 
large pores formed by Bax alone[57]. However, Bax-induced apoptosis could be 
inhibited by selective anti-VDAC antibodies[51]. This indicates, that Bax induced 
apoptosis is also dependent on VDAC. However, the involvement of VDAC in 
apoptosis is a matter of a strong controversy. Recently Baines et al.[58] demonstrated 
that by eliminating one or more VDAC isoforms either by genetic kockout or with 
knock-down using small interfering RNAs, mitochondria were still able to undergo 
mitochondrial permeability transition in vitro. Yet the authors admit, that cell death in 
the absence of all three VDAC isoforms may also reflect a defect in the metabolic 
function of mitochondria, as the VDACs are the most abundant proteins in the 
mitochondrial outer membrane and maintain homeostasis in ions and other small 
metabolites. 
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 Due to this diversity of functional models structural information of the VDAC 
channel and subsequent determination of its binding sites to different effectors could 
shed light on several aspects of mitochondrial and cellular physiology[59]. A number 
of structural models are proposed in the literature. They are based on sequence 
alignment[44, 60-62] or biochemical data[63-66], like accessibility to either proteases or 
antibodies[64, 66], or electrophysiological investigations of VDAC-mutants[63, 65]. All 
models are consistent in one point. They propose a β-barrel. Nevertheless the models 
disagree in the number of transmembrane β-strands, which vary from 12 to 19. 
Additionally they differ in the position of the predicted[59, 67] N-terminal amphiphilic 
α-helix. Two models predict the helix to be a part of the barrel wall[63, 65]. Other 
models place the helix outside of it[60, 62, 64].  
Further structural information of fungal VDAC could be obtained from 2D 
crystals by electron microscopy (EM)[59]. This study provides the molecular envelope 
with approx. 20 Å resolution. It is consistent with a β-barrel-shape. In general, the 
barrel wall has several irregular features. It has regions were the walls are shorter than 
the average, grooves, a flap or a concave bulge. Furthermore the authors propose, that 
the N-terminal helix is not part of the barrel wall, but extends laterally away from the 
lumen. Additionally membrane crystals could be obtained from the human VDAC, 
but diffraction spots extended only up to 8.2 Å[68]. Similar to the fungal VDAC the 
authors reported, that the barrel wall has a nonuniform height and that the protein 
mass is asymmetrically distributed around the diffusion channel.  
Since a variety of different structural models has been proposed and structures 
are only present at very low resolution there is still a strong need for detailed 
structural information of the VDAC. As described above, membrane proteins are 
challenging objects to study, both for NMR-spectroscopy and X-ray crystallography. 
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This is also demonstrated by the fact, that first structural information of the VDAC 
was present in 1984[69] and until the year 2007 there was no high resolution structure 
of the VDAC available. Since until now common methods for high resolution 
structure determination for the VDAC failed, unconventional methods are required. In 
collaboration with Thomas Meins, Max-Planck-Institute for Biochemistry, Munich, 
we determined the high-resolution structure of the biggest part of human VDAC 
conjointly by NMR-spectroscopy and X-ray crystallography. Only the combination of 
local information from NMR-spectroscopy and global information from X-ray 
crystallography is powerful enough to allow a structure determination of this “badly 
behaved” protein on a reasonable timescale. The human VDAC has indeed a β-barrel 
fold. It is composed of 18 transmembrane β-strands and an amphiphilic α-helix at the 
N-terminus, which points inside the barrel in the direction of the C-terminus. It is the 
first reported structure of a human, mitochondrial integral membrane protein. 
Furthermore I investigated binding sites for different effectors. It was demonstrated, 
that the pro-apoptotic protein Bid and the anti-apoptotic Bcl-xL compete for the same 
binding site. This site is close to the region, where the N- and the C-terminus close the 
β-barrel. In contrast to that, interaction sites for nucleotides are distributed over the 
whole protein.  
 
3.2 Materials and methods 
3.2.1 Production of HVDAC1 for NMR analysis 
 HVDAC1 and its mutants were prepared by Thomas Meins and Christl 
Weyrauch at the Max-Planck-Institute for Biochemistry in Munich. Later samples 
were also prepared by Stefan Becker and Karin Giller at the Max-Planck-Institute for 
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Biophysical Chemistry in Göttingen. This chapter (3.2.1) is taken from the doctoral 
thesis of Thomas Meins[29]. 
 
3.2.1.1 Cloning of HVDAC1-His6 
The His6 tagged version of hVDAC1 was achieved by cloning a vdac1 
containing PCR construct into the pDS56/RBSII-6xHis expression vector yielding 
pDS56/RBSII-VDAC1His6 (Fig. 3) as described in[70]  
 
Fig. 3 pDS56/RBSII-VDACHis6-Sequence 
 
   1 ctcgagaaat cataaaaaat ttatttgctt tgtgagcgga taacaattat aatagattca 
  61 attgtgagcg gataacaatt tcacacagaa ttcattaaag aggagaaatt aactatgaga 
 121 ggatccgctg tgccacccac gtatgccgat cttggcaaat ctgccaggga tgtcttcacc 
 181 aagggctatg gatttggctt aataaagctt gatttgaaaa caaaatctga gaatggattg 
 241 gaatttacaa gctcaggctc agccaacact gagaccacca aagtgacggg cagtctggaa 
 301 accaagtaca gatggactga gtacggcctg acgtttacag agaaatggaa taccgacaat 
 361 acactaggca ccgagattac tgtggaagat cagcttgcac gtggactgaa gctgaccttc 
 421 gattcatcct tctcacctaa cactgggaaa aaaaatgcta aaatcaagac agggtacaag 
 481 cgggagcaca ttaacctggg ctgcgacatg gatttcgaca ttgctgggcc ttccatccgg 
 541 ggtgctctgg tgctaggtta cgagggctgg ctggccggct accagatgaa ttttgagact 
 601 gcaaaatccc gagtgaccca gagcaacttt gcagttggct acaagactga tgaattccag 
 661 cttcacacta atgtgaatga cgggacagag tttggcggct ccatttacca gaaagtgaac 
 721 aagaagttgg agaccgctgt caatcttgcc tggacagcag gaaacagtaa cacgcgcttc 
 781 ggaatagcag ccaagtatca gattgaccct gacgcctgct tctcggctaa agtgaacaac 
 841 tccagcctga taggtttagg atacactcag actctaaagc caggtattaa actgacactg 
 901 tcagctcttc tggatggcaa gaacgtcaat gctggtggcc acaagcttgg tctaggactg 
 961 gaatttcaag caagatctca tcaccatcac catcactaag cttaattagc tgagcttgga 
1021 ctcctgttga tagatccagt aatgacctca gaactccatc tggatttgtt cagaacgctc 
1081 ggttgccgcc gggcgttttt tattggtgag aatccaagct agcttggcga gattttcagg 
1141 agctaaggaa gctaaaatgg agaaaaaaat cactggatat accaccgttg atatatccca 
1201 atggcatcgt aaagaacatt ttgaggcatt tcagtcagtt gctcaatgta cctataacca 
1261 gaccgttcag ctggatatta cggccttttt aaagaccgta aagaaaaata agcacaagtt 
1321 ttatccggcc tttattcaca ttcttgcccg cctgatgaat gctcatccgg aatttcgtat 
1381 ggcaatgaaa gacggtgagc tggtgatatg ggatagtgtt cacccttgtt acaccgtttt 
1441 ccatgagcaa actgaaacgt tttcatcgct ctggagtgaa taccacgacg atttccggca 
1501 gtttctacac atatattcgc aagatgtggc gtgttacggt gaaaacctgg cctatttccc 
1561 taaagggttt attgagaata tgtttttcgt ctcagccaat ccctgggtga gtttcaccag 
1621 ttttgattta aacgtggcca atatggacaa cttcttcgcc cccgttttca ccatgggcaa 
1681 atattatacg caaggcgaca aggtgctgat gccgctggcg attcaggttc atcatgccgt 
1741 ctgtgatggc ttccatgtcg gcagaatgct taatgaatta caacagtact gcgatgagtg 
1801 gcagggcggg gcgtaatttt tttaaggcag ttattggtgc ccttaaacgc ctggggtaat 
1861 gactctctag cttgaggcat caaataaaac gaaaggctca gtcgaaagac tgggcctttc 
1921 gttttatctg ttgtttgtcg gtgaacgctc tcctgagtag gacaaatccg ccgctctaga 
1981 gctgcctcgc gcgtttcggt gatgacggtg aaaacctctg acacatgcag ctcccggaga 
2041 cggtcacagc ttgtctgtaa gcggatgccg ggagcagaca agcccgtcag ggcgcgtcag 
2101 cgggtgttgg cgggtgtcgg ggcgcagcca tgacccagtc acgtagcgat agcggagtgt 
2161 atactggctt aactatgcgg catcagagca gattgtactg agagtgcacc atatgcggtg 
2221 tgaaataccg cacagatgcg taaggagaaa ataccgcatc aggcgctctt ccgcttcctc 
2281 gctcactgac tcgctgcgct cggtctgtcg gctgcggcga gcggtatcag ctcactcaaa 
2341 ggcggtaata cggttatcca cagaatcagg ggataacgca ggaaagaaca tgtgagcaaa 
2401 aggccagcaa aaggccagga accgtaaaaa ggccgcgttg ctggcgtttt tccataggct 
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2461 ccgcccccct gacgagcatc acaaaaatcg acgctcaagt cagaggtggc gaaacccgac 
2521 aggactataa agataccagg cgtttccccc tggaagctcc ctcgtgcgct ctcctgttcc 
2581 gaccctgccg cttaccggat acctgtccgc ctttctccct tcgggaagcg tggcgctttc 
2641 tcaatgctca cgctgtaggt atctcagttc ggtgtaggtc gttcgctcca agctgggctg 
2701 tgtgcacgaa ccccccgttc agcccgaccg ctgcgcctta tccggtaact atcgtcttga 
2761 gtccaacccg gtaagacacg acttatcgcc actggcagca gccactggta acaggattag 
2821 cagagcgagg tatgtaggcg gtgctacaga gttcttgaag tggtggccta actacggcta 
2881 cactagaagg acagtatttg gtatctgcgc tctgctgaag ccagttacct tcggaaaaag 
2941 agttggtagc tcttgatccg gcaaacaaac caccgctggt agcggtggtt tttttgtttg 
3001 caagcagcag attacgcgca gaaaaaaagg atctcaagaa gatcctttga tcttttctac 
3061 ggggtctgac gctcagtgga acgaaaactc acgttaaggg attttggtca tgagattatc 
3121 aaaaaggatc ttcacctaga tccttttaaa ttaaaaatga agttttaaat caatctaaag 
3181 tatatatgag taaacttggt ctgacagtta ccaatgctta atcagtgagg cacctatctc 
3241 agcgatctgt ctatttcgtt catccatagc tgcctgactc cccgtcgtgt agataactac 
3301 gatacgggag ggcttaccat ctggccccag tgctgcaatg ataccgcgag acccacgctc 
3361 accggctcca gatttatcag caataaacca gccagccgga agggccgagc gcagaagtgg 
3421 tcctgcaact ttatccgcct ccatccagtc tattaattgt tgccgggaag ctagagtaag 
3481 tagttcgcca gttaatagtt tgcgcaacgt tgttgccatt gctacaggca tcgtggtgtc 
3541 acgctcgtcg tttggtatgg cttcattcag ctccggttcc caacgatcaa ggcgagttac 
3601 atgatccccc atgttgtgca aaaaagcggt tagctccttc ggtcctccga tcgttgtcag 
3661 aagtaagttg gccgcagtgt tatcactcat ggttatggca gcactgcata attctcttac 
3721 tgtcatgcca tccgtaagat gcttttctgt gactggtgag tactcaacca agtcattctg 
3781 agaatagtgt atgcggcgac cgagttgctc ttgcccggcg tcaatacggg ataataccgc 
3841 gccacatagc agaactttaa aagtgctcat cattggaaaa cgttcttcgg ggcgaaaact 
3901 ctcaaggatc ttaccgctgt tgagatccag ttcgatgtaa cccactcgtg cacccaactg 
3961 atcttcagca tcttttactt tcaccagcgt ttctgggtga gcaaaaacag gaaggcaaaa 
4021 tgccgcaaaa aagggaataa gggcgacacg gaaatgttga atactcatac tcttcctttt 
4081 tcaatattat tgaagcattt atcagggtta ttgtctcatg agcggataca tatttgaatg 
4141 tatttagaaa aataaacaaa taggggttcc gcgcacattt ccccgaaaag tgccacctga 
4201 cgtctaagaa accattatta tcatgacatt aacctataaa aataggcgta tcacgaggcc 
4261 ctttcgtctt cac 
 
3.2.1.2 Site directed mutagenesis of HVDAC1-His6  
 Point mutations were introduced into the pDS56/RBS2-His6 cloned HVDAC1 
gene with the QuickChange® site-directed mutagenesis kit (Stratagene, La Jolla, 
USA), which used essentially as recommended by Stratagene™. The primers for 
introduction of the indicated point mutations are summarised in Table 9. Double and 
multi mutants were achieved one after another by introduction of a further point 
mutation in already mutated plasmids. Successful mutagenesis was verified by DNA 
sequence analysis.   
 











C235S nativ 5’-gattgaccctgacgcctccttctcggctaaagtg-3’ 5’-cactttagccgagaaggaggcgtcagggtcaatc-3’ 
C130S / C235S C130S 5’-gattgaccctgacgcctccttctcggctaaagtg-3’ 5’-cactttagccgagaaggaggcgtcagggtcaatc-3’ 
S49C / C130S / C235S C130S / C235S 5'-gaatttacaagctcaggctgcgccaacactgagaccacc-3' 5'-ggtggtctcagtgttggcgcagcctgagcttgtaaattc-3' 
S263C / C130S / C235S C130S / C235S 5'-gtattaaactgacactgtgcgctcttctggatggcaag-3' 5'-cttgccatccagaagagcgcacagtgtcagtttaatac-3' 
V20C / C235S  C235S 5’-caaatctgccagggattgcttcaccaagggctatg-3’ 5’-catagcccttggtgaagcaatccctggcagatttg-3’ 
 
3.2.1.3 Expression of HVDAC1-His6  
 All solutions, buffers and media were sterilised by filtration. Applied laboratory 
ware for bacterial cultivation was heat sterilized at 180 °C for 3 h prior to utilization. 
All antibiotics were dissolved in 70% ethanol and stored at -20 °C until use. 
Antibiotics containing media were supplemented with 100 µg/ml ampicillin and if 
indicated additionally with 25 µg/ml kanamycin shortly before use. Antibiotics 
containing media are labelled in the following by the indices [media]Amp or 
[media]Amp/Kan. If not indicated otherwise all cultures were grown in 100% deuterium 
oxide (D2O; OntarioPower, Pickering, Canada). 
 
3.2.1.3.1 Expression of 2H, 15N and 13C labelled HVDAC1-His6  
 2H, 15N and 13C labelled HVDAC1-His6 was expressed in the Escherichia coli 
strain M15 [prep4] (Quiagen, Hilden; phenotype: E. coli K12 NaIS StrS RifS Thi- Lac- 
Ara+ Gal+ Mtl- F- RecA+ Uvr+ Lon+; carries prep4 (lacI encoding repressor plasmid)). 
Cells were grown in M9 minimal medium (see Table 6). According to labelling 
requirements, ammonium chloride and glucose have been replaced by 15N-
Ammonium Chloride (15N, 99%; Larodan Fine chemicals, Malmö, Sweden) and 13C-
D-Glucose (13C6, 99%; D7, 97-98%;  Larodan Fine chemicals, Malmö, Sweden) in 
the expression cultures. Labelled compounds containing media are in the following 
indicated as 15N-[media] and 15N 13C-[media], respectively.  
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 Pre-cultures of PDS/RBSII-VDAC1His6 transformed E. coli DM15 (prep4) 
cells were initially grown on non-deuterated M9Amp/Kan at 37°C and 200 rpm 
overnight. In order to adapt the culture to D2O based media the cells were 
consecutively inoculated to 2H-M9Amp/Kan with a D2O content of 70, 80 and at last 
100%. Each culture was thereby incubated for 24 h at 37°C and 200 rpm. After 
adaption, 1.5 l expression cultures of [2H,15N]-M9Amp/Kan or [2H,15N,13C]-M9Amp/Kan 
were inoculated to an OD600 of 0.1 AU and incubated in 5 l baffled Erlenmeyer flasks 
at 37 °C and 200 rpm. Adding IPTG to a final concetration of 1 mM at an OD600 of 
0.8 AU induced HVDAC I-His6 inclusion body formation. Cells were harvested 8 h 
after induction by centrifugation at 5000 g for 30 min, shock frozen in liquid N2 and 
stored at -70 °C..  
 
3.2.1.3.2 Expression of selective labelled HVDAC1-His6  
 Selective labelled HVDAC1-His6 was expressed in the amino transferase 
negative Escherichia coli strain DL39 [prep4]. E. coli DL39 [prep4] was constructed 
by transformation of E. coli DL39 CGSC#:6913 (CGSC, Yale, USA; phenotype: F- 
araD139 D(argF-lac)Ui69 rpsL150 relA1 thiA zei-724: :Tn10 glpR gyrA D(glpT-
glpA)593) with the prep4 plasmid via electroporation. The prep4 plasmid was purified 
from E. coli M15 [prep4] (Quiagen, Hilden) overnight cultures using the Qiaprep® 
Miniprep protocol as recommended by Quiagen™.  
 E. coli DL39 was grown in algal extract supplemented (AES) media[71] (Table 
10, 11, 12). Selective labelling was achieved by adding the respective labelled amino 
(Table 13) acids 15 min prior to induction in a tenfold access compared to the algal 
extract source to the expression culture.  
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                        Table 10 Algal extract supplemented media (AES media)[71] 
substance  amount 
M9 Salt deuterated (10x) v.s.   100 ml 
Glucose (10% w/v)  10 ml 
MgSO4 (0.1 M)  20 ml 
L-leucine$  0.25 g 
Vitamin mix  5 ml 
Trace element solution  1 ml 
Deuterated algal lysate amino acid mixture (10% w/v)*  10 (30) ml# 
D2O Ad up to 1000 ml 
*) The deuterated algal lysate amino acid mixture was produced and characterised at the MPI of 
Biochemistry; Dept. of Membrane Biochemistry as described in[72]. #) Preparatory cultures and 
overproduction cultures contained 30 ml and 10 ml of the algal extract, respectively. $) The 
overproduction culture for selective leucine labelling contained no unlabeled leucine.  
 
                     Table 11 Vitamin mix 
substance  amount 
Thiamine (B1)  100 mg 
d-biotin (H)  20 mg 
Choline bromide  20 mg 
Folic acid (B9)  20 mg 
Niacin amide (B3)  20 mg 
d-panthotenic acid (B5)  20 mg 
Pyridoxal (B6)  20 mg 
Riboflavin (B2)  20 mg 
Tris-base (saturated)  0.2 ml 
D2O Ad up to 100 ml 
 
                       Table 12 Trace element solution 
substance  amount 
HCl (5M)  16 ml 
FeCl2 × 4H2O  10 g 
CaCl2 × 2H2O  370 mg 
H3BO3  130 mg 
CoCl2 × 6H2O  36 mg 
CuCl2 × 2H2O  8 mg 
ZnCl2  680 mg 
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substance  amount 
Na2MoO4 × 2H2O  1.21 g 
MnCl2 × 4H2O  80 mg 
D2O Ad up to 1000 ml 
  
                     Table 13 Labeled amino acids 
Amino Acid (AA)  Amount AA per 500 ml 
expression culture    
L-Methionine (15N, 95-99%)*  90 mg 
L-Leucine (U-13C6, 98%; 15N)*  80  mg 
L-Isoleucine (U-13C6,98%; 15N, 98%)*  50  mg 
L-Phenylalanine (15N, 98%)*  150  mg 
L-Valine (U-13C5,98%; 15N)*  70  mg 
DL-Lysine 2HCl (15N2, 98%)#  250  mg 
L-Tyrosine (15N, 98%)#  80  mg 
L-Arginin HCl (15N4, 98%)#  100  mg 
DL-Alanine (15N, 98%)$  250  mg 
Amino acids were purchased from *) Euriso-top, Saint-Aubin Cedex, France. #) OMNI Life Science, 
Bremen. $) Sigma-Aldrich, St. Louis, USA.  
 
Pre-cultures of PDS56/RBSII-VDAC1His6 transformed E. coli DDL39 
(prep4) cells were initially grown overnight in partially deuterated AESAmp/Kan at 37°C 
and 200 rpm. In order to adapt the culture to D2O based media the cells were 
consecutively inoculated to AESAmp/Kan with a D2O content of 70, 80 and at last 
100%. Each culture was thereby incubated for 24 h at 37°C and 200 rpm. After 
adaption, 2.0 l pre-cultures of AESAmp/Kan were inoculated to an OD600 of 0.1 AU and 
incubated in 5 l buffled Erlenmeyer flasks at 37 °C and 200 rpm. At an OD600 of 
0.5 AU, cells were harvested by centrifugation at 5000 g for 30 min and resuspended 
in 500 ml 2H-M9. The cells were harvested again at 5000 g for 30 min and 
resuspended in 500 ml AESAmp/Kan for overproduction. The expression culture was 
further incubated in 2.5 l buffled Erlenmeyer flasks at 37 °C and 200 rpm. After 
45 min of incubation the culture was supplemented with the labelled amino acid and 
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further 15 min later with IPTG to a final concentration of 1 mM. Cells were harvested 
12 h after induction by centrifugation at 5000 g for 30 min, shock frozen in liquid N2 
and stored at -70 °C until further use.  
3.2.1.4 Purification and refolding of HVDAC1-His6  
3.2.1.4.1 Purification of HVDAC1-His6  inclusion bodies 
Cells were resuspended in buffer 1 (100 mM Tris/HCl pH 7,5; 1 mM EDTA; 5 
mM DTT, 100 mM NaCl, 0.2 mM PMSF) and incubated with 0,1 mg/ml Lysozym for 
0.5 h. After addition of 1 mM MgCl2, 0.1 mM MnCl2 and 0.05 mg/ml DNAse I the 
cells were finally lysed by two French press passes. Inclusion bodies were harvested 
by centrifugation at 5000 x g for 30 min at 4 °C. The pellet was resuspended in 
buffer 1 containing 3% w/v OPOE, stirred for 2 h at room temperature and pelleted by 
centrifugation at 5000 x g for 30 min at 4 °C followed. Finally the pellet was washed 
with buffer 1 to remove detergent contaminations. Inclusion bodies were then 
solubilized in buffer 2 (100 mM Tris/HCl pH 7,5; 1 mM EDTA; 5 mM DTT, 6 M 
guanidinium chloride) and insoluble material was removed by centrifugation at 
100 000 x g for 45 min. The denatured HVDAC I-His6 protein containing supernatant 
was adjusted with buffer 2 to 15 mg/ml and stored at -70°C. 
3.2.1.4.2 Refolding of denatured HVDAC1-His6 
HVDAC I-His6 refolding was performed at 4 °C by dropwise dilution of 
solubilized protein in buffer 3 (100 mM Tris/HCl pH 8,0; 1 mM EDTA; 5 mM DTT, 
1% w/v LDAO) until a final concentration of 0.6 M guanidinium chloride was 
reached. The resulting protein solution was stirred over night at 4 °C, centrifuged at 
100 000 x g for 45 min and finally 5-fold diluted with buffer 4 (100 mM phosphate 
buffer pH 7.5). 
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3.2.1.4.3 Purification of refolded HVDAC1-His6 
The HVDAC I-His6 protein was bound to a 5 ml Ni2+-Sepharose HP column 
(GE Healthcare), washed with 100 ml buffer 5 (20 mM phosphate buffer pH 7,5; 20 
mM imidazole; 0,2% LDAO) and afterwards eluted by 50 ml buffer 6 (20 mM 
phosphate buffer pH 7,5; 300 mM imidazole; 0,2% LDAO).  
 
3.2.1.5 Preparation of HVDAC1-His6 NMR samples 
HVDAC I-His6 containing fractions were verified by SDS PAGE and pooled. 
After determination of the protein concentration at 280 nm wavelength, the 
HVDAC1-His6 sample was supplemented with a certain amount of a 15% LDAO 
solution, depending on the HVDAC1-His6 concentration. The LDAO volume was 
adjusted in a way that after concentration of the protein to 0.6 mM the LDAO 
concentration was 6%. After LDAO addition the sample was dialysed against buffer 7 
(25 mM BisTris/HCl pH 6.5, 0.2% LDAO) for 4 h and concentrated with a centrifugal 
filter device (Amicon Ultra- 30k, Millipore) to a protein content of 0.6 mM 
HVDAC I-His6. NMR samples were further supplemented with 0.05% sodium azide 
and stored at 4 °C until measurement. 
 
3.2.2 NMR samples 
 NMR spectra of HVDAC were recorded from different samples. They all 
contained 0.6 mM HVDAC in an aqueous solution of 25 mM BisTris buffer, pH 6.8, 
and approx. 250 mM Lauryldimethylamine-oxide (LDAO), with 10% D2O. 
Assignment spectra were measured on a perdeuterated and 15N/13C-labelled HVDAC 
sample. 15N-edited NOESY spectra were measured from a perdeuterated and 15N/13C 
labelled and an approx. 75% deuterated 15N-labelled sample. Additionally the 75% 
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deuterated sample was lyophilised and redissolved in 100% D2O. TROSY-HSQC 
spectra were measured from different amino acid specific 15N and 15N/13C-labelled 
samples, respectively: 2H-HVDAC-15N-Met-15N/13C-Leu-15N/13C-Ile, 2H-HVDAC-
15N13C-Val, 2H-HVDAC-15N-Tyr, 2H-HVDAC-15N-Ala, 2H-HVDAC-15N-Phe, 2H-
HVDAC-15N-Lys, 2H-HVDAC-15N-Arg. Furthermore TROSY-HSQC spectra were 
measured from different HVDAC mutants: C130S, C235S, C235SV20C, 
C235SL34C, C235SC130SS49C, C235SC130SS263C. All mutants were approx. 
75% deuterated and 15N-labelled. 
 
3.2.3 NMR Spectroscopy 
 All spectra were recorded at 37 °C on either Bruker 600, 800 or 900 MHz 
spectrometers equipped with cryogenic probeheads. Three different TROSY-type 
triple resonance experiments were recorded: HNCA, HNCO and multiple quantum 
(mq) HNCOCA. Additionally 15N-edited 1H-1H NOESY-TROSY[73] spectra and an 
mixed-time parallel evolution HMQC-NOESY[74] spectrum were recorded. The 
summary of which spectrum was measured on which sample can be found in 
Table 14. Paramagnetic relaxation enhancement (PRE) data were gained by 
measuring TROSY-HSQC spectra of MTSL-labelled single cysteine mutants (see 
2.2.3.8) of HVDAC and the corresponding reference spectrum without MTSL. 
Dynamics were studied by measuring steady state heteronuclear 15N{1H}-NOEs in a 
TROSY version[75] in an interleaved manner. The molecular weight of the 
protein/micelle complex was estimated by recording a 15N-edited 1D T1ρ experiment. 
The NMR data were processed and analyzed using NMRPipe, NMRDraw[76] and 
SPARKY (T. D. Goddard and D. G. Kneller, SPARKY 3, University of California, 
San Francisco, CA). 
 59 
Table 14 Assignment- and NOESY-spectra  
Sample Experiment  Experimental details Spectrometer Remarks 
2H(99%)/13C/15N TROSY-HNCA 45x25x512 pts, NS 60 900cryo  
2H(99%)/13C/15N TROSY-HNCA 47x25x512 pts, NS 56 900cryo distinguish noise peaks 
2H(99%)/13C/15N TROSY-HNCA 42x18x512 pts, NS 80 800cryo optimised to 2JN-Cα 
2H(99%)/13C/15N TROSY-HNCO 30x30x512 pts, NS 36 600cryo  
2H(99%)/13C/15N mq-TROSY-
HNCOCA 
12x20x512 pts, NS 268  600cryo  
2H(99%)/13C/15N 15N-NOESY-
TROSY 
94x20x512 pts, NS 32, 
160 ms mixing time 




60x25x512 pts, NS 48, 
100 ms mixing time 






53x25x512 pts, NS 48, 
180 ms mixing time 
900cryo D2O exchange 
2H(50%)/15N 15N-NOESY-
TROSY 
107x19x512 pts, NS 32, 






91x25x512 pts, NS 26, 
120 ms mixing time 
800cryo  
 
3.2.4 Structure determination by NMR Spectroscopy and X-ray 
crystallography 
 The backbone resonance assignment of the NMR-spectra was achieved based 
on Cα chemical shifts and interstrand HN-HN NOEs. Amino acid specific 15N-
labelling, chemical shift perturbations due to mutations and PRE data helped with the 
assignment process. Based on the interstrand HN-HN NOEs a topology model for the 
backbone with atomic resolution was built.  
Parallel to the NMR-investigations HVDAC 1 was crystallised by Thomas 
Meins for X-ray structure determination. The used SeMet and Pt MAD data sets were 
collected at the ESRF beamlines ID29 and ID23-1. During the data collection, 
crystals were maintained at 100 K by a gaseous nitrogen stream. Diffraction data was 
integrated with MOSFLM[77], XDS[78] and d*TREK[79]. Data scaling and merging was 
done with SCALA[80] and prepared by SHELXC for heavy atom substructure 
determination in SHELXD[81]. Refinement of Se and Pt sites as well as the phase 
probability calculations were carried out in SHARP[82]. Subsequent density 
modification using different values for solvent content was done with SOLOMON[83]. 
Further phase improvement was attempted using inter-crystal averaging of 
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isomorphous datasets with DMMULTI[84]. Map interpretation was started by placing 
poly-alanine fragments of high-resolution beta barrel protein structures (PDB ID 
1PRN, 2F1C) in B-factor sharpened[85] electron density maps with MOLREP[86]. 
Subsequent manual placement of further beta-sheets and iterative model building and 
geometry refinement was performed with O[87] and COOT[88], respectively. This 
resulted in a poly-alanine structural model of HVDAC. The alanines were exchanged 
manually to the correct amino acid based on the NMR-derived topology model. The 
starting point for this exchange was the selenium site M132. The rest of the molecule 
was then oriented and remodelled according to the interstrand HN-HN NOEs, which 
were translated in hydrogen bonds and the selenium sites, M158 and M230 in COOT. 
Positioning of the predicted N-terminal helix was done by fitting a model helix into a 
corresponding portion of the electron density map. Orientation and fitting of the α-
helix was verified through the selenium site of M13. 
 
3.3 Results 
3.3.1 NMR Resonance Assignment Strategy 
Because of strong relaxation, the standard heteronuclear (1H, 13C, 15N) 
assignment strategy[89] was very difficult to use. Out of this standard experiments the 
HNCA and the HNCO could be recorded. Therefore sequential information was only 
available for CA chemical shifts. Problematic was the fact, that only 50 % of the 
expected CAi-1 peaks were present in the HNCA spectrum. Therefore, based on the 
HNCA spectrum, an overall sequential resonance assignment of 50 % could 
maximally be achieved. To circumvent this, a modified version of the HNCA was 
recorded. Usually in an HNCA the insensitive nuclei enhancement by polarisation 
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transfer (INEPT) from N to CA is optimised to the 1JN-CA coupling. This is done by 
maximising the term, in which the 1JN-CA is modulated by the sinus:  
2NyCAz Sin[π · 1JN-CA · t] · Cos[π · 2JN-CA · t] · Exp[-t/T2]                 (13). 
T2 is the transverse relaxation time, and t is the INEPT delay. To enhance the CAi-1 
peak, the term, in which the 2JN-CA is modulated by the sinus, has to be maximised:  
2NyCAz Sin[π · 2JN-CA · t] · Cos[π · 1JN-CA · t] · Exp[-t/T2]               (14). 
1JN-CA was set to 10.9 Hz, 2JN-CA to 8.3 Hz. T2 was estimated from T1ρ measurements 
and was set to 25 ms. This lead to a maximum at t = 15.6 ms. The resulting HNCA 
spectrum displayed 60 % of the expected CAi-1 peaks. Further improvement in the 
number of CAi-1 peaks could be obtained by recording a multiple quantum version of 
a TROSY-HNCOCA, which was kindly provided by Roland Riek (Salk Institute, La 
Jolla). This finally led to 70 % of the expected CAi-1 peaks, which gives rise to a 
sequential resonance assignment limit of 70 %, based on the HNCA.  
 The chemical shift dispersion of CA’s is approx. 21 ppm[38]. Compared to the 
approx. 55 ppm dispersion of the CB’s this is rather small. This leads to the fact that 
CA chemical shifts appear for the most amino acids in a very similar range. 
Consequently the amino acid type cannot be unambiguously established from CA 
chemical shifts alone. This problem was solved by the preparation of different amino 
acid specific 15N or 15N/13C-labelled samples. Initially a sample design as proposed by 
Shi et al.[90] was planned. They choose two amino acids for 15N/13C-labelling, which 
can be readily distinguished by their carbon chemical shifts. Additionally, a third 
amino acid was 15N-labelled. With such a sample the amino acid type of three 
residues can be established. Furthermore sequential information can be gained for the 
two 15N/13C-labelled residues from e.g. HNCA spectra, if they appear pairwise in the 
sequence. Based on this scheme a 15N-Met, 15N/13C-Leu and 15N/13C-Ile (ILM) 
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labelled HVDAC sample was prepared. Unfortunately the concentration of 15N and 
13C labels was too low to record a HNCA spectrum. Nevertheless, the 15N-TROSY-
HSQC spectrum of the ILM labelled sample, which ran for 35 h, exhibited 41 of the 
43 expected peaks (95 %). Therefore following selectively labelled samples contained 
only 1 amino acid, which was 15N-labelled (see 3.2.2). Figure 4 shows the overlay of 
the TROSY-HSQC spectra for the different selectively labelled samples.  
 
Fig. 4 Overlay of the TROSY-HSQC spectra for the amino acid specific labelled 
HVDAC samples.  
 
 A further problem, which is caused by the low dispersion of the CA chemical 
shifts, is the strong ambiguity in the sequential information. Every CA frequency 
appears very often in the spectrum (Fig. 5). Therefore the major effort during 
assignment was to exclude wrong connectivities. On the one hand this was done 
based on the selectively labelled samples, on the other hand mutations were helpful, 
which caused chemical shift perturbations in the NMR-spectra. These perturbations 
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appear only for residues, which upon mutation experience a different electronic 
environment, i.e. residues close to the mutation site. Moreover, single cysteine 
mutants have been modified with the paramagnetic spin label MTSL (2.2.3.8). Due to 
paramagnetic relaxation enhancement, peak intensities of residues, which are closer 
than 20-25 Å to the spin label, are reduced[13]. This helped both for the sequential 
assignment and for the establishment of the topology model. 
 
 
Fig. 5 Strips from the TROSY-HNCA spectrum. The blue bar points out peaks with, 
in the range of the error, similar CA chemical shifts.  
 
 Mainly, the topology model relied on HN-HN interstrand long range NOE’s. 
Additionally the HN-HN NOE’s were used to verify the sequential assignment. If 
inter-strand NOE’s could be established, the sequential assignment was considered to 
be reliable. To maximise the information from NOE’s 5 15N-edited NOESY spectra 
were recorded on different samples (see Table 14). The samples were either 50, 75 or 
99 % deuterated. The NOESY-TROSY spectrum of the 99% deuterated sample 
displayed only HN-HN crosspeaks, the 75% had additional crosspeaks to aromatic 
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and very few to HA protons. Due to strong relaxation, no additional information was 
gained from the 50% deuterated sample. Initially it was prepared to observe 
sequential HN-HA crosspeaks. To reduce overlap and determine residues, which are 
involved in tight hydrogen bonds, one NOESY-TROSY was recorded in 100% D2O. 
Because of rapid exchange of the amide protons with the solvent only 19 crosspeaks 
could still be observed. The NOESY-TROSY spectra were recorded either with low 
resolution and higher sensitivity or vice versa. In addition to the NOESY-TROSY 
spectra one HMQC-NOESY[74] spectrum was recorded on the C235SV20C mutant of 
HVDAC. In this spectrum the frequency labelling of the NOE-crosspeaks takes place 
in the direct dimension and therefore the crosspeak-frequency is very well resolved.  
Only the combination of all information from the different assignment and 
NOESY spectra and from various selectively labelled and mutant samples made the 
assignment process and the establishment of the topology model possible.  
 
3.3.2 Resonance Assignment and Secondary Structure 
The molecular weight of the HVDAC/LDAO complex was estimated by T1ρ 
measurements (see 2.2.5.5) to be approx. 100 kDa. For a complex of that size, the 
15N TROSY-HSQC of HVADC displayed excellent chemical shift dispersion 
indicative of a well folded protein composed mainly of β-strands (Fig. 6). Out of the 




Fig. 6 15N TROSY-HSQC spectrum of 0.6 mM HVDAC in approx. 250 mM LDAO 
micelles in 25 mM BisTris buffer, pH 6.8. The spectrum was recorded on a 900 MHz 
spectrometer equipped with cryogenic probehead at 310 K. 
 
In total 56 % of the backbone resonances were assigned (see Appendix A). Since only 
86 % of the peaks were observed in the TROSY-HSQC this corresponds to 65 % of 
all possible assignments. In general the majority of assigned residues are in the C-
terminal two thirds of the HVDAC, therefore the N-terminal third is less well defined. 
The assignment process was aided by site-directed mutations. The chemical shift 
perturbations of assigned residues upon mutations are exemplarily shown for the 
mutants C130S and C235S in Figure 7. Strong perturbations are observed for the 
mutated residue and its direct neighbours. Further away from the mutation site the 
perturbations decrease but appear again periodically. A linear anti-parallel β-strands 
fold can explain this behaviour. In such a case residues in adjacent β-strands cause the 




Fig. 7 Chemical shift changes of HN and N upon mutation to either C130S or C235S. 
Only assigned residues are plotted. 
 
Secondary structure elements were identified by the difference of the observed CA 




Fig. 8 Secondary chemical shifts of CA and C’ for HVDAC plotted against the 
residue number.  
 
The majority of secondary chemical shifts are negative. These negative shifts 
cumulate in most cases. Consequently HVDAC consists mainly of β-strands. Small 
positive values found between the β-strands indicate loop regions. The biggest 
positive values are located in the N-terminus, which agrees with the predicted N-
terminal α-helix.  
 
3.3.3 Solvent Accessibility And Dynamics 
 In order to probe the solvent accessibility of single residues in HVDAC, a D2O 
exchange experiment was performed (see 2.2.5.3). The first TROSY-HSQC spectrum 
was recorded 1 h after dissolving the sample in D2O. It displayed 91 peaks, which is 
32 % of all resonances (Fig. 9). Out of these 91 resonances 90 have been assigned. 
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Only three of them correspond to residues, which are located in the N-terminal third 
of HVDAC. These are L29, I30 and K31. This indicates, that hydrogen bonds in the  
 
Fig. 9 TROSY-HSQC of HVDAC in 100 % D2O, recorded 1 h after solvation in D2O. 
Assigned residues are labelled with the one letter amino acid code. 
 
N-terminal third of HVDAC are weaker than in the rest of the protein. This implies, 
that the secondary structure is less pronounced, or that enhanced flexibility can be 
observed for the N-terminal third of HVDAC. The D2O-exchange data correlate very 
well with secondary structure determined by secondary chemical shift analysis (Fig. 
10a). In most cases residues with strong negative secondary chemical shift do not 
exchange with D2O after 1 h. This indicates a β-strand. In all cases where assignment 
is available, β-strands are flanked by residues, which exchange with water after 1 h. 
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This corresponds to loops or turns, which connect the β-strands. From this analysis 13 
β-strands can unambiguously be established. These are between residue 286 – 281, 
266 – 260, 252 – 246, 240 – 236, 228 – 223, 212 – 205, 197 – 193, 188 – 183, 176 –
 172, 158 – 152, 148 – 142 and 132 – 126. An additional β-strand can be identified 
between residue 103 and 98. In this strand only two residues, T101 and F102, don’t 
exchange with D2O after 1 h. This points out that already this strand is more flexible 
than the others. Furthermore, three fragments of β-strands can be identified in the N-
terminus. These are between residue 91 – 89, 51 – 48 and 33 – 31. In these fragments 
only three residues don’t exchange with D2O after 1 h. These are V90, T89 and K32. 
This again points out the enhanced flexibility of the N-terminus.  
 Additional proof for enhanced N-terminal flexibility stems from the 
measurement of heteronuclear NOEs (2.2.5.6) (Fig. 10b). Overall 62.5 % of the 
steady state heteronuclear 15N{1H}-NOEs are above 0.7, indicating a well-ordered 
protein in solution. Residues with 15N{1H}-NOEs above 1 are peaks with low signal 
to noise ratio. A more detailed analysis reveals, that for 61 % of the residues in the N-
terminal third (from 1-96) and for 65 % of the unassigned residues the 15N{1H}-NOEs 
are below 0.7 (see Table 15). Since the majority of the assignments is in the C-
terminus, this demonstrates that the N-terminal third of HVDAC is more mobile, than 
the rest of the protein. A closer inspection of the C-terminal part of HVDAC reveals, 
that 62 % of the residues with higher flexibility are located in loop regions. Most 
pronounced is the loop between residues G268 and L278.  
 
           Table 15 15N{1H}-NOE values for HVDAC parts 
 15N{1H}-NOEs below 0.7 
N-terminus (1 – 96) 61 % 
C-terminus (97 – 288) 33 %  (of these are 62 % located in loops) 




Fig. 10 a) Secondary chemical shifts of CA and C’ for HVDAC plotted against the 
residue number. Red bars indicate residues, which exchange with D2O after 1 h, blue 
bars, which don’t exchange with D2O after 1 h. Black arrows indicate β-strands, grey 
arrows potential β-strand fragments. b) The 15N{1H}-NOEs plotted against the 




3.3.4 Topology model 
 The topology model of the β-strands given in Figure 11 is based on HN-HN 
NOE connectivities, secondary chemical shift analysis and the amide proton 
exchanging behaviour with D2O. The topology could  unambiguously  be  determined  
 
 
Fig. 11 Topology model of HVDAC. Amino acids are given in the one letter code. 
Red letters denote assigned, black letters unassigned residues. Black lines indicate 
HN-HN NOE connectivities. A check on top of the line refers to NOE-peaks, which 
are also present in 100 % D2O. The abbreviation “n.r.” on top of the line stands for 
not resolved NOEs, “aro” indicates NOEs of aromatic protons. Residues bordered 
blue, or light blue do not exchange with D2O after 1 h. Residues in squares are part of 
a β-strand. β-strands are based on HN-HN NOE connectivities, secondary chemical 
shift analysis and the amide proton exchanging behaviour with D2O. The β-strands 
could theoretically extend further because negative secondary chemical shifts are also 
found for some residues, which exchange rapidly with D2O. Strands given in light 
grey and light blue feature increased flexibility. Residues in yellow boxes have side 
chains pointing towards the hydrophobic membrane, whereas white squares indicate 
side chains facing the hydrophilic channel pore. The ß-strands are numbered from the 
N- to the C-terminus, numbers are given in magenta. The helix is based on the 
PSIPRED[91, 92] prediction and secondary chemical shift analysis.  
 
for the 14 C-terminal β-strands. They are basically similar to the ones given in 5.3.3, 
including the more flexible β-strand between residue 98 and 103. These 14 β-strands 
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occupy 2/3 of the sequence. Theoretically the β-strands could extend further because 
negative secondary chemical shifts are also found for some residues, which exchange 
rapidly with D2O. Additionally 2 N-terminal β-strands were localised between residue 
55 – 58 and 29 – 33, but the NOE connectivities are not unambiguous (Fig 11). 
Furthermore the secondary chemical shifts for the strand between 55 and 58 are not 
negative, except for V57. The helix is based on a prediction by the PSIPRED 
server[91, 92] (Fig. 23) and secondary chemical shift analysis.  
 
3.3.4.1 Mutations that probe the position of the N-terminal helix 
The position of the N-terminal helix was probed by the mutation V20C and 
the corresponding chemical shift perturbation in the TROSY-HSQC spectrum. The 
residue V20 was predicted to be part of the α-Helix. The strongest perturbations upon 
this mutation are observed for residues close to V20. An additional cluster of strong 
effects can be located around residue A226. This region is indicated by a blue 
ellipsoid in Fig. 12. Additional effects can be observed for residues located in loops, 
opposite to the helix. Residues that show upon mutation chemical shift changes of HN 
and N bigger than 0.05 ppm are A17, R18, K23, G26, N114, I141, R166, T207, 
A226, Y228, A238, L262, Q285 (they are bordered in dark green in Fig. 12). 
Residues with perturbations between 0.035-0.05 ppm are N40, K112, A137, A208, 




Fig. 12 Effects due to the mutation V20C in the TROSY-HSQC spectrum mapped on 
the topology model of HVDAC. The green circle denotes the mutation site. Residues 
bordered dark green show chemical shift changes of HN and N bigger than 0.05 ppm, 
for residues bordered in light green the perturbations are between 0.035-0.05 ppm. 
The blue ellipsoid highlights the most clustered effects. The rest of the nomenclature 
is the same as in Figure 11. 
 
Additionally PRE data of the mutant C130S (Fig. 13) probed the helix position. In 
this case the MTSL spin label was at the position C235. The signal to noise ratio of 
the TROSY-HSQC was very low. Therefore only peaks, which were broadened 
beyond detection, were actually counted as an effect. Residues specifically broadened 
beyond detection are: A17, R18, I30, G48, K56, K118 - Y121, G129, D131, G143, 
A144, L205 - A208, A225 - D231, A234 – K239, S244, G249 – T251, L260, L262 – 
A264, G281, L282, Q285 (bordered dark blue in Fig. 13). Additionally some residues 
were unspecifically broadened beyond detection. These are residues which are not 
broadened beyond detection in the case of the wild type HVDAC with MTSL labels 
at positions C130 and C235. These residues are: Y25, I117, S196, L248, Q252, T261, 
K277, L278 (bordered light blue in Fig. 13). Therefore most effects are located in the 
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region around the mutation site. However, additionally the resonances of A17 and 
R18, which are located in the N-terminal helix, are broadened beyond detection.  
 
 
Fig. 13 Effects due to spin labelling of the mutant C130S with MTSL at the position 
C235 in the TROSY-HSQC spectrum mapped on the topology model of HVDAC. 
The green circle denotes the position of the MTSL. Peaks of residues bordered dark 
blue are specifically broadened beyond detection. Peaks of residues bordered in light 
blue are unspecifically broadened beyond detection. The rest of the nomenclature is 
the same as in Figure 11.  
 
3.3.5 Structure Determination of human VDAC by NMR and X-ray 
crystallography 
In solution the N-terminus of HVDAC shows an enhanced flexibility, which 
leads to exchange broadening of the NMR signals. Thus for this part only partial 
assignment was possible, which was insufficient to build a reliable two-dimensional 
model. However, HN-HN NOE-crosspeaks could be unambiguously assigned for the 
14 C-terminal β-strands. Therefore the β-barrel fold for this part of the protein could 
be established. Consequently a two-dimensional model with atomic resolution for the 
backbone was built. This was fitted into the electron density map, based on the 
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selenomethionine positions M132, M158 and M230. This resulting 3D-model is 
reliable because starting from any of the selenomethionine positions in the electron 
density and following the hydrogen bonds according to the NMR-topology model 
always results in the correct two other seleniummethionine positions in the electron 
density. Additionally all loops determined by NMR fit in the electron density 
envelope, if density is present at the corresponding position. Due to a resolution of 
4 Å building of this 3D-model of HVDAC would not have been possible without the 
NMR-topology model. Spare electron density, which does not belong to the 14 β-
strands defined by NMR, gives  rise  to  4  additional  N-terminal  β-strands  (Fig. 14).  
 
 
Fig. 14 NMR/X-ray structure of human VDAC. A) The backbone is shown as a 
string. Red indicates residues which exchange with D2O after 1 h, blue indicates 
residues which don’t exchange with D2O after 1 h. Electron density, which forms 4 β-
strands in addition to the NMR-model, is shown in yellow.  
 
In the present structure these sheets are between residues 27 – 35, 54 – 64, 67 – 76 
and 84 – 93. This is consistent with the two ambiguous β-strands between residues 
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31 – 33 and 55 – 58 and with the β-strand-fragment between residue 31 and 33 
determined by NMR. The structure of human VDAC displays a typical β-barrel fold. 
It consists of 18 anti-parallel β-strands, which construct the β-barrel, and a N-terminal 
α-helix, which is located inside the barrel, close to the C-terminus (Fig. 15). The 
position of the helix is based on the electron density map. It is in agreement with the 
NMR-data, because V20 is located close to A226 in strand number 14 as can be seen 
from Fig 15.  
 
 
Fig. 15 NMR/X-ray structure of human VDAC. It is a ribbon presentation of the 
backbone. Helices are marked in red and ß-strands in cyan. The ß-strands are 
numbered from the N- to the C-terminus, numbers are given in magenta. The position 
of V20 and A226 are indicated with the one letter amino acid code. The N-terminus is 
marked with a blue N, the C-terminus with a red C.  
 
3.3.6 Functional investigation of HVDAC 
 To investigate the functional behaviour of HVDAC several titrations of 
effectors to a 2H, 15N-labelled HVDAC sample were carried out. After each titration 
point a 2D TROSY-HSQC spectrum was recorded.  
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3.3.6.1 ADP-Titration 
 VDAC is primarily responsible for nucleotide transport across the outer 
mitochondrial membrane (reviewed in [44]). To map potential interaction sites of 
nucleotides and HVDAC an ADP titration was performed. Chemical shift 
perturbations based on addition of ADP are mapped on the topology model in 
Figure 16. ADP was added up to a 16-fold molar excess. Residues with chemical shift 
changes of HN and N upon ADP addition bigger than 0.02 ppm are: G26, K56, R123, 
N159, T185, A212, S237, A273, S288 (labelled with a green star in Fig. 16). In 
general, the effects are equally distributed over the whole channel. 
 
 
Fig. 16 Effects in the TROSY-HSQC spectrum due to addition of ADP mapped on 
the topology model of HVDAC. Residues labelled with a green star show 
perturbations bigger than 0.02 ppm upon addition of a 16-fold molar excess of ADP. 
The rest of the nomenclature is the same as in Figure 11. 
 
3.3.6.2 Fluoxetine-Titration 
 Fluoxetine is a clinically used potent antidepressant[93]. It is known under trade 
names like Prozak® or Fluctin®. Thinnes[94] demonstrated that fluoxetine increases the 
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voltage dependence of HVDAC. In order to understand the interaction of fluoxetine 
with VDAC on an atomic level, a fluoxetine titration was performed. 
 
 
Fig. 17 Effects in the TROSY-HSQC spectrum upon addition of the antidepressant 
fluoxetine mapped on the topology model of HVDAC. Residues labelled with a 
yellow circle show chemical shift changes of HN and N bigger than 0.025 ppm upon 
addition of a 32-fold molar excess of fluoxetine. The blue ellipsoid highlight 
interaction sites with fluoxetine. The inlet shows the structure of fluoxetine. The rest 
of the nomenclature is the same as in Figure 11. 
 
Chemical shift perturbations upon titration are mapped on the topology model of 
HVDAC in Fig. 17. Fluoxetine was added up to a 32-fold molar excess. The most 
clustered effects with chemical shift changes of HN and N bigger than 0.025 ppm are 
found in the C-terminal loop from residue V271 and G274-L278. Additional effects 
can be observed in other loops on the same side. Affected residues are L42, D103, 





3.3.6.3 Interaction of HVDAC with anti-apoptotic Bcl-xL[47] 
 Malia et al.[47] described the interaction of the anti-apoptotic protein Bcl-xL 
with HVDAC. They presented an unassigned 15N-TROSY-HSQC spectrum of 2H, 
15N-HVDAC in the presence of 50 % Bcl-xL (Fig. 18).  
 
 
Fig. 18[47] Chemical shift perturbations of 2H, 15N-HVDAC in the presence of 
unlabeled Bcl-xL. The TROSY-HSQC spectrum of HVDAC in the absence (black) 
and presence (red) of 50 % Bcl-xL. Arrows indicate some of the major changes in the 
HVDAC spectrum.  
 
Since HVDAC was reconstituted in LDAO micelles the TROSY-HSQC spectrum 
looks similar to the one shown in Fig. 6. Therefore the assignment could be 
transferred and the interaction site of HVDAC with Bcl-xL was established. Fig. 19 
shows major chemical shift perturbations upon addition of Bcl-xL as classified by 




Fig. 19 Chemical shift perturbations in the presence of Bcl-xL[47] mapped on the 
topology model of HVDAC. Residues, which are classified by Malia et al. to have 
major changes in the HVDAC spectrum, are labelled with a green hexagon. In the 
original publication these residues are pointed out with a black arrow in the 
unassigned TROSY-HSQC spectrum. The rest of the nomenclature is the same as in 
Figure 11. 
 
These are: K56, T119, G151, A226, I230, D231, A234, G249, L254, T261, S263, 
A264. The majority of residues, which are affected by Bcl-xL, are located in the C-
terminus between A226 and A264.  
 
3.3.6.4 Interaction of HVDAC with pro-apoptotic Bid 
 Rostovtseva et al.[45] reported, that pro-apoptotic Bid, which was activated by 
Caspase 8, induced channel closure of VDAC. To investigate the binding interface of 
Bid and HVDAC 15N-TROSY-HSQC spectra of 2H, 15N-HVDAC in the presence of a 
4-fold molar excess of unlabelled mouse Bid were recorded. Human and mouse Bid 
share 91.5 % sequence identity (based on the sequences in the PDB files 2BID 
(human) and 1DDB (mouse)). Additionally a sample with MTSL-labelled Bid was 
prepared. The effects of Bid and Bid-MTSL on the TROSY-HSQC spectrum of 
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HVDAC are summarised in Fig. 20. On the one hand chemical shift and peak 
intensity changes upon Bid addition compared to the reference spectrum without Bid 
are plotted. On the other hand peak intensity changes are indicated, which 
additionally  appear  upon  MTSL-labelling  of  Bid.  Effects  with  Bid  alone  appear  
 
 
Fig. 20 Chemical shift perturbations in the presence of mouse Bid mapped on the 
topology model of HVDAC. Residues with a peak intensity ratio < 0.61 of the spectra 
with and without Bid are labelled with a magenta triangle. Residues, which upon Bid 
addition are broadened beyond detection, are labelled with a red triangle. Residues, 
which upon Bid addition show HN and N chemical shift changes > 0.03, are labelled 
with a purple triangle. Residues with a peak intensity ratio < 0.5 of the spectra with 
Bid and Bid-MTSL are labelled with a turquoise triangle. Residues, which upon 
MTSL labelling of Bid, are additionally broadened beyond detection are labelled with 
a green triangle. The rest of the nomenclature is the same as in Figure 11. 
 
primarily in the C-terminal region starting from L205. Affected residues in this area 
are L205 – T207, A212, A225 – I230, D233 – A234, F236, V240, I246 – G247, 
G249, Q252, T261 – S263, H276 and Q285 – A286. Interestingly, again residues in 
the N-terminal helix are affected together with the residues in the C-terminus. These 
are R18, K23 and Y25. Additional effects, which show up upon MTSL-labelling of 
Bid, appear like a semicircle around the region, which is also influenced by Bid alone. 
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These MTSL induced effects extend up to the N-terminus. Effected residues are I30, 
L32, N40, G48 – S49, V57, T63, D103, K116, E192, G223, L245, T251, Q252, 
S263 – A264, G275, L278 – G279, F284 and A286 – R287.  
 Addition of Bid to the HVDAC sample led to partial unfolding of HVDAC. 
However, HVDAC slowly refolded again and was completely folded after one month. 
Fig. 21 shows the first 1 D spectrum of a TROESY-HSQC of HVDAC after addition 
of Bid and of the same sample one month later.  
 
 
Fig. 21 Overlay of the first 1 D spectra of a TROESY-HSQC of HVDAC directly 
after addition of Bid (red) and one month later (blue). 
 
3.3.6.5 Calcium (II) chloride and Gadolinium (III) chloride-Titration 
 Gincel et al[95]. reported, that VDAC is highly permeable to Ca2+ and has Ca2+-
binding sites. In contrast, Ruthenium Red and lanthanides close the VDAC. The 
authors suggest, that the inhibition of mitochondrial Ca2+ uptake by Ruthenium Red 
and lanthanides results from their interaction with the Ca2+-binding site. Israelson et. 
al[96] established the Ca2+-binding sites as E72 and E202 (E76 and E206 in the 
nomenclature used here) by interaction of VDAC with azido ruthenium. In order to 
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test these results a Ca2+-titration was performed. However no major chemical shift 
perturbations or peak intensity changes could be observed upon addition of a 32-fold 
molar excess of Ca2+. Since it was suggested, that lanthanides interact with the Ca2+-
binding site of VDAC, an additional titration with GdCl3 was performed. Gd3+ is 
paramagnetic. Because of paramagnetic relaxation enhancement, the interaction of 
Gd3+ with HVDAC will have much stronger effects on the TROSY-HSQC than the 
interaction of Ca2+. Thus the interaction site of Gd3+ with HVDAC could be 
established. It  is  mapped  on  the  topology  model  in  Fig. 22.  Residues,  which  are 
 
 
Fig. 22 Effects in the TROSY-HSQC spectrum upon addition of GdCl3 mapped on 
the topology model of HVDAC. Residues labelled with a purple cross are broadened 
beyond detection upon addition of an equimolar amount of GdCl3. Purple crosses 
indicate peaks, which are very likely to be broadened beyond detection. They are in 
very overlapping regions. The rest of the nomenclature is the same as in Figure 11. 
 
broadened beyond detection upon addition of an equimolar amount of Gd3+, are in the 
majority observed at the C-terminus in the last 5 β-strands. Affected residues are 
E204, K227 – I230, A234 – S237, G249 – Q252, L260 – A264 and Q281-L282. 
Additional effects can be observed for Y25, K56, K99. 
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3.4 Discussion 
In this work, the structure of HVDAC was determined conjointly by NMR-
spectroscopy and X-ray crystallography. In addition, binding interfaces of HVDAC 
and different effectors were established.  
 
3.4.1 The combination of NMR and X-ray crystallography for 
structure determination of membrane proteins 
The structure elucidation of the human VDAC pushes both methods, NMR 
spectroscopy and X-ray crystallography, to their limits. As mentioned in the 
introduction, the major problem for solution NMR is the size limit. As molecular 
masses increase, NMR spectra become increasingly difficult to interpret because of 
spectral crowding and line broadening due to fast transverse relaxation[5]. The human 
VDAC has a molecular weight of 32 kDa and is reconstituted in LDAO detergent 
micelles. This leads to an overall molecular weight of approx. 80 to 120 kDa, as 
estimated from T1ρ measurements. Additionally challenging is the fact, that the NMR 
measurements cannot be performed at a temperature higher than 37 °C. Since VDAC 
is a human protein it degrades above this temperature. Compared to other structural 
investigations of membrane proteins by NMR this temperature is still intermediate, 
e.g. spectra for the β-barrel protein PagP were recorded at 45 °C[97]. This situation 
does not only make the resonance assignment difficult but most important, it makes 
long range distance restraints for structure calculations hard to obtain. Because of the 
strong relaxation it was not possible to attain accurate isotropic 1JHN couplings. 
Therefore the utilization of residual dipolar couplings (RDCs) as long-range restraints 
was impossible. This restricts long-range distance restraints to NOEs and 
paramagnetic relaxation enhancement data. Due to the high deuteration level the 
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NOEs are limited to HN-HN crosspeaks. Nevertheless, in anti-parallel β-strands 
interstrand HN-HN crosspeaks can be observed. These are sufficient to determine the 
global fold of a β-barrel. In general, a structure calculation from NMR data would be 
difficult and time consuming. Yet, to obtain a 2 dimensional model with atomic 
resolution is from this data, compared to the structure calculation, rather 
straightforward.  
 The biggest problem for X-ray crystallography is the fact that the so far 
obtained crystals of human VDAC I only diffract up to 4 Å. Nevertheless, it was 
possible to obtain an electron density map corresponding to about 4 Å resolution. So 
far, the maps enabled the detection of the overall fold as well as several secondary 
structure elements in some areas of the electron density after b-factor sharpening. 
Unfortunately, the low resolution of the electron density map did not allow an exact 
tracing of the protein backbone. Hence, an initial map interpretation was only possible 
by placing poly-alanine fragments of high-resolution beta barrel protein structures 
into the more distinct defined portions of the electron density. The remaining 
somewhat ambiguous sites of the electron density map were further interpreted 
through the fitting of additional poly-alanine beta sheet fragments under consideration 
of the established beta barrel geometries. The final electron density map seems to be 
most consistently explained by an idealized 18 stranded beta barrel. In conclusion, 
this map only allowed the rough localisation of secondary structure elements, but not 
the placement of single amino acids.  
 In order to gain an extended molecular structure of the VDAC protein, the 
NMR derived topology was applied on the X-ray derived model. This was done by 
replacing manually the alanines of the X-ray model with the HVDAC sequence 
according to the NMR topology model. The resulting structure complies with both 
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restrains, interstrand HN-HN NOEs and the selenium sites of M132, M158 and M230. 
Although the NMR topology structure covers only about two thirds of the whole 
barrel accurately, the derived hybrid model enabled a significantly improved 
interpretation of the electron density map. Until now, the electron density map could 
not be improved by the NMR-data. Nevertheless the resulting hybrid model is well 
suited for the ongoing structural refinement process.  
In the end the combination of the local information from NMR-spectroscopy 
and the global information from X-ray crystallography yielded the structure of human 
VDAC. This clearly points out, that the combination of the two methods can be 
advantageous for the structure determination of integral membrane proteins.  
 
3.4.2 NMR and X-ray Structure of HVDAC  
The structure of human VDAC resembles the typical β-barrel fold (Fig. 23). It 
consists of 18 anti-parallel β-strands, which construct the β-barrel, and a N-terminal 
α-helix, which is located inside the barrel, pointing in the direction of the C-terminus. 
Additional proof, that the N-terminal helix is not part of the barrel wall, as proposed 
by other studies[63, 65], is given by NMR spectroscopy. 
It was observed that the mutation V20C, which is located in the helix, affects 
the chemical shift of residues located in the 6 C-terminal β-strands (from strand 
number 13 to 18) around residue A226. If the helix would close the barrel and would 
be part of the barrel wall, this effect would very likely be restricted to residues in β-
strands next to the helix, for example sheet number one and eighteen. Noteworthy is 
the fact, that upon this mutation in the C-terminus mainly residues are affected, whose 
side chains point outside of the barrel wall towards the micelle.  Therefore  the  amide  
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Fig. 23 Stereo view of the NMR/X-ray structure of human VDAC. It is a ribbon 
presentation of the backbone. Helices are marked in red and ß strands in cyan. The N-
terminus is marked with a blue N, the C-terminus with a red C. 
 
bond of these residues is inside the barrel less shielded. This implies, that the helix is 
rather located inside the barrel, because stronger effects are observed for residues that 
are rather unshielded from the inside. Additional effects can be observed for residues 
located in loops, that are positioned on the top of the barrel, according to the 
presentation in Fig. 23. This can be due to another conformation because of the 
enhanced flexibility of the N-terminus. 
 Further support, that the helix is located in the neighbourhood of the C-
terminal part stems from PRE data of the mutant C130S (Fig. 13). In this case the spin 
label is attached to C235. Most effects are located in the region around this mutation 
site. However, additionally the resonances of A17 and R18, which are located in the 
N-terminal helix, are broadened beyond detection. This indicates, that the helix is 
located close to residue C230 and therefore at the C-terminal side of HVDAC. Further 
effects can be observed around residue G129. In the presented topology model this 
region is located directly opposite to C235. The effects can be explained by the 
position of the MTSL tag. The side chain of C235 points to the inside of the barrel, 
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therefore also the MTSL points inward. Broadening effects of the MTSL can be 
observed up to 20-25 Å[13]. The distance between the CA of C235 and the nitroxide 
radical is approx. 11 Å. Therefore the diameter of the barrel from backbone to 
backbone must be approx. between 31-36 Å. Otherwise no effects would be observed 
in a region opposite to the spin label. This distance correlates very well with the 
diameter of 35 Å observed by X-ray crystallography. Another explanation for the 
effects around G129 can be an impurity of the sample, which would still contain 
C130. Consequently a spin-label would also be present at position C130 and would 
cause the line broadening around G129.  
 In addition to the mutational data, also the functional investigations indicated 
that the N-terminal helix is close to the C-terminal part. For example the pro-
apoptotic Bid (Fig. 20) interacts most strongly with the C-terminal part of HVDAC 
but in addition also with residues located in the N-terminal α-helix.  
 
3.4.3 Comparison of the human VDAC structure with existing 
models 
Models, which are based on sequence alignment with bacterial porins[60-62], 
suffer from the fact that the flexible N-terminal part differs significantly from the 
bacterial homologues. This is probably due to a widely observed extensive divergence 
of the primary sequences of β-barrels[98]. Therefore these methods are unlikely to give 
decent results for the human VDAC.  
 The model proposed by De Pinto et al.[64] is based on analysis of 
amphipathic secondary structure elements and enzymatic digestion of hydrophilic, 
extramembranous segments of human VDAC. The authors suggest 16 transmembrane 
β-strands and a N-terminal α-helix, which lies on the membrane surface on the 
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cytosolic side (see Fig. 24A). The reported enzymatic cleavage sites are at P232, 
Y176, Y121 and K116. In our structure P232 is located in a loop, Y176 is vicinal to a 
loop, but Y121 and K116 are located in a β-strand (see Fig. 24B). Nevertheless, the β-
strand is directly adjacent to the flexible N-terminus and might therefore be accessible 
to proteases.  
 
Fig. 24 A) Topology model of human VDAC from B-lymphocytes according to De 
Pinto et al.[64] The loops contain the cleavage sites of protease V8, trypsin and 
chemotrypsin. B) Enzymatic cleavage sites of De Pinto[64] mapped on the NMR-
derived topology model of human VDAC.  
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The model proposed by Blachly-Dyson et al.[63] is based on site directed 
mutagenesis with subsequent electrophysiological investigation of yeast VDAC. They 
suggest that replacement of positively charged residues within the channel wall 
should change the selectivity of VDAC. Contrary a change in charge of residues 
located outside of the pore might not affect the selectivity. Residues, which upon 
mutation change the selectivity, are: D15, K19, D30, K46, K61, K65, K84, K95, 
R124, G179, K234, K248, T256, D282. These correspond to D19, K23, D33, S49, 
K64, T68, E87, K99, G129, H184, S237, T251, K269, Q285 in our human VDAC 
construct (see Fig. 25). Residues, which upon mutation don’t change the selectivity, 
are: D51, K108, K132, D156, K174, K205, K211, E220, R252, K267, K274. These 
correspond to T54, K113, A137, E161, D179, N210, G216, G223, K255, N270, K267 
in our human VDAC construct (see Fig. 25). In general, there is a good agreement 
between Blachly-Dysons data and our structure. Only the residues, for which the 
backbone is resolved on an atomic level, will be discussed here. The majority of 
residues for which mutation does not alter the selectivity are in our structure located 
in loops. The only exceptions are N210 and G223, which are close in space. 
Additionally G223 is on the border of a β-strand. Likewise all residues, which upon 
mutation do alter the selectivity, are in our structure located in β-strands or at the 
border of one. Furthermore residues, which are located in the N-terminal α-Helix, 
change the selectivity upon mutation. Since in our structure the helix is located inside 





Fig. 25 A) Topology model of yeast VDAC according to Blachly-Dyson et al.[63]. 
Residues for which mutation altered selectivity are boxed; residues for which the 
mutation left the selectivity unchanged are circeld. B) Mutation sites of Blachly-
Dyson[63] mapped on homologous residues in the NMR-derived topology model of 
human VDAC. Residues for which mutation altered selectivity are encircled green; 
residues for which the mutation left the selectivity unchanged are encircled magenta. 
 
Columbini[44] proposes a model for the human VDAC that is based on Biotin 
modification data from Song et al.[65] that was obtained for the Neurosposa crassa 
VDAC. The model consists of 13 anti parallel β-strands and a N-terminal 
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transmembrane helix, which closes the barrel (see Fig. 26A). In this study streptavidin 
was bound to biotinylated sites of the protein followed by electrophysiological 
investigation. Amino acids were classified in type 1 and type 2. Type 1 amino acids 
show reduced conductance, type 2 a total block of current upon streptavidin binding 
to biotinylated sites. Previous studies revealed, that type 1 sites are static and 
permanently located on the VDAC surface. Type 2 sites are located on mobile 
domains, which only get accessible upon conformational rearrangement. By double 
mutations it was then investigated, if the corresponding amino acids are on the same 
or on opposite sites of the membrane. These mutations are all related to T53, which 
belongs to type 2. In human VDAC V57 corresponds T53. Since V57 is located in the 
flexible N-terminus its exact position cannot be determined, but it is most likely 
located in a β-strand. Our structure only agrees with the data for those residues, which 
are type 1 sites and are predicted to be located on the same side as T53, these are 
T135, D156, R240 and D264. In our structure homologous residues (S140, E161, 
S243, D267) are located in loops at the cytosolic side of the channel (see. Fig 26). 
Residues, which are said to be on the opposite site of T53, are in our structure mostly 
located in β-strands. The only exception is S111, which corresponds to A215. It is a 
type 1 residue and is located in a loop at the cytosolic side. Overall the data presented 
by Song et al.[65] do not agree very well with our structure. One explanation could be, 
that the observed effects are influenced by the flexibility of T53. Another explanation 
would be, that data obtained from Neurosposa crassa VDAC are not directly 




Fig. 26 A) Topology model of Neurosposa Crassa VDAC according to Song et al.[65] 
Residues, which were mutated to cysteins, are numbered. B) Mutation sites of 
Song[65] mapped on homologous residues in the NMR-derived topology model of 
human VDAC. Residues, which should be on the same side as V57, are encircled 
green; residues, which should be on the opposite side as V57, are encircled magenta. 
Type 1 and type 2 residues are indicated with a red 1 or 2, respectively.  
 
Nevertheless, Columbinis model, which is based on Songs et al.[65] data, is 
also used in other studies for the visualisation of results. For example, Israelson et 
al.[96] localised the Ca2+ binding sites of human VDAC as E72 and E202. They 
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mapped these residues on Columbinis model, which reveals that they are in loops at 
the cytosolic side of the barrel. Even though this does make sense, because these 
residues can come close in space, the authors would have expected the Ca binding site 
at the intermembrane space. This is because Ca2+ induces the opening of the 
permeability transition pore and therefore should accumulate in the inner membrane 
space. However in our structure E202 is located in a loop in the intermembrane space. 
E72 is in the N-terminal part and cannot be localised reliably. 
 
3.4.4 Support for the presented structure from “in silico” analysis 
The presented structure is supported by results of several web servers, which 
predict secondary structure elements or flexible parts in proteins. The secondary 
structure prediction was done with the PSIPRED server[91, 92]. It revealed an N-
terminal helix and 19 β-strands separated by coil regions. The prediction was run at a 
very early stage of the structure determination and was considered as very unlikely to 
be correct. The reason for this was the fact, that a β-barrel, which solely consists of 
anti parallel β-strands, can only be composed of an even number of β-strands. 
However, at an advanced stage of the structure determination the located β-strands 
were aligned to the PSIPRED prediction. Surprisingly the position of the 14 C-
terminal β-strands determined by NMR spectroscopy were in very good agreement 




Fig. 27 Comparison of secondary structure elements determined either with the 
Psipred[91, 92] server or experimentally. Red boxes indicate experimentally established 
β-strands; white arrows β-strands predicted by Psipred. Green boxes indicate negative 
secondary chemical shifts in the N-terminus, which gives rise to a loop or a helix, the 
white helix indicates a helix predicted by Psipred. The numbers in the row marked 
with “Conf” specify the confidence of the prediction, with 0 = low and 9 = high. The 
line marked with “Pred” shows the prediction, where H stands for Helix, E for strand 
and C for coil. The line marked with “AA” gives the one letter amino acid code for 
our construct of human VDAC.  
 
 The prediction of flexible parts was done with the DisProt[99] (Fig. 28a) and 
with the DisEMBLTM 1.5[100] (Fig. 28b) server. Even though these servers are 
optimized for natively unfolded proteins, the results fitted very well to the presented 
structure. DisProt showed significantly higher flexibility for residues between 25 to 
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125 than for residues between 126 to 255. DisEMBL differentiates between 
loops/coils and hot-loops. Loops are considered as a necessary but not a sufficient 
requirement of disorder. Hot-loops are loops with a high degree of mobility. For the 
human VDAC these hot loops can only be found in region between residue 40 and 
120, except of the N- and C-terminus. In conclusion, both programs predicted higher 
flexibility for the N-terminal third of human VDAC, which is in good agreement with 
the NMR data.  
 
 
Fig. 28 Output of a) DisProt and b) DisEMBLTM 1.5 protein disorder prediction 
servers for human VDAC. 
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3.4.5 Biological relevance of enhanced flexibility in the N-terminus 
The enhanced flexibility in the N-terminus, which makes structure 
determination for this part difficult, results from interesting biological features of the 
human VDAC. The protein is encoded in the nucleus, synthesised in the cytosol, 
targeted to mitochondria as a chaperone-bound species, recognized by the translocase 
of the outer membrane (TOM complex) and then inserted into the outer membrane[101] 
by the help of the sorting and assembly machinery (Sam or Tob complex)[102]. In most 
cases of pre-protein import into the mitochondria the Tom complex recognizes a N-
terminal amphiphilic helix, with one positively charged and one hydrophobic 
phase[103]. Since the N-terminal amphiphatic helix is sufficient for TOM recognition, 
this part interacts first with the TOM complex. Therefore the translocation of the 
proteins will start with the N-terminus. However for β-barrel proteins it is believed 
that the targeting information is encoded in a structural element, which involves 
different regions of the protein, rather than exclusively the N or the C-terminus[104-107]. 
Nevertheless the human VDAC has an N-terminal amphiphatic helix from residue P8 
to K23. The polar site has a net charge of +1. It is therefore very likely, that this helix 
is, besides other targeting sites, involved into TOM recognition, even though a Δ(1-
19)HVDAC deletion mutant can still be incorporated into the mitochondrial 
membrane[108]. Thus the direction of the translocation of human VDAC is expected to 
be from the N- to the C-terminus. It is known, that the driving force for protein 
translocation through the TOM complex does neither come from ATP nor from the 
membrane potential across the inner membrane. It rather stems from interactions with 
different binding sites with increasing affinity. Therefore the cis-binding site at the 
cytosol has a lower affinity to the pre-protein than the trans-binding site at the inter 
membrane space. This trans-binding site is thought to hold the pre-proteins until 
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further sorting to the mitochondrial sub-compartments takes place[98, 102, 109, 110]. Thus, 
once the protein is trapped at the inter membrane space it can be easily incorporated 
into the mitochondria. An enhanced flexibility at the recognition site of the pre-
protein would be extremely beneficial for this process, because it facilitates the 
sliding of the pre-protein through the TOM complex to the high affinity binding site. 
Therefore the observed flexibility in the N-terminus of human VDAC can be readily 
explained by its translocation behaviour through the TOM complex.  
 An additional explanation for the observed N-terminal flexibility is given by 
the study of Thomas et al.[111]. They investigated the voltage-sensing domain of 
VDAC and found that a large portion of the protein, particularly the N-terminal third, 
contains residues that upon mutation affect the voltage gating properties of yeast 
VDAC. Therefore these residues identify regions of the protein that are translocated 
through the field in response to voltage changes. Additionally Thomas et al.[111] refer 
to a previous study by Peng et al.[112] where residues were located, which only affect 
the voltage gating properties of the open state but not, or only slightly, of the closed 
state of VDAC. Therefore the authors conclude, that the residues with impact on the 
voltage gating move out of the channel wall during channel closure. This behaviour is 
only possible, if this moving part has conformational freedom, which leads to 
increased flexibility. Thus, these results agree very well with the flexibility of the N-
terminal third of VDAC observed by NMR.  
Additionally, this helps to understand the difference between eukaryotic 
VDAC and bacterial porins. In contrast to the VDAC, bacterial porins are in vivo not 
voltage-gated[113, 114]. This could be an explanation for the bad correlation between 
structural models for VDAC based on sequence alignment with bacterial porins and 
the actual structure.  
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3.4.6 Functional investigation of HVDAC 
3.4.6.1 ADP-Titration 
 The residues, which are affected by the addition ADP, are equally distributed 
over the sequence (see 3.3.6.1). This corresponds well to the fact, that HVDAC is 
permeable to nucleotides. Since the nucleotides pass the channel, they can come close 
to the majority of residues. Additionally interactions can only be observed, if the 
nucleotide is present in large excess. This indicates a week binding affinity. Again, 
this corresponds to VDAC’s permeability to nucleotides. They should not bind tightly 
to the channel, but rather pass through it quickly. Of the 19 residues, which are 
influenced by ADP, 10 could not be assigned. Thus the existence of an additional 
binding site cannot be excluded.  
 
3.4.6.2 Fluoxetine-Titration 
The anti-depressant fluoxetine interacts primarily with the C-terminal loop. 
Additional effects can be observed in other loops, which are on the same side of the 
barrel (see 3.3.6.2). Since fluoxetine stabilises the low conducting state of VDAC[115], 
the C-terminal loop might, upon binding to fluoxetine, block the channel pore. This 
could be initiated by moving this loop like a cap on top of the barrel. This would 
explain, why also other loops on the same side of the barrel are affected. This model 
is demonstrated in Fig. 29. Fluoxetine is a small organic compound. Therefore 
additional effects that are wider distributed over the sequence can be caused by 
further binding sites. Of the 28 peaks which are influenced by fluoxetine 12 could not 
be assigned. Since most assignment are missing in the N-terminus and in loops, these 





Fig. 29 Interaction sites of fluoxetine with HVDAC mapped on the NMR/x-ray 
structure of HVDAC. The position of the C-terminal loop is modelled in A and B 
because no electron density is present at this position. Residues with chemical shift 
changes of HN and N bigger than 0.025 ppm upon addition of a 32-fold molar excess 
of fluoxetine are shown in red (these residues are labelled with a yellow circle in Fig. 
17). The position of the C-terminal loop is indicated. Residues Ile136 and Arg166 are 
labelled with the one letter amino acid code. A) Model without fluoxetine. B) Model 
upon fluoxetine binding. 
 
 Nahon et al[115]. reported that fluoxetine inhibited the opening of the PTP, the 
release of cytochrome c and protected against staurosporine-induced apoptosis. It is 
suggested, that the apoptosis-related effects are mediated by the interaction of 
fluoxetine with the VDAC. Therefore the interaction of fluoxetine with the C-terminal 
loop of HVDAC might prevent apoptosis and might thus lead to an increased cancer 
risk upon fluoxetine treatment. However there are conflicting reports about this 
cancer risk. In vitro studies with tumor cells exposed to fluoxetine have shown 





3.4.6.3 Interactions with pro- and anti-apoptotic proteins 
 Apoptosis is an essential cellular process strictly regulated by proteins of the 
Bcl-2 family[47]. Members of this family are the anti-apoptotic Bcl-xL and the BH3-
only pro-apoptotic Bid. Both proteins interact with HVDAC. Most interestingly, they 
bind to the same site of HVDAC (see 3.3.6.3 and 3.3.6.4), even though their function 
is contrary. This implies, that pro- and anti-apoptotic proteins compete for the binding 
site in HVDAC. This site is located at the C-terminus (see Fig. 30).  
 
 
Fig. 30 Comparison of the interaction sites of Bcl-xL and Bid with HVDAC mapped 
on the NMR/X-ray structure of HVDAC. In the case of Bcl-xL residues, which are 
classified by Malia et al.[47] to have major changes in the HVDAC spectrum, are 
coloured magenta. In the case of Bid residues with a peak intensity ratio < 0.61 of the 
spectra with and without Bid or which, upon Bid addition are broadened beyond 
detection, are coloured magenta. The N- and the C-terminus are labelled with a 
yellow N or C, respectively. The β-strand numbers are given in green. Residues 
Thr261 and Ile230 are labelled with the one letter amino acid code.  
 
Bid interacts primarily with residues between L205 and A284, Bcl-xL with residues 
between A224 and A284. Of the 48 residues, which are influenced by Bid or Bid-
MTSL 15 could not be assigned. These missing assignments are most probably 
located in the N-terminus, since many assigned residues in the N-terminus are 
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affected and many assignments are missing in this region. The binding interface of 
Bcl-xL was established by transferring the assignment of HVDAC on a published[47], 
unassigned 15N-TROSY-HSQC spectrum of HVDAC in the presence of Bcl-xL. Malia 
et al. pointed out some residues with major changes in the HVDAC spectrum. Of 
these 17 residues 5 could not be assigned. As for the case of Bid, these residues are 
most probably located in the N-terminus. Because of the low quality of the figure only 
these residues are considered to be in the binding interface of Bcl-xL and HVDAC. 
The fact, that the binding site of Bid seems to be more extended than the one of Bcl-
xL, is most probably due to a more sophisticated evaluation of the Bid/HVDAC 
spectra. Most interestingly, the pro- and anti-apototic factors bind to a different site 
than fluoxetine, indicating a different binding mechanism.  
 Malia et al[47] proposed, that helices 5 and 6 of Bcl-xL move out of the protein 
core, insert into the mitochondrial membrane and that way bind to HVDAC. These 
helices are shown in green in Figure 31A. Bid is homologous to Bcl-xL and both 
proteins interact with the same site of HVDAC. Therefore it is possible, that also the 
binding site of Bid is homologous to the one in Bcl-xL.The helices homologous to 
helix 5 and 6 in Bcl-xL are in mouse bid between M142 – H162 and L167 – Q180. 
They are also coloured green in Figure 31B. An indirect hint, that these helices can 
indeed be involved in HVDAC binding is provided by PRE-data of MTSL-labelled 
Bid. Mouse Bid contains two cysteines, C30 and C126, that can react with the MTSL. 
They are shown in red in Figure 31B. Both cysteines are not located in the helices 
hypothetically binding to HVDAC. Therefore no additional line broadening upon 
MTSL labelling of Bid are expected for residues in the binding core. Rather residues 
in the neighbourhood should be affected. This is exactly the observed situation (see 
5.3.5.4). Therefore the helices from  M142 – H162  and  L167 – Q180  in  mouse  Bid 
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Fig. 31 A) Crystal structure of human Bcl-xL[119] (PDB code: 1R2D). Helices, which 
are proposed to insert into the membrane[47], are coloured green B) NMR-structure of 
mouse Bid[120] (PDB code: 1DDB). Helices, which are homologous to the membrane 
inserting ones of Bcl-xL, are coloured green. Cysteine residues are shown in red.  
 
should bind to the C-terminal part of HVDAC, namely to residues L205-T207, A225-
I230 and D233-F236. These are the most clustered residues in HVDAC affected by 
Bid addition, but unaffected by further MTSL labelling of Bid. MTSL-labelling of 
Bid induces line broadening in the upper C-terminal part and in the N-terminus of 
HVDAC. Therefore the rest of the Bid molecule must bend towards the N-terminus of 
HVDAC. 
 VDAC is known to appear in oligomeric states[121]. Malia et al[47]. reported, 
that micelle-bound HVDAC is in intermediate exchange between monomer and 
trimer. If Bcl-xL is present, a heterotrimer (HVDAC : Bcl-xL 2:1) or a heterodimer is 
favoured. Therefore Bcl-xL can break down the oligomeric state of HVDAC. A 
similar result was observed for the interaction of Bid with HVDAC[29]. Chemical 
crosslinking experiments with glutaraldehyde and Ruthenium Red were performed. In 
the absence of Bid HVDAC monomers, dimers and trimers were observed. The 
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presence of Bid led to a decrease of the oligomeric HVDAC population and the 
appearance of HVDAC/Bid heterodimers. The fact, that in the presence of Bid 
HVDAC dimers are not favoured can be rationalised with the HVDAC/Bid binding 
interface. This interface overlaps on the HVDAC site with the region, where crystal 
contacts of HVDAC dimers are observed (Fig. 32). This points out, that upon 
HVDAC/Bid complex formation, the dimerisation site of VDAC is blocked. 
 
 
Fig. 32 Bid interaction sites are visualised on the Van-der-Waals surface plot of 
HVDAC. Residues with a peak intensity ratio < 0.61 of the spectra with and without 
Bid or which upon Bid addition are broadened beyond detection are coloured in 
magenta. Residues with a peak intensity ratio < 0.5 of the spectra with Bid and Bid-
MTSL or which upon MTSL labelling of Bid, are additionally broadened beyond 
detection are coloured in green. The N-terminus is shown in blue, the C-terminus in 
red. Grey residues are unaffected by Bid. The residues Ala63 and Ile230 are labelled 
with the one letter amino acid code. A) HVDAC dimer. Crystal contacts are observed 
at the dimeric interface. B) HVDAC monomer. The direct view on the dimeric 
interface is given. For this purpose the dimer in A was rotated by 90° and one 
molecule was removed.  
 
 Addition of Bid leads to partial unfolding with successive refolding of 
HVDAC. This behaviour was never observed for any other partially unfolded 
HVDAC sample. Usually once HVDAC is partially unfolded it stays like this. 
Therefore Bid influences the folding of HVDAC. Bid binds to the region in HVDAC 
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where the N- and the C-terminus close the barrel (Fig. 32). Therefore the influence on 
the HVDAC folding might be due to an opening of the HVDAC pore. This could be a 
hint for HVDAC’s possible involvement in the permeability transition pore. If 
HVDAC was involved in the PTP it would experience a structural rearrangement. 
This might therefore be induced by the pro-apoptotic Bid.  
 
3.4.6.4 Calcium (II) chloride and Gadolinium (III) chloride-Titration 
 The binding interface of HVDAC and Ca2+ could not be established. No 
chemical shift perturbations or peak intensity changes were observed in the 15N-
TROSY-HSQC of HVDAC upon addition of a 32-fold molar excess of Ca2+. Gincel 
et al.[95] suggested that Ca2+ and lanthanides bind to the same site in VDAC. The 
paramagnetic relaxation enhancement of lanthanide ions causes severe line 
broadening in the NMR spectra of their interaction partners. Therefore it was possible 
to establish the binding site Gd3+ in HVDAC (see Fig. 33). It is located in the C-
terminal part of HVDAC. Primarily affected by the addition of Gd3+ are the 5 C-
terminal β-strands. Of the 29 residues, which are influenced by Gd3+, six could not be 
assigned. The Ca2+ binding sites established by Israelson et al.[96] are at E76 and 
E206. These Ca2+ binding sites were indirectly identified by the interaction with azido 
ruthenium. The region around E76 could not be identified as a Gd3+ binding site, 
because this region was not assigned. However, 6 peaks that interact with Gd3+ were 
not assigned. Thus these peaks could possibly correspond to residues, which are 
located around E76. E206 also interacts with Gd3+ but it is rather located at the border 
of the Gd3+-binding cluster. If Gd3+ would primarily interact wit E206 the 




Fig. 33 Interaction site of Gd3+ with HVDAC mapped on the NMR/X-ray structure of 
HVDAC. Residues labelled in purple are broadened beyond detection upon addition 
of an equimolar amount of GdCl3. Additionally residues, which are very likely to be 
broadened beyond detection because they are in very overlapping regions, are labelled 
purple. The N- and the C-terminus are indicated with a blue N or red C, respectively. 
The β-strand numbers are given in black. Residues Thr261 and Ile230 are labelled 
with the one letter amino acid code.  
 
sites are definitely very close in space. Additionally this region in the 5 C-terminal β-
strands also interacts with the pro-apoptotic protein Bid and the anti-apoptotic protein 
Bcl-xL. Ca2+ influences apoptosis[122, 123] and lanthanides inhibit mitochondrial Ca2+ 
uptake[124, 125]. This points out that apoptosis related factors compete for the same 
binding site in HVDAC. Most interestingly the N-terminal helix is located close to 
this area. Thus the helix might perhaps be involved in the regulation of interactions 
between HVDAC and apoptotic factors.  
 
3.5 Conclusions 
 In conclusion, the structure of HVDAC was determined conjointly by NMR-
spectroscopy and X-ray crystallography. This is the first time that these methods were 
united to solve a de novo membrane protein structure. It is the first structure of a 
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human, mitochondrial ion channel. HVDAC adopts a β-barrel fold composed of 18 β-
strands and one α-Helix that is not part of the barrel wall. The N-terminal part, which 
contains the voltage-sensing domain[111], shows in solution an increased flexibility. 
The C-terminal part is mainly responsible for binding of interaction partners. The pro-
apoptotic protein Bid and the anti-apoptotic protein Bcl-xL are interacting with the 
same site in the C-terminal part of HVDAC. Bid and Bcl-xL both belong to the Bcl-2 
family and are structurally homologous. Due to their contrary function related to 
apoptosis their similar binding behaviour with HVDAC is surprising. The lanthanide 
Gadolinium binds to the same site as Bid and Bcl-xL, close to the Ca2+ binding site 
known from literature. This points out that apoptosis related factors compete for the 
same binding site in HVDAC. The antidepressant fluoxetine interacts mainly with the 
C-terminal loop that is not affected by apoptotic factors. Fluoxetine, like Bid, 
stabilises the low conducting state of HVDAC. Since the interaction sites of both 
molecules are not the same this indicates a different mechanism of channel closure. 
ADP interacts with low affinity with HVDAC and the binding sites distributed over 
the whole sequence. This is in line with nucleotide conductivity of HVDAC. The 
nucleotides should not bind tightly to the channel, but rather pass through it quickly. 
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4  




 Kunitz domain proteins, like the bovine pancreatic trypsin inhibitor (BPTI)[126] 
or the dendrotoxins [127], are small, basic proteins that contain three highly conserved 
disulfide bonds. The three disulfide crosslinks make these extracellular proteins 
extremely stable. Two different general functions are known for the different Kunitz 
proteins. One group, including BPTI consists of potent protease inhibitors. The 
complex of BPTI and trypsin is exceptionally stable, with an association constant of 
>1013 M-1 [128]. The dendrotoxins belong to another group of Kunitz peptides found in 
the venom of the black mamba, that block different potassium channels with high 
specificity and selectivity [129]. In snake and scorpion venoms a diverse set of different 
potassium channel blockers has been identified [127]. 
 Despite the great variety of toxins from the venoms of the predatory cone 
snails, relatively few have been identified so far that interact with K+ channels [20]. 
Most conotoxins are small, peptidic toxins, that typically contain 10-30 amino acids 
and bind with high affinity and specificity to various ligand gated or voltage gated ion 
channels. One striking feature of these peptides is that they usually contain a diverse 
complement of posttranslational modifications, like C-terminal amidation, 
hydroxyprolines or glycosylation of serine or threonine [130]. Conotoxins can be 
broadly divided into two groups, the non-disulfide-rich peptides and the disulfide-rich 
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conotoxins. The latter conotoxins are further separated into several families based on 
cysteine bridge pattern and biological activities [20].   
The K+ channel-targeted toxin Conkunitzin-S1 (Conk-S1) from the venom of 
Conus striatus is the first member of a new family of polypeptides. Recently it has 
been shown that Conk-S1 blocks Shaker K+ channels with an IC50 of less than 100 
nM (Imperial et al., unpublished results). Compared to most toxins from Conus 
venoms, Conk-S1 is unusually long (60 amino acids). The only post-translational 
modification of this peptide is the amidation of the C-terminal carboxylic acid. Conk-
S1 shares 33% sequence identity with BPTI and 35% with Dendrotoxin I, indicating 
that it belongs to the Kunitz domain family of proteins (see Table 16). Therefore we 
do not use the term “conotoxin” for Conk-S1, which is restricted to smaller disulfide-
rich peptide toxins from cone snails.  
Table 16 Amino acid sequence of Conk-S1 and alignment with selected Kunitz 
domain proteins 
 1       10        20        30        40        50        60 
Conk-S1 KDRPSLCDLPADSGSGTKAEKRIYYNSARKQCLRFDYTGQGGNENNFRRTYDCQRTCLYT 
BPTI   RPDFCLEPPYTGPCKARIIRYFYNAKAGLCQTFVYGGCRAKRNNFKSAEDCMRTCGGA 
DTI QPLRKLCILHRNPGRCYQKIPAFYYNQKKKQCEGFTWSGCGGNSNRFKTIEECRRTCIRK 
DTK   AAKYCKLPLRIGPCKRKIPSFYYKWKAKQCLPFDYSGCGGNANRFKTIEECRRTCVG 
 
BPTI is the bovine pancreatic trypsin inhibitor [131], DTI and DTK are dendrotoxin I 
and K from Dendroaspis polylepsis polylepsis[131].  
 
One striking difference between Conk-S1 and other native Kunitz-type 
proteins is that it contains only four cysteine residues, resulting in only two disulfide-
bridges instead of the three found in all other native proteins that have been 
biochemically characterized in this group. The homologous cysteine residues of BPTI 
and Dendrotoxin I are replaced by Gly16 and Gln40 of Conk-S1. Therefore, Conk-S1 
is a Kunitz domain protein, in which one of the highly conserved disulfide bridges is 
missing.  
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4.2 Materials and methods 
4.2.1 Expression, refolding and purification of Conk-S1 
The expression construct was prepared and the expression conditions were 
optimized by Roland Graf under supervision of Stefan Becker at the Max-Planck-
Institute for Biophysical Chemistry in Göttingen. Full-length Conkunitzin-S1 cDNA 
sequence was obtained by 5’ and 3’ RACE procedures, as previously described[132, 
133] Degenerate oligonucleotide PCR primers were based on portions of amino acid 
sequence of the isolated peptide[134] and mRNA was isolated from C. striatus venom 
ducts. Details of the isolation of the conkunitzin gene family are being prepared in a 
separate manuscript (J. Garrett et al., in preparation). The cDNA clone coding for the 
Conk-S1 precursor protein (Fig. 34) was used as a template to amplify by PCR the 
coding sequence of mature Conk-S1.  
 
 
Fig. 34 Sequence of the Conk-S1 precursor protein cDNA. The arrowhead indicates 




The forward primer 5‘-GGT GGT TGC TCT TCC AAC AAG GAT CGA 
CCG AGT CTA TGC G-3’ contained an engineered SapI restriction site (underlined). 
The reverse primer 5’-GCT GAA TTC CTG CAG TCA TGT ATA CAG ACA 
CGT TCG TTG GC-3’ contained an engineered PstI restriction site (underlined). The 
PCR product was purified with the MinElute PCR purification kit (Qiagen). The 
SapI- and PstI-digested fragment was purified and cloned into the corresponding sites 
of the pTWIN1 vector (New England Biolabs) downstream of the coding sequence of 
a modified form of the Synechocystis sp. dnaB gene (Ssp DnaB) intein[23, 135]. The 
selected clone was verified by DNA sequencing. 
Conk-S1 and its mutants were expressed in E. coli BL21 (DE3). A one liter 
culture was grown at 37° C in Luria Bertani medium. Six hours after induction with 1 
mM IPTG the culture was harvested and resuspended in a buffer containing 20 mM 
Tris, pH 8.5, 500 mM NaCl, 1 mM EDTA and 0.5 mM PMSF. The cells were lysed 
by ultrasonication and the inclusion bodies were pelleted by centrifugation.  
The inclusion body pellet was dissolved in 20 ml of 6 M guanidinium 
hydrochloride and 50 mM ß-mercaptoethanol. Insoluble debris was removed by 
centrifugation. The supernatant was dialysed for 16 h at 4 °C against 1 liter of a buffer 
containing 3 M guanidinium hydrochloride, 2 mM reduced glutathione, 0.2 mM 
oxidized glutathione, 2 mM EDTA and 50 mM Tris at pH 8. Afterwards the sample 
was dialysed for 16 h at 4 °C against 1 l of the same buffer without guanidinium 
hydrochloride. Precipitant was removed by centrifugation at 75000 x g for 20 min. 
For cleaving the CBD-Ssp DnaB intein tag from the peptide, the supernatant was 
dialysed against a buffer containing 0.5 M NaCl, 1 mM EDTA, 0.5 mM PMSF and 
20 mM Tris, pH 6.5 for 5h at 4 °C, followed by 16 h of dialysis at room temperature. 
Afterwards the buffer was exchanged via dialysis to 50 mM HEPES, pH 7.0. The 
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solution was loaded on a 1 ml HiTrapTM SP XL cation exchange column and the 
peptide was eluted with a 30 ml linear gradient to 1 M NaCl in the same buffer. 
Fractions containing the toxin were pooled, dialyzed against water and lyophilized. 
The toxin was further purified by high performance liquid chromatography (HPLC) 
on a preparative VYDAC C18 reversed phase column. It was eluted with a 30 ml 
linear gradient from 0 to 60% acetonitrile in water and 0.1% trifluoroacetic acid. 
 
4.2.2 NMR Sample Preparation 
NMR spectra were recorded from two samples, which contained either 
0.5 mM 15N-labeled, or 1 mM 15N/13C-labeled Conk-S1 in 0.1 M sodium acetate 
buffer, pH 5.2, with 10% 2H2O. Dipolar couplings were measured from an anisotropic 
sample, in which the peptide was partially aligned. It contained 0.5 mM 15N/13C-
labeled Conk-S1 in 85.5% 0.1 M sodium acetate buffer, pH 5.2, 9.5% 2H2O, 4.3% 
pentaethylene glycol monododecyl ether (C12E5) and 0.7% n-hexanol. The nematic 
phase was formed after vigorous mixing[35].  
 
4.2.3 NMR Resonance Assignment and Structure Calculation 
All spectra were recorded at 27°C on Bruker 600, 700, 800 or 900 MHz 
spectrometers equipped with shielded gradient triple resonance probes. For the 
backbone and side chain assignment the standard heteronuclear (1H, 13C, 15N) strategy 
based on 3D HNCACB, CBCA(CO)NH, HNCO, HN(CA)CO, HCCNH-TOCSY, 
CCONH-TOCSY, and HCCH-TOCSY experiments was used[89]. The backbone 
resonance assignment was achieved automatically with the assignment program 
MARS [136]. 3JHN-HA coupling constants were obtained using two-dimensional CT-
HMQC-J spectra and were converted to Φ torsion angles with the empirical Karplus 
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equation [137]. χ1 torsion angles were gained from two-dimensional HNCG spectra 
[138]. The program TALOS was used to obtain the backbone dihedral angles (Φ and Ψ) 
on the basis of chemical shift information [139]. Interproton distance restraints were 
derived from 3D 15N-edited NOESY (120 ms mixing time) and 13C-edited NOESY 
spectra (128 ms mixing time). The NMR data were processed and analyzed using 
NMRPipe, NMRDraw [76] and SPARKY (T. D. Goddard and D. G. Kneller, SPARKY 
3, University of California, San Francisco, CA). 
The NOE spectra were automatically peak picked and integrated with 
SPARKY. NOE cross peaks were assigned both manually and automatically by the 
programs ARIA2alpha [140]. Unambiguous cross peak assignments with a range of 1.7 
to 5 Å set by ARIA2alpha were used for the final structure calculations. 
Residual 1DN-H, 1DCA-HA, 1DN-C and 1DC-CA dipolar couplings were gained from 
the difference between the J couplings measured in the aligned and isotropic media. 
1JN-H and 1JN-C couplings were measured simultaneously from interleaved 3D 
TROSY-HNCO[141] spectra and 1JCA-HA and 1JCA-C were obtained simultaneously from 
interleaved 3D CBCA(CO)NH spectra [142]. The magnitude (normalized to 1DN-H) and 
rhombicity of the alignment tensor were 13.0 Hz and 0.38, respectively, as 
determined from the histogram of dipolar couplings by the program PALES [37].  
Initially, a medium resolution structure was calculated with the program 
Rosetta NMR [143] based on dipolar couplings and chemical shift information, and 
applying the ITAS approach [144]. This structure was used as a starting point for 
calculation of a high-resolution structure using CNS Solve 1.1 [145], interfaced with 
ARIA 2alpha. A simulated annealing protocol with 14 iterations was performed. In 
the last iteration step a total of 500 structures were calculated. The 20 structures with 
lowest total energy were further refined in explicit water[146] and were used for the 
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statistics. A total of 659 NOE’s, 493 of them short range (|i - j| ≤ 1), 78 medium range 
(1 < |i - j| < 5) and 88 long range (|i - j| ≥ 5) NOE’s, 201 dipolar couplings, 126 
dihedral angles and two disulfide bridge constraints were used in structure 
calculations.  
 
4.2.4 Electrophysiological Measurements 
To study the effects of the wild type and mutants of Conk-S1 with the Shaker K 
channel the Xenopus oocyte expression system was used. Oocyte preparation and 
Shaker RNA injection were basically performed as described by Jacobson et al. [147] 
(see 2.2.4).  
 
4.3 Results 
4.3.1 Refolding and Purification of Conk-S1 
 Conk-S1 could be expressed as a fusion protein with a modified Ssp DnaB 
intein[23, 135] in large amounts, but mainly in insoluble form. Active Conk-S1 contains 
two disulfide bridges. Therefore oxidants for the disulfide bridge formation were 
added during refolding trials. Initially refolding was done at pH 7.7 in the presence of 
1 mM ß-mercaptoethanol as a reducing agent. The C-terminal cleavage reaction of the 
Ssp DnaB intein was found to be pH-dependent, with an optimum between pH 6.0 
and 7.5[23]. Therefore after refolding the fusion protein was cleaved by shifting the pH 
from 7.7 to 6.5. Since the Ssp DnaB intein tag also contained a chitin-binding domain 
(CBD) the cleavage reaction was at first carried out on chitin resign. However only 
approx. 50 % of the fusion protein could be cleaved this way. Executing the cleavage 
reaction in solution during a dialysis step resulted in an almost complete cleavage. In 
an SDS-PAGE analysis (Fig. 35, lanes 1-2) only a minor band of the fusion protein 
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was left after cleavage while a new band with the expected molecular weight of 
Conk-S1 became clearly visible. Subsequent purification by HPLC resulted in an 
average yield of 0.5 mg. By introducing a cation exchange chromatography step 
before HPLC the yield was increased more than 1.5 fold. Hereby the very basic Conk-
S1 (pI 9.12) was successfully separated by cation exchange chromatography from the 
acidic fusion partner Ssp DnaB (pI 6.15) as well as from most E. coli proteins 
(Fig. 35, lane 3). Furthermore, replacing ß-mercaptoethanol as oxido shuffling agent 
by 2 mM reduced glutathione and 0.2 mM oxidized glutathione resulted in doubling 
of the yield. The combination of reduced/oxidized glutathione in the refolding buffer 
at pH 8.0  with the  two  step  purification  by  cation  exchange  chromatography  and  
 
 
Fig. 35 Analysis by Coomassie-stained SDS-PAGE. Lane 1: supernatant of refolding 
from 6 M Gdn-HCl; lane 2: after cleavage of the SspDnaB/Conk-S1 fusion protein by 
pH shift; lane 3: combined fractions below peak 2 from SP Sepharose column; lane 4: 
final product after HPLC purification. 
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HPLC proved to be most successful. In the end from 1 L of LB expression culture 
1.9 mg of highly pure, refolded Conk-S1 (Fig. 35, lane 4) were reproducibly obtained. 
 
4.3.2 Resonance Assignment and Tertiary Structure 
The 15N HSQC of Conk-S1 displayed an excellent chemical shift dispersion 
indicative of a well-folded, rigid protein (Fig. 36) 
 
 
Fig. 36: 15N-HSQC spectrum of 1 mM Conk-S1 in 0.1 M sodium acetate buffer, pH 
5.2. The spectrum was recorded at 27°C on a 600 MHz spectrometer. Assigned 
residues are labelled with the one letter amino acid code.  
 
Backbone resonances for all residues except Gly39 and Tyr51 could be 
identified in the 15N HSQC spectrum. In total 96.97% of the backbone resonances and 
91.63% of the side chain chemical shifts have been assigned. The superposition of the 
20 structures with the lowest total energy is shown in Figure 37b.  
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Fig. 37: NMR solution structures of Conk-S1. (a) Stereo view of the backbone atoms 
(N, Cα, C, O). Represented is the mean structure of the 20 structures with lowest total 
energy. Cysteine bridges are marked in orange. (b) Superposition of the 20 structures 
with lowest total energy. Ribbon presentation of the backbone including side chains, 
represented as lines. Helices are marked in red and ß strands in cyan. All figures were 
created with the program MOLMOL [148] 
 
The quality of the solution structures is summarised in Table 17. In the 
Ramachandran plot 82.5% of the dihedral angles appear in the most favourable region 
and 16.5% in the additionally allowed region. For all heavy atoms the root mean 
square deviation from the mean structure is 1.4 Å and for the backbone atoms it is 0.5 










Table 17 Structural statistics 
Parameter  
R.m.s.d.s from experimental restraints   
NOEs (659) [Å] 0.085 ± 0.023 
Dihedral angles (126) [°] 2.75 ± 0.15 
  






R.m.s.d.s to the averaged coordinates [Å]  
Backbone heavy atoms  0.5 
All heavy atoms  1.4 
  
Distance restraint violations  
Number > 0.5 Å  0.6 ± 0.9 
Maximum [Å]  1.60 ± 0.65 
  
Energies [kcal/mol]  
Eall  -560 ± 108  
Eangle  322 ± 12  
ENOE  187 ± 24  
  
Ramachandran statistics  
Most favouable region (%)  82.5  
Additional allowed region (%)  16.5  
Generally allowed region (%)  0.3  
Disallowed region (%)  0.7  
 
Steady state heteronuclear 15N{1H}-NOEs for most of the Conk-S1 backbone 
amides are above 0.6 indicating that the backbone of Conk-S1 is well ordered in 
solution (Fig. 38). Only Thr 60 and Ala19 are flexible with 15N{1H}-NOE values of 
0.22 and 0.15, respectively, and the three N-terminal residues are affected by motion. 
Ala19 is located in the region homologous to the antiprotease loop of BPTI and is 
close to the “missing” third disulfide bond, which would link the positions of Gly16 
and Gln40.  
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Fig. 38 The 15N-1H-NOE of Conk-S1 plotted against the residue number 
 
The solution structure of Conk-S1 resembles the typical Kunitz type fold. It 
consists of a 310-helix of residues 6 to 8, a twisted β-hairpin of residues 20 to 36 and 
an α-helix of residues 50 to 56. The two helices are connected by the disulfide bridge 
between Cys7 and Cys57. The C-terminal helix is also connected to the β sheet by the 
disulfide bridge between Cys32 and Cys53. The disulfide bridge 7-57 was confirmed 
by 4 direct NOE contacts between these residues. For the other S-S pairing no direct 
contact could be observed. In this case NOEs between Cys32 and Gln54 and other 
long-range NOEs between residues close to the cysteines were used to confirm the 
cysteine bridge.  
To verify, that the disulfide bonds were actually formed, electrospray 
quadrupole mass spectra were recorded. The theoretical mass of Conk-S1 without 
disulfide bridge formation would be 6933,6 Da. The experimentally derived mass was 
6929,3 ± 0.8 Da, consistent with the formation of two disulfide bonds. The same 
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analysis was carried out for the G16CQ40C mutant Conk-S1CC. Theoretical mass of 
the reduced state and experimental mass are 6954,7 Da and 6948,2 ± 0.9 Da, 
respectively, consistent with the formation of three disulfide bonds.  
 
4.3.3 Functional characterization with voltage clamp experiments  
Since the recombinant Conk-S1 does not contain the amidated C-terminus 
observed in the native peptide, the affinity of the recombinant peptide on Shaker K+ 
channels expressed in Xenopus oocytes was measured. The functionality of the 
recombinant Conk-S1 with the free acid at the C-terminus was assayed by two-
electrode voltage clamp measurements. For these experiments the Shaker K+ channel 
with removed N-terminal inactivation domain (Shaker-Δ6-46)[149] was used because it 
was reported that the current mediated by this mutant is more strongly modified by 
the presence of toxins[150, 151]. Fig. 39 shows that this channel was blocked by Conk-
S1 with an IC50 value of 502 ± 140 nM (n = 3).  
Since it has been reported that κM-conotoxin RIIIK[152], which is also 
blocking Shaker K+ channels, showed an increase in affinity when tested on a are pore 
mutant of this channel (K427D), the functional effect of Conk-S1 on this mutated 
Shaker channel was also investigated. Most interestingly the affinity of Conk-S1 for 
this mutant was 0.22 ± 0.08 nM (n = 4), which is more than 2000-fold higher than for 




Fig. 39 a) Whole cell currents upon depolarizing from –100 to 0 mV are shown 
before and after toxin application. Currents were recorded from oocytes expressing 
either wild type or K427D Shaker-Δ6-46 channel. The corresponding channel is 
indicated beside, the corresponding toxin above the curves, respectively. The toxin 
concentration is shown next to the curve, which was recorded after toxin application. 
The vertical bars represent 2 µA. The filled and open circles and squares are related to 
section b. b) Dose-response curves of wild type (filled symbols) and K427D (open 
symbols) Shaker-Δ6-46 channels. Currents were blocked by Conk-S1 (circles) and 
Conk-S1CC (squares). The symbols are also shown in section a) at the corresponding 
toxin/channel combination. The test potential was 0 mV and n was between 2 and 5 
for the different toxin concentrations.  
 
All Kunitz domain proteins functionally analysed so far contain three disulfide 
bridges. To evaluate the importance of the "missing" disulfide bridge in Conk-S1 a 
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double cysteine mutant (Conk-S1CC) carrying an additional cysteine bridge between 
the positions 16 and 40 was constructed and the activity of this peptide on K+ 
channels was measured. Most interestingly the affinity of Conk-S1CC to Shaker-Δ6-46 
was 385 ± 58 nM (n= 3) showing that within the accuracy of measurements wild type 
and mutant Conk-S1 displayed the same inhibitory potential for Shaker channels. In 
addition, the affinity of Conk-S1CC to Shaker-Δ6-46 K427D channels is 
0.22 ± 0.05 nM (n= 3), which is also identical to the binding affinity of Conk-S1 to 
this channel mutant. Therefore, for both the wild type sequence and Conk-S1CC an 
increase in affinity by a factor of approximately 2000 is observed. For Conk-S1 and 
Conk-S1CC dose response measurements with the wild type and K427D K+ channels 
were performed as well, resulting in almost identical IC50 values (see Fig. 39). The 
Hill coefficients for the block of both channels by both peptides were all about 1, 
indicating no cooperativity for the binding of both peptides to the channels. 
The kinetic analysis of the block of Shaker-Δ6-46 K427D channels by Conk-
S1 and Conk-S1CC resulted in kon values (for the forth reaction) of 17 ± 5 s-1µM-1 for 
Conk-S1 and 7 ± 3 s-1µM-1 for Conk-S1CC. The koff values (for the back reaction) 
were 0.0041 ± 0.0006 s-1 for Conk-S1 and 0.0029 ± 0.0023 s-1 for Conk-S1CC. This 
analysis revealed that although the steady state affinity of Conk-S1 and Conk-S1CC is 
virtually identical there are some differences in the kinetics of binding of both 
peptides to the ion channel.  
Like Conk-S1, dendrotoxins are also Kunitz domain proteins, which interact 
with potassium channels. From literature[129, 153-158] it is known, that mainly positively 
charged and aromatic residues of the dendrotoxins are involved in receptor binding. 
Based on this knowledge, alanine-scanning mutagenesis of positively charged and 
aromatic residues in Conk-S1 was carried out, in order to characterise the binding 
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surface. The affinity of the toxin mutants was functionally investigated by voltage 
clamp experiments using Xenopus oocytes expressing either Shaker-Δ6-46 or Shaker-
Δ6-46 K427D channel. The results of this assay are summarised in Table 18.  
 
Table 18 IC50 values for Shaker-Δ6-46 and Shaker-Δ6-46 K427D block by Conk-S1 
and its mutants. The ratio of mutant and wild type IC50  value is given in brackets.  
IC50 [nM] Shaker-Δ6-46 Shaker-Δ6-46 K427D 
Conk-S1 wt 502 ± 140 0.22 ± 0.8 
Conk-S1CC 385 ± 58 (0.8) 0.22 ± 0.05 (1) 
K18A 1047 ± 619 (2) 0.42 ± 0.06 (2) 
R29A 3678 ± 1500 (7.3) 3.36 ± 1.9 (16) 
K30A 4127 ± 2397 (8.2) 3.77 ± 1.1 (18) 
R29KK30A 1016 ± 89 (2) 0.56 ± 2.7 (2.5) 
R3A 5124 ± 1289 (10.2) 2.98 ± 0.75 (12.9) 
Y37A did not refold  
R48A 3186 ± 1672 (6.4) 0.9 ± 0.5 (4.3) 
Y24A 4273 ± 2342 (8.4) 0.92 ± 0.2 (4.4) 
R22A 2177 ± 747 (4.3) 1.2 ± 0.7 (5.7) 
R55A 7076 ± 2719 (14) 3.16 ± 1.2 (15) 
K21A 273 ± 143 (0.5) 7.1 ± 3.8 (33.8) 
R49A 5111 ± 2253 (10) 7.6 ± 3.9 (36.2) 
R34A 924 ± 102 (1.8) 8.3 ± 2.7 (39.5) 
F35A no block 9.33 ± 3.2 (44.4) 
Y51A no block 9.55 ± 1 (45.5) 
 
The mutants can be divided into 4 groups, based on their affinity to the receptors. The 
first group (coloured in white in Fig. 40) contains residues for which the alanine 
substitution resulted in an IC50 value, which was up to 5 fold bigger than the one of 
the wild type blocking Shaker-Δ6-46 K427D. These are K18, R48 and Y22. G16 and 
Q40 were replaced by cysteine, which had no effect, and therefore join this group. 
The second group (coloured in yellow in Fig. 40) contains the residues, which gave 
rise to a 5 to 10 fold increase of the IC50 value. This is R22. The third group (coloured 
in orange in Fig. 40) contains the residues, which gave rise to a 10 to 30 fold increase 
of the IC50 value. These are R3, R29, K30 and R55. The fourth group (coloured in red 
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in Fig. 40) includes the residues with the strongest effect, resulting in IC50 values, 
which are more than 30 times bigger than that of the wild type Conk-S1. These are 
K21, R34, F35, R49 and Y51. These results are visualized on the Van-der-Waals 
surface plot of Conk-S1 in Fig.  40.  
 
 
Fig. 40 Van-der-Waals surface plots of Conk-S1 stepwise rotated by 90°. Residues in 
Conk-S1 coloured in blue are not mutated, coloured in red are mutated to alanine and 
have a more than 30 times (group 4), coloured in orange a 30-10 times (group 3), in 
yellow a 10-5 (group 2) times and in white less than 5 times (group 1) lower affinity 
to K427D Shaker-Δ6-46 channel. 
 
4.4 Discussion 
 In this work, the structure of a Kunitz domain polypeptide toxin from the 
venom of the fish-hunting cone snail Conus striatus was solved. Proteins with Kunitz 
domains can be divided into two general classes: the “heterogeneous Kunitz-domain-
containing proteins”, with one or more Kunitz domains, but in combination with other 
structural motifs, and the “homogeneous Kunitz-domain polypeptides” (which was 
referred to above simply as “Kunitz domain proteins”) that are exclusively composed 
of Kunitz domains.  Such polypeptides may contain one or more Kunitz domains, but 
have no other domain motifs. Conkunitzin-S1 clearly belongs to the latter class. 
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 Conkunitzin-S1 is the first natural Kunitz-domain protein with only two 
disulfide bonds (all other natural Kunitz-domain proteins such as BPTI or the 
dendrotoxins have three disulfide crosslinks). Only among the heterogeneous Kunitz-
domain-containing proteins Kunitz domains with only two disulfides have been 
reported (the trophoblast Kunitz-domain proteins (TKDPs) [159]).  These appear to 
function as protease inhibitors, and their structure has not been solved yet. 
It has been demonstrated that, despite containing only two cysteine bridges, 
the structure of Conk-S1 is very similar to that of other Kunitz domain peptides like 
BPTI (backbone Cα r.m.s.d. = 1.3 Å) and the dendrotoxins (backbone Cα r.m.s.d. to 
Dendrotoxin I = 2.2 Å).   
 
4.4.1 Comparison of Conk-S1 with the structures of BPTI and 
dendrotoxins  
Native BPTI with three disulphide bonds is extremely stable. It has been 
demonstrated that removing any one of these cysteine bridges still results in the native 
conformation, which is stable under normal conditions [160]. The most productive 
BPTI folding pathway includes a cysteine bridge rearrangement of non-native 
disulfide intermediates. This rearrangement facilitates the folding process under most 
experimental conditions. The most important of these intermediates of BPTI are 
(Cys30-Cys51, Cys5-Cys14) and (Cys30-Cys51, Cys5-Cys38)[161]. This folding 
pathway is not possible for Conk-S1 because the cysteines 14 and 38 (corresponding 
to 16 and 40 in Conk-S1) are replaced by glycine and glutamine, respectively. The 
folding of Dendrotoxin I and Dendrotoxin K uses similar folding pathways as BPTI, 
but with important energetic and kinetic differences. In particular, a direct pathway, 
without disulfide rearrangements, is significantly more populated than in BPTI 
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folding [160]. The existence of a native Kunitz domain with two replaced cysteines, as 
determined in this study, confirms that non-native disulfide intermediates are not 
necessary for the folding of Kunitz domains. This is also consistent with other studies, 
where mutants of BPTI, which lack Cys14 and Cys38, still folded properly[162]. 
Another mutant of BPTI with only two disulfide bridges (Cys30-Cys51, Cys14-
Cys38) also shows a native fold while the corresponding mutant in Dendrotoxin K is 
only partly folded. This is due to the generally lower stability of dendrotoxins 
compared to BPTI [160]. Conk-S1 is structurally and functionally similar to the 
dendrotoxins. Considering the compromised folding of cysteine mutants in 
dendrotoxins, it is surprising that Conk-S1 still attains the typical Kunitz fold. 
 
4.4.2 Comparison of the NMR and crystal structure of Conk-S1  
 Dy et al[163]. solved the crystal structure of Conk-S1 by X-ray crystallography. 
The fold determined by NMR agrees very well with the crystal structure[163]. The 
backbone RMSD of the NMR-structure with lowest total energy compared to one 
representative of the crystal structure (PDB code1Y62) is 0.98 Å. This value is similar 
to others reported for NMR and X-ray structure comparisons at similar experimental 
resolution[163, 164]. To test, if differences in the atomic coordinates are due to real 
structural differences, protons where added to the crystal structure by Dy and co-
workers and the NOE energies where calculated. These energies where similar to or 
lower as the NOE distant restraint energies of the NMR ensemble. Therefore greater 
perturbation of Conk-S1 by crystallisation can be excluded. The difference in the 
atomic coordinates can rather be explained by different mathematical treatment of the 
X-ray and NMR data[163]. The correlation of the experimentally observed RDCs 
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compared to the ones calculated based on the NMR structure with lowest total energy 
is 0.983 (see Fig.41a).  
 
 
Fig. 41 Correlation between experimentally observed and calculated HN, C’N, C’Cα 
and CαHα RDCs of Conk-S1. The C’N, C’Cα and CαHα RDCs are normalized to the 
values of HN by the factor γHγNr-3HN/γAγBr-3AB, where γx is the gyromagnetic ratio of x 
and rAB is the distance between A and B. In a) the RDCs are calculated based on the 
NMR structure with the lowest total energy, in b) they are calculated based on one of 
the crystal structures deposited in 1Y62 in the PDB, which has the lowest RMSD to 
the observed RDCs.  
 
RDCs calculated based on one member of the crystal structure ensemble have a 
correlation of 0.933 (see Fig. 41b) to experimentally observed ones. This also 
supports the view, that Conk-S1 is not much perturbed by crystallisation. 
 
4.4.3 Functional investigation of Conk-S1  
Recently it has been shown that the native, C-terminally amidated Conk-S1 
blocks Shaker K+ channels with an IC50 of about 60 nM (Imperial et al., unpublished 
results). In our study a recombinant Conk-S1 has been used, which is lacking the C-
terminal amidation. The functional consequence of this difference was studied by 
measuring the affinity of the recombinant Conk-S1 on Shaker-Δ6-46 channels 
expressed in Xenopus oocytes. The IC50 value of the recombinant Conk-S1 used in 
this study is 6 to 7 times higher than that of the native Conk-S1, indicating a reduced 
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inhibitory potential of the recombinant toxin. Despite this contribution of C-terminal 
amidation of Conk-S1 for K+ channel inhibition, our results demonstrate that 
recombinant Conk-S1 is functional. This provided the opportunity to use this 
recombinant neurotoxin for investigating structure, dynamics, electrophysiological 
properties and the effects of mutations. 
 Most interestingly the electrophysiological measurements revealed that there 
is no difference in the affinity between Conk-S1 with two disulfide bonds and the 
three-disulfide bonded mutant Conk-S1CC. Furthermore, both peptides exhibit an 
approximately 2000 fold higher affinity to the K427D mutant of the Shaker K+ 
channel than to the wild type channel. This result indicates that Conk-S1 blocks K+ 
channels by interacting with the ion channel pore. Furthermore it underscores the 
importance of residue 427, located in the outer vestibule of the ion permeation 
pathway, for the binding of different conotoxins to K+ channels. In addition, it 
suggests that the "missing" cysteine bridge is not of critical functional importance for 
the block of the K+ channel by Conk-S1. 
 Despite the identical steady state values, the kinetic analysis revealed some 
differences in the binding of both toxin analogues. The kon and the koff values for 
Conk-S1 were approximately two times higher than for Conk-S1CC. Thus, Conk-S1 
binds twice as fast to the channel as Conk-S1CC, but it is also released twice as fast 
from its binding site. Therefore, the two effects compensate, resulting in identical IC50 
values of Conk-S1 and Conk-S1CC. From the kinetic point of view, this indicates that 
for Conk-S1CC the formation of the complex with the channel as well as the 
dissociation of this complex might have a higher energy barrier. This is likely related 
to the number of disulfide bonds: the additional cysteine bridge makes Conk-S1CC 
more rigid, especially because Conk-S1 shows decreased 15N{1H}-NOE values in the 
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region of the “missing” disulfide bond (Fig. 38). These residues are K18, A19 and 
G41 with 15N{1H}-NOE values of 0.57, 0.22 and 0.62, respectively. Due to a low 
expression level of Conk-S1CC no NMR-sample of Conk-S1CC was prepared. 
Therefore 15N{1H}-NOE values could not be obtained. However it is very likely that 
the 15N{1H}-NOE values in the region of the “missing” disulfide bond will be 
increased compared to the wild type. For binding of the toxin to the channel, 
flexibility within Conk-S1 may enhance the rate of binding to the channel by allowing 
the toxin to adjust more easily into the binding pocket within the ion channel pore. 
This agrees very well with the observation that KcsA-Kv1.3, a K+ channel 
homologous to Shaker, undergoes particular conformational changes upon Kaliotoxin 
binding[165]. The authors suggest that these intrinsic dynamics are prerequisite for 
high-affinity receptor binding. These results imply, that toxins and their receptors act 
like ligand/enzyme complexes, because all enzymes require dynamic processes during 
substrate binding events (reviewed in [166]). It was described, that pre-existing 
equilibria of conformational substates are important for conformational changes 
(reviewed in [167]). The presented data suggest that this is also the case for the 
interaction of Conk-S1 with Shaker K+.  
Interestingly, experiments with non-native disulfide bond patterns in 
dendrotoxins resulted in the reverse situation [168] as for Conk-S1. When the disulfide 
bond homologous to the missing third disulfide bond of Conk-S1cc was selectively 
removed from Dendrotoxins I and K with iodoacetamide, derivatized dendrotoxins 
showed a 5 to 10 times lower affinity than the unmodified toxins. One possible 
explanation for this effect could be steric hindrance by the acetamide group. On the 
other hand, the different results obtained for dendrotoxins and Conk-S1 may indicate 
a different binding mode of Conk-S1 and dendrotoxins, even though these peptides 
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both target voltage gated K+ channels. In another report it was shown, that by 
selectively reducing the cysteine bridge in BPTI, which is homologous to the one 
introduced into Conk-S1CC, with borohydride, no change in activity was observed 
[169]. Therefore, Conk-S1 more closely resembles BPTI than the dendrotoxins with 
respect to the importance of this disulfide bond for the functional activity of the 
peptide. 
Further mutational analysis of Conk-S1 support the hypothesis of a different 
binding mode compared to dendrotoxins. Several studies present the functionally 
important side chains of dendrotoxins that are involved in receptor interactions. The 
residues in the N-terminus, especially in the 310-helix, are known to be important in 
dendrotoxins for the interaction with the K+ channel [129] [153] [154] [155] [156]. Particularly 
the point mutation K3A in Dendrotoxin K [155] [153] or K5A and L9A in α Dendrotoxin 
[154] show more than 1000 times lower binding affinities to the receptor. The β hairpin 
region, where a lysine triplet is located, is known to be involved into the channel 
recognition only in Dendrotoxin K [153], δ Dendrotoxin [129] and Dendrotoxin I [157] but 
not in α Dendrotoxin [158]. Another binding site in Dendrotoxin I which is proposed 
by Katho et al. [156] is the triad Lys19/Thyr17/Trp37, which is located in the anti-
protease loop (Fig. 42a-d).  
Based on these data, the following mutations were introduced into Conk-S1: 
R3A, which is located in the N-terminus of Conk-S1, R29A and K30A, which are 
located in the hairpin region, and K18A and Y37A, which are located in the anti-
protease loop. Electrophysiological measurements revealed that, against any 
expectation, only moderate changes in affinity to the receptor were observed for the 
mutants compared to wild type Conk-S1. Therefore one can assume, that the mutated 
residues are not or very weakly involved in the binding to the channel. To map 
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functionally important residues, also positively charged and aromatic residues were 
investigated by alanine scanning mutagenesis. The mutants K21A, R34A, R49A, 
F35A and Y51A showed the strongest decrease of affinity to the Shaker channels. 
Therefore they most likely belong to the binding interface of Conk-S1. The binding 
sites of Conk-S1 and, in comparison to that, of the dendrotoxins are visualized on the 
Van-der-Waals surface plots in Figure 42.  
 
 
Fig. 42 Equivalent views of Van-der-Waals surface plots of DTX-I (a-d) and Conk-S1 
(e-h), stepwise rotated by 90° from a to d and e to h, respectively. a-d) Residues in 
Dendrotoxins known from literature[129, 153-158] to be involved into receptor binding are 
coloured in magenta. e-h) Residues in Conk-S1 coloured in blue are not mutated, 
coloured in red are mutated to alanine and have a more than 30 times (group 4), 
coloured in orange a 30-10 times (group 3), in yellow a 10-5 (group 2) times and in 
white less than 5 times (group 1) lower affinity to K427D Shaker-Δ6-46 channel.  
 
Most interestingly the binding sites of the dendrotoxins are located on the bottom and 
on the top of the molecule, while for Conk-S1 the residues, which are most likely 
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involved in receptor binding are located in the middle of the toxin (Fig. 42). This 
demonstrates a different mode of binding of Conk-S1 compared to the dendrotoxins. 
  
4.5 Conclusions 
 In conclusion, the structure of Conk-S1 was determined by solution NMR. It 
is an unusual K channel-targeting toxin that has a consensus Kunitz-domain amino 
acid sequence, but lacks one of the three disulfide bonds that are conserved in all 
natural Kunitz domain peptides characterized to date. The structure does not strongly 
diverge from those of standard Kunitz domains with three disulfide bonds. A Conk-S1 
double mutant with the third Kunitz domain disulfide bond had similar K channel 
blocking activity, indistinguishable from that of the native peptide. Both the two- and 
three-disulfide crosslinked toxins had much higher affinity for the K427D Shaker K-
channel mutant, suggesting that they interacted equally avidly with the vestibule of 
the ion channel pore. Interestingly, Conk-S1 adopts a different mode of receptor 
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A   Chemical shift assignment of HVDAC 
 CAi CAi-1 C’i-1 HN N 
A17 - - - 8.317 122.1 
R18 59.86 - - 7.285 117.3 
K23 - - - 7.816 122.0 
Y25 55.82 44.24 171.6 6.585 113.7 
G26 46.02 55.96 175.9 8.672 105.3 
G28 46.54 - 178.2 7.550 105.0 
L29 53.86 46.74 175.8 7.331 120.5 
I30 60.62 53.67 - 8.916 126.3 
K31 54.81 60.75 175.0 8.746 126.8 
L32 53.32 54.87 174.0 8.699 124.1 
D33 53.73 - 173.9 9.104 123.9 
N40 52.65 54.84 175.2 8.572 120.3 
G41 45.16 52.63 - 7.849 106.5 
L42 53.03 45.19 172.9 7.466 118.4 
G48 44.92 53.58 173.2 9.111 111.5 
S49 56.66 44.88 172.0 9.076 116.0 
A50 49.40 56.67 172.2 9.149 123.9 
N51 52.64 49.40 - 8.303 122.5 
T55 62.03 60.26 176.2 7.652 122.5 
K56 56.32 62.10 - 9.273 122.2 
V57 59.74 56.25 176.8 8.606 125.1 
T58 60.17 59.67 177.1 7.863 111.7 
E62 54.88 54.71 175.0 8.685 127.0 
T63 60.06 55.02 - 9.008 116.0 
T89 60.73 59.82 174.5 9.064 123.7 
V90 59.92 60.83 173.0 9.300 124.4 
E91 54.88 - - 8.765 124.5 
G97 45.08 57.74 177.2 9.382 115.5 
L98 53.69 45.00 173.7 7.896 122.8 
K99 55.13 53.81 175.3 9.674 132.5 
T101 61.15 53.49 174.5 9.123 120.4 
F102 56.05 49.96 172.8 9.448 127.1 
D103 52.22 56.10 173.0 8.623 129.0 
G111 45.70 60.02 175.5 9.377 112.8 
K112 56.33 45.45 173.7 7.445 120.5 
K113 55.39 56.55 173.8 8.804 129.5 
N114 53.63 55.58 172.9 8.248 125.6 
K116 54.53 - - 8.987 119.7 
I117 59.34 - 177.8 8.778 120.4 
K118 54.64 59.25 175.0 9.268 126.8 
T119 60.15 54.62 175.8 8.671 117.2 
G120 44.45 60.64 174.5 9.157 113.8 
Y121 56.54 44.33 171.1 9.126 123.5 
K122 52.80 56.48 172.2 7.572 124.9 
R123 53.77 52.85 172.9 8.697 117.6 
I126 59.84 - 173.5 7.886 118.0 
N127 52.77 59.90 171.9 8.962 125.4 
L128 53.25 52.78 174.5 9.487 128.9 
G129 44.77 53.18 175.8 9.480 113.6 
C130 58.10 44.78 171.9 8.519 121.3 
D131 52.41 58.19 172.7 9.366 130.1 
M132 52.44 - 174.9 9.396 123.2 
I136 62.70 53.07 174.8 8.375 119.4 
A137 52.42 63.02 - 8.461 123.4 
G138 44.52 52.42 178.0 7.670 106.3 
 CAi CAi-1 C’i-1 HN N 
S140 57.55 64.69 - 8.492 119.8 
I141 59.55 57.33 172.7 9.083 122.5 
R142 53.82 59.62 173.3 9.027 128.5 
G143 43.79 53.88 176.1 8.720 113.4 
A144 50.83 43.76 170.7 8.928 124.0 
L145 53.60 50.83 174.9 9.229 123.9 
V146 60.92 53.62 174.4 9.009 125.2 
L147 51.98 60.88 174.7 9.344 126.2 
G148 44.66 51.93 176.2 8.136 105.2 
Y149 59.06 44.71 172.9 8.577 122.4 
E150 56.91 59.10 173.6 9.203 125.6 
G151 45.09 57.04 175.3 8.006 108.1 
W152 57.23 45.09 173.3 8.100 121.5 
L153 53.47 57.21 177.4 8.954 123.5 
A154 50.68 53.47 175.4 8.860 121.7 
G155 45.25 50.70 175.4 9.625 107.7 
Y156 55.91 45.26 171.2 9.200 122.2 
Q157 53.08 55.97 171.9 8.204 128.0 
M158 52.87 52.75 172.2 8.736 121.3 
N159 52.27 52.60 174.3 7.961 119.4 
F160 56.11 52.30 175.4 9.539 127.7 
E161 54.87 56.17 173.5 8.035 127.7 
S165 58.34 54.53 175.3 7.469 114.7 
R166 53.72 58.65 173.1 6.795 115.0 
S170 57.05 55.27 174.6 8.320 119.0 
N171 51.47 57.03 172.6 9.110 127.3 
F172 56.04 51.47 171.9 8.602 118.3 
A173 50.97 56.05 173.4 8.818 122.7 
V174 60.09 50.98 176.2 8.211 116.8 
G175 45.66 60.13 175.5 9.415 113.0 
Y176 56.54 45.67 170.0 8.578 119.4 
L183 53.42 53.54 173.9 9.349 127.8 
T185 60.22 53.74 174.5 9.064 120.8 
N186 53.06 60.02 171.8 8.854 116.5 
V187 60.00 52.97 172.6 8.915 118.4 
N188 51.27 59.98 175.0 9.315 129.3 
E192 54.47 60.94 172.7 8.918 126.9 
F193 55.80 54.51 174.3 8.869 125.8 
G194 44.50 55.80 175.7 8.533 110.5 
G195 45.43 44.46 171.6 8.626 105.6 
S196 56.02 45.49 171.4 9.752 114.7 
I197 56.49 56.29 174.6 8.752 119.3 
L205 53.10 - - 9.043 130.0 
E206 54.11 53.30 174.1 8.830 125.6 
T207 59.45 54.02 174.8 8.383 112.2 
A208 50.75 59.43 171.6 9.022 122.5 
V209 59.45 50.71 - 8.951 116.9 
N210 51.98 59.45 174.4 8.858 122.6 
L211 54.12 51.90 172.5 8.705 121.7 
A212 51.81 54.14 175.2 9.193 126.5 
W213 57.67 51.78 175.4 8.965 121.3 
T214 60.35 57.77 173.2 8.513 120.6 
A215 53.19 60.35 173.7 8.672 127.2 
R221 54.98 62.66 174.5 9.036 125.6 
F222 55.79 54.92 175.1 8.026 119.2 
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 CAi CAi-1 C’i-1 HN N 
G223 45.01 55.86 173.5 8.561 107.8 
I224 59.57 45.01 171.0 8.804 118.7 
A225 50.16 59.60 172.1 8.857 126.3 
A226 50.20 49.68 175.3 9.198 119.4 
K227 56.11 50.27 177.0 8.755 122.6 
Y228 55.22 56.06 174.2 9.855 129.0 
Q229 54.39 55.26 173.5 9.010 131.6 
I230 64.58 54.29 173.7 7.810 130.1 
D231 52.69 - 175.7 8.422 118.4 
D233 53.54 - 177.7 7.210 115.2 
A234 51.62 53.82 - 7.662 124.3 
C235 56.21 51.62 175.1 8.452 119.1 
F236 55.63 56.00 171.8 9.232 128.0 
S237 57.35 55.55 173.0 9.319 124.5 
A238 50.70 57.38 - 8.016 122.9 
K239 54.61 50.67 175.7 9.033 114.8 
V240 59.45 54.62 174.6 8.948 117.0 
S244 56.50 56.30 - 8.630 120.6 
L245 54.77 56.37 175.8 8.464 124.7 
I246 59.45 53.77 176.7 9.037 126.7 
G247 44.03 59.49 174.8 9.280 114.5 
L248 53.21 44.05 171.4 9.370 122.3 
G249 44.66 53.20 - 9.169 110.5 
Y250 56.15 44.64 170.9 9.088 125.5 
T251 60.76 56.06 174.7 8.354 124.5 
Q252 52.52 - - 9.019 126.1 
L254 53.73 59.44 - 7.279 118.5 
K255 55.69 53.63 174.5 8.901 130.5 
 CAi CAi-1 C’i-1 HN N 
L260 52.98 54.71 174.7 8.803 127.8 
T261 61.28 52.94 174.3 9.585 122.9 
L262 52.87 61.26 - 9.216 129.6 
S263 56.80 52.47 174.6 8.797 115.3 
A264 51.11 56.73 172.8 9.536 120.6 
L265 52.41 51.11 173.4 8.709 124.9 
L266 52.33 52.28 175.2 9.486 126.2 
G268 46.03 52.32 176.9 8.457 112.4 
K269 56.79 45.99 173.8 8.124 117.3 
N270 51.80 56.76 177.1 7.423 117.5 
V271 65.06 51.82 175.1 8.508 122.1 
A273 51.73 54.27 175.8 7.488 120.7 
G274 44.74 51.71 177.7 7.694 106.7 
G275 45.46 44.81 174.0 8.509 109.1 
H276 54.54 45.45 174.0 7.251 120.7 
K277 54.64 64.35 176.1 8.831 119.4 
L278 53.50 54.74 175.2 8.654 121.6 
G279 45.03 53.44 178.0 9.096 111.1 
L280 53.78 45.13 170.9 8.198 121.0 
G281 44.27 53.82 - 9.574 115.9 
L282 53.36 44.28 171.6 8.669 124.6 
E283 55.90 53.30 177.5 7.354 125.4 
F284 55.90 - - 9.313 128.1 
Q285 53.72 56.15 174.2 8.675 122.7 
A286 51.25 53.91 174.4 8.282 126.4 
R287 55.89 51.27 - 9.030 125.0 
S288 57.14 55.74 174.1 7.745 125.8 
 
B   Chemical shift assignments of Conk-S1 
        1  1 LYS CB   C  33.080 0.042 1  
        2  1 LYS CD   C  29.158 0.03  1  
        3  1 LYS CE   C  42.048 0.03  1  
        4  1 LYS CG   C  23.873 0.03  1  
        5  1 LYS C    C 172.311 0.03  1  
        6  1 LYS HA   H   4.009 0.003 1  
        7  1 LYS HB2  H   1.901 0.003 2  
        8  1 LYS HD2  H   1.689 0.003 2  
        9  1 LYS HE2  H   2.991 0.003 2  
       10  1 LYS HG2  H   1.455 0.003 2  
       11  2 ASP CA   C  54.432 0.03  1  
       12  2 ASP CB   C  41.344 0.009 1  
       13  2 ASP C    C 175.290 0.03  1  
       14  2 ASP H    H   8.690 0.001 1  
       15  2 ASP HA   H   4.651 0.003 1  
       16  2 ASP HB2  H   2.515 0.003 2  
       17  2 ASP HB3  H   2.694 0.003 2  
       18  2 ASP N    N 123.473 0.057 1  
       19  3 ARG CA   C  54.211 0.03  1  
       20  3 ARG CB   C  30.490 0.03  1  
       21  3 ARG H    H   8.454 0.001 1  
       22  3 ARG N    N 123.151 0.005 1  
       23  4 PRO CA   C  63.199 0.001 1  
       24  4 PRO CB   C  32.121 0.018 1  
       25  4 PRO CD   C  51.116 0.03  1  
       26  4 PRO CG   C  27.753 0.03  1  
       27  4 PRO C    C 178.002 0.03  1  
       28  4 PRO HA   H   4.509 0.003 1  
       29  4 PRO HB2  H   2.431 0.001 2  
       30  4 PRO HB3  H   2.069 0.003 2  
       31  4 PRO HD2  H   3.950 0.004 2  
       32  4 PRO HD3  H   3.847 0.003 2  
       33  4 PRO HG2  H   2.166 0.003 2  
       34  4 PRO HG3  H   2.062 0.003 2  
       35  5 SER CA   C  61.191 0.031 1  
       36  5 SER CB   C  62.776 0.037 1  
       37  5 SER C    C 177.273 0.03  1  
       38  5 SER H    H   8.829 0.001 1  
       39  5 SER HA   H   4.194 0.003 1  
       40  5 SER HB2  H   3.983 0.003 2  
       41  5 SER N    N 120.366 0.138 1  
       42  6 LEU CA   C  57.762 0.03  1  
       43  6 LEU CB   C  40.582 0.023 1  
       44  6 LEU CD1  C  26.591 0.03  1  
       45  6 LEU C    C 176.584 0.03  1  
       46  6 LEU H    H   8.115 0.001 1  
       47  6 LEU HA   H   4.102 0.003 1  
       48  6 LEU HB2  H   1.799 0.004 2  
       49  6 LEU HB3  H   1.438 0.001 2  
       50  6 LEU HD1  H   0.931 0.007 2  
       51  6 LEU HD2  H   0.800 0.003 2  
       52  6 LEU HG   H   1.558 0.003 2  
       53  6 LEU N    N 122.169 0.012 1  
       54  7 CYS CA   C  57.260 0.050 1  
       55  7 CYS CB   C  39.349 0.026 1  
       56  7 CYS C    C 173.714 0.03  1  
       57  7 CYS H    H   7.669 0.002 1  
       58  7 CYS HA   H   4.292 0.003 1  
       59  7 CYS HB2  H   2.812 0.003 2  
       60  7 CYS HB3  H   3.104 0.003 2  
       61  7 CYS N    N 116.543 0.003 1  
       62  8 ASP CA   C  54.368 0.029 1  
       63  8 ASP CB   C  41.901 0.013 1  
       64  8 ASP C    C 177.020 0.03  1  
       65  8 ASP H    H   7.582 0.003 1  
       66  8 ASP HA   H   4.931 0.003 1  
       67  8 ASP HB2  H   2.590 0.003 2  
       68  8 ASP HB3  H   2.964 0.003 2  
       69  8 ASP N    N 114.479 0.008 1  
       70  9 LEU CA   C  53.388 0.03  1  
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       71  9 LEU CB   C  41.062 0.03  1  
       72  9 LEU H    H   7.580 0.002 1  
       73  9 LEU N    N 122.253 0.003 1  
       74 10 PRO CA   C  61.764 0.011 1  
       75 10 PRO CB   C  32.087 0.032 1  
       76 10 PRO CD   C  49.756 0.03  1  
       77 10 PRO CG   C  26.997 0.03  1  
       78 10 PRO C    C 175.352 0.03  1  
       79 10 PRO HA   H   4.516 0.003 1  
       80 10 PRO HB2  H   1.848 0.003 2  
       81 10 PRO HB3  H   2.220 0.004 2  
       82 10 PRO HD2  H   3.565 0.003 2  
       83 10 PRO HD3  H   3.787 0.003 2  
       84 10 PRO HG2  H   2.046 0.003 2  
       85 11 ALA CA   C  52.088 0.010 1  
       86 11 ALA CB   C  15.363 0.046 1  
       87 11 ALA C    C 178.573 0.03  1  
       88 11 ALA H    H   7.469 0.001 1  
       89 11 ALA HA   H   3.555 0.003 1  
       90 11 ALA HB   H  -0.401 0.003 1  
       91 11 ALA N    N 120.824 0.005 1  
       92 12 ASP CA   C  52.375 0.013 1  
       93 12 ASP CB   C  43.863 0.005 1  
       94 12 ASP C    C 176.480 0.03  1  
       95 12 ASP H    H   7.676 0.002 1  
       96 12 ASP HA   H   4.904 0.003 1  
       97 12 ASP HB2  H   2.302 0.003 2  
       98 12 ASP HB3  H   2.616 0.003 2  
       99 12 ASP N    N 121.934 0.004 1  
      100 13 SER CA   C  61.726 0.03  1  
      101 13 SER CB   C  64.029 0.031 1  
      102 13 SER C    C 175.398 0.03  1  
      103 13 SER H    H   9.252 0.001 1  
      104 13 SER HA   H   4.794 0.003 1  
      105 13 SER HB2  H   4.186 0.003 2  
      106 13 SER N    N 121.765 0.011 1  
      107 14 GLY CA   C  45.264 0.009 1  
      108 14 GLY C    C 173.969 0.03  1  
      109 14 GLY H    H   9.184 0.003 1  
      110 14 GLY HA2  H   3.844 0.003 2  
      111 14 GLY HA3  H   4.526 0.003 2  
      112 14 GLY N    N 111.730 0.008 1  
      113 15 SER CA   C  57.360 0.037 1  
      114 15 SER CB   C  64.269 0.030 1  
      115 15 SER C    C 175.079 0.03  1  
      116 15 SER H    H   7.896 0.002 1  
      117 15 SER HA   H   4.737 0.003 1  
      118 15 SER HB2  H   3.627 0.003 2  
      119 15 SER HB3  H   4.111 0.003 2  
      120 15 SER N    N 113.228 0.005 1  
      121 16 GLY CA   C  44.568 0.021 1  
      122 16 GLY C    C 174.472 0.03  1  
      123 16 GLY H    H   8.816 0.002 1  
      124 16 GLY HA2  H   3.598 0.003 2  
      125 16 GLY HA3  H   4.448 0.003 2  
      126 16 GLY N    N 111.011 0.006 1  
      127 17 THR CA   C  61.119 0.03  1  
      128 17 THR CB   C  70.004 0.065 1  
      129 17 THR CG2  C  21.482 0.03  1  
      130 17 THR C    C 174.870 0.03  1  
      131 17 THR H    H   8.390 0.001 1  
      132 17 THR HA   H   4.572 0.006 1  
      133 17 THR HB   H   4.492 0.005 2  
      134 17 THR HG1  H   1.121 0.003 2  
      135 17 THR N    N 107.262 0.004 1  
      136 18 LYS CA   C  55.081 0.056 1  
      137 18 LYS CB   C  33.763 0.009 1  
      138 18 LYS CD   C  28.897 0.03  1  
      139 18 LYS CE   C  42.288 0.03  1  
      140 18 LYS CG   C  24.895 0.03  1  
      141 18 LYS C    C 174.331 0.03  1  
      142 18 LYS H    H   7.939 0.002 1  
      143 18 LYS HA   H   4.493 0.003 1  
      144 18 LYS HB2  H   1.438 0.003 2  
      145 18 LYS HB3  H   1.789 0.003 2  
      146 18 LYS HD2  H   1.621 0.003 2  
      147 18 LYS HE2  H   2.953 0.003 2  
      148 18 LYS HG2  H   1.314 0.003 2  
      149 18 LYS N    N 122.813 0.003 1  
      150 19 ALA CA   C  52.286 0.025 1  
      151 19 ALA CB   C  19.485 0.050 1  
      152 19 ALA C    C 176.224 0.03  1  
      153 19 ALA H    H   8.111 0.001 1  
      154 19 ALA HA   H   4.497 0.003 1  
      155 19 ALA HB   H   1.181 0.003 1  
      156 19 ALA N    N 124.378 0.007 1  
      157 20 GLU CA   C  54.586 0.037 1  
      158 20 GLU CB   C  33.176 0.012 1  
      159 20 GLU CG   C  36.159 0.03  1  
      160 20 GLU C    C 174.985 0.03  1  
      161 20 GLU H    H   8.683 0.002 1  
      162 20 GLU HA   H   4.642 0.003 1  
      163 20 GLU HB2  H   1.982 0.006 2  
      164 20 GLU HB3  H   2.064 0.006 2  
      165 20 GLU HG2  H   2.070 0.001 2  
      166 20 GLU HG3  H   2.220 0.003 2  
      167 20 GLU N    N 121.603 0.022 1  
      168 21 LYS CA   C  55.460 0.043 1  
      169 21 LYS CB   C  32.763 0.012 1  
      170 21 LYS CD   C  28.762 0.03  1  
      171 21 LYS CE   C  42.193 0.03  1  
      172 21 LYS CG   C  24.578 0.03  1  
      173 21 LYS C    C 177.006 0.03  1  
      174 21 LYS H    H   8.690 0.001 1  
      175 21 LYS HA   H   4.839 0.003 1  
      176 21 LYS HB2  H   1.915 0.003 2  
      177 21 LYS HB3  H   1.665 0.003 2  
      178 21 LYS HD2  H   1.701 0.003 2  
      179 21 LYS HD3  H   1.452 0.003 2  
      180 21 LYS HE2  H   2.910 0.003 2  
      181 21 LYS N    N 122.447 0.015 1  
      182 22 ARG CA   C  52.253 0.024 1  
      183 22 ARG CB   C  34.978 0.009 1  
      184 22 ARG CD   C  42.606 0.03  1  
      185 22 ARG CG   C  29.554 0.03  1  
      186 22 ARG C    C 173.035 0.03  1  
      187 22 ARG H    H   8.527 0.003 1  
      188 22 ARG HA   H   4.673 0.003 1  
      189 22 ARG HB2  H   0.822 0.003 2  
      190 22 ARG HB3  H   1.808 0.003 2  
      191 22 ARG HD2  H   2.875 0.003 2  
      192 22 ARG HD3  H   3.456 0.003 2  
      193 22 ARG HG2  H   1.216 0.003 2  
      194 22 ARG N    N 125.387 0.007 1  
      195 23 ILE CA   C  58.038 0.018 1  
      196 23 ILE CB   C  40.023 0.026 1  
      197 23 ILE CG1  C  27.749 0.03  1  
      198 23 ILE CG2  C  20.592 0.03  1  
      199 23 ILE C    C 174.732 0.03  1  
      200 23 ILE H    H   8.881 0.002 1  
      201 23 ILE HA   H   5.492 0.003 1  
      202 23 ILE HB   H   1.738 0.003 2  
      203 23 ILE HD1  H   0.654 0.003 1  
      204 23 ILE HG12 H   1.125 0.003 2  
      205 23 ILE HG13 H   1.318 0.003 2  
      206 23 ILE HG2  H   0.923 0.003 1  
      207 23 ILE N    N 120.316 0.008 1  
      208 24 TYR CA   C  54.760 0.022 1  
      209 24 TYR CB   C  41.202 0.009 1  
      210 24 TYR CD1  C  54.990 0.03  1  
      211 24 TYR C    C 172.540 0.03  1  
      212 24 TYR H    H   9.882 0.002 1  
      213 24 TYR HA   H   5.244 0.003 1  
      214 24 TYR HB2  H   2.667 0.003 2  
      215 24 TYR HB3  H   2.714 0.003 2  
      216 24 TYR HD1  H   6.959 0.003 3  
      217 24 TYR HE1  H   6.653 0.003 3  
      218 24 TYR N    N 126.812 0.006 1  
      219 25 TYR CA   C  58.048 0.035 1  
      220 25 TYR CB   C  39.656 0.013 1  
      221 25 TYR C    C 173.477 0.03  1  
      222 25 TYR H    H  10.385 0.002 1  
      223 25 TYR HA   H   4.352 0.003 1  
      224 25 TYR HB2  H   3.237 0.003 2  
      225 25 TYR HB3  H   2.788 0.003 2  
      226 25 TYR N    N 123.062 0.005 1  
      227 26 ASN CA   C  51.612 0.019 1  
      228 26 ASN CB   C  40.014 0.013 1  
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      229 26 ASN C    C 174.623 0.03  1  
      230 26 ASN H    H   8.048 0.002 1  
      231 26 ASN HA   H   4.585 0.003 1  
      232 26 ASN HB2  H   2.603 0.003 2  
      233 26 ASN HB3  H   1.967 0.003 2  
      234 26 ASN N    N 126.650 0.007 1  
      235 27 SER CA   C  60.626 0.090 1  
      236 27 SER CB   C  63.008 0.073 1  
      237 27 SER C    C 176.131 0.03  1  
      238 27 SER H    H   8.429 0.003 1  
      239 27 SER HA   H   3.827 0.004 1  
      240 27 SER HB2  H   4.082 0.003 2  
      241 27 SER N    N 121.116 0.006 1  
      242 28 ALA CA   C  54.788 0.011 1  
      243 28 ALA CB   C  18.297 0.047 1  
      244 28 ALA C    C 179.723 0.03  1  
      245 28 ALA H    H   8.017 0.001 1  
      246 28 ALA HA   H   4.201 0.003 1  
      247 28 ALA HB   H   1.486 0.003 1  
      248 28 ALA N    N 124.917 0.003 1  
      249 29 ARG CA   C  55.533 0.029 1  
      250 29 ARG CB   C  31.087 0.019 1  
      251 29 ARG CD   C  43.232 0.03  1  
      252 29 ARG CG   C  27.181 0.03  1  
      253 29 ARG C    C 175.418 0.03  1  
      254 29 ARG H    H   7.779 0.002 1  
      255 29 ARG HA   H   4.112 0.003 1  
      256 29 ARG HB2  H   1.078 0.003 2  
      257 29 ARG HB3  H   1.923 0.003 2  
      258 29 ARG HD2  H   3.033 0.003 2  
      259 29 ARG HG2  H   1.539 0.003 2  
      260 29 ARG N    N 114.463 0.002 1  
      261 30 LYS CA   C  56.794 0.017 1  
      262 30 LYS CB   C  29.253 0.003 1  
      263 30 LYS CD   C  29.571 0.03  1  
      264 30 LYS CE   C  42.523 0.03  1  
      265 30 LYS CG   C  24.886 0.03  1  
      266 30 LYS C    C 174.803 0.03  1  
      267 30 LYS H    H   7.927 0.003 1  
      268 30 LYS HA   H   3.677 0.003 1  
      269 30 LYS HB2  H   2.039 0.003 2  
      270 30 LYS HB3  H   1.814 0.003 2  
      271 30 LYS HD2  H   1.667 0.003 2  
      272 30 LYS HD3  H   1.701 0.003 2  
      273 30 LYS HE2  H   3.018 0.003 2  
      274 30 LYS HG2  H   1.380 0.003 2  
      275 30 LYS HG3  H   1.298 0.003 2  
      276 30 LYS N    N 117.604 0.006 1  
      277 31 GLN CA   C  54.072 0.026 1  
      278 31 GLN CB   C  35.027 0.120 1  
      279 31 GLN CG   C  33.758 0.03  1  
      280 31 GLN C    C 174.118 0.03  1  
      281 31 GLN H    H   6.800 0.003 1  
      282 31 GLN HA   H   4.546 0.006 1  
      283 31 GLN HB2  H   1.378 0.001 2  
      284 31 GLN HB3  H   1.753 0.001 2  
      285 31 GLN HG2  H   2.246 0.001 2  
      286 31 GLN N    N 111.927 0.009 1  
      287 32 CYS CA   C  57.264 0.095 1  
      288 32 CYS CB   C  44.627 0.005 1  
      289 32 CYS C    C 173.556 0.03  1  
      290 32 CYS H    H   8.674 0.001 1  
      291 32 CYS HA   H   5.157 0.003 1  
      292 32 CYS HB2  H   3.096 0.003 2  
      293 32 CYS HB3  H   2.620 0.003 2  
      294 32 CYS N    N 121.910 0.014 1  
      295 33 LEU CA   C  53.319 0.034 1  
      296 33 LEU CB   C  46.394 0.010 1  
      297 33 LEU CD1  C  22.887 0.03  1  
      298 33 LEU CG   C  26.234 0.03  1  
      299 33 LEU C    C 174.921 0.03  1  
      300 33 LEU H    H   9.026 0.002 1  
      301 33 LEU HA   H   4.768 0.003 1  
      302 33 LEU HB2  H   1.385 0.003 2  
      303 33 LEU HB3  H   1.667 0.003 2  
      304 33 LEU HD1  H   0.778 0.003 2  
      305 33 LEU HD2  H   0.821 0.003 2  
      306 33 LEU HG   H   1.167 0.003 2  
      307 33 LEU N    N 127.175 0.034 1  
      308 34 ARG CA   C  55.951 0.008 1  
      309 34 ARG CB   C  32.149 0.016 1  
      310 34 ARG CD   C  43.994 0.03  1  
      311 34 ARG CG   C  27.868 0.03  1  
      312 34 ARG C    C 176.755 0.03  1  
      313 34 ARG H    H   8.351 0.002 1  
      314 34 ARG HA   H   5.436 0.003 1  
      315 34 ARG HB2  H   1.809 0.005 2  
      316 34 ARG HB3  H   1.885 0.002 2  
      317 34 ARG HD2  H   3.162 0.003 2  
      318 34 ARG HG2  H   1.671 0.003 2  
      319 34 ARG HG3  H   1.796 0.002 2  
      320 34 ARG N    N 119.037 0.005 1  
      321 35 PHE CA   C  55.927 0.003 1  
      322 35 PHE CB   C  41.344 0.047 1  
      323 35 PHE C    C 171.916 0.03  1  
      324 35 PHE H    H   9.497 0.002 1  
      325 35 PHE HA   H   4.947 0.003 1  
      326 35 PHE HB2  H   3.103 0.003 2  
      327 35 PHE HB3  H   2.992 0.003 2  
      328 35 PHE HD1  H   7.104 0.003 3  
      329 35 PHE HE1  H   7.157 0.003 3  
      330 35 PHE N    N 121.396 0.006 1  
      331 36 ASP CA   C  54.108 0.045 1  
      332 36 ASP CB   C  41.241 0.008 1  
      333 36 ASP C    C 173.714 0.03  1  
      334 36 ASP H    H   8.359 0.001 1  
      335 36 ASP HA   H   4.843 0.003 1  
      336 36 ASP HB2  H   2.580 0.003 2  
      337 36 ASP HB3  H   2.410 0.002 2  
      338 36 ASP N    N 120.047 0.048 1  
      339 37 TYR CA   C  55.304 0.046 1  
      340 37 TYR CB   C  41.800 0.013 1  
      341 37 TYR C    C 175.382 0.03  1  
      342 37 TYR H    H   8.837 0.002 1  
      343 37 TYR HA   H   4.976 0.001 1  
      344 37 TYR HB2  H   2.297 0.003 2  
      345 37 TYR HB3  H   2.401 0.001 2  
      346 37 TYR N    N 124.067 0.004 1  
      347 38 THR CA   C  58.747 0.03  1  
      348 38 THR CB   C  63.914 0.030 1  
      349 38 THR C    C 175.226 0.03  1  
      350 38 THR H    H   7.911 0.002 1  
      351 38 THR HA   H   4.435 0.003 1  
      352 38 THR HB   H   3.894 0.003 2  
      353 38 THR N    N 114.714 0.005 1  
      354 39 GLY CA   C  45.724 0.018 1  
      355 39 GLY C    C 172.504 0.03  1  
      356 39 GLY HA2  H   4.192 0.003 2  
      357 39 GLY HA3  H   3.337 0.003 2  
      358 40 GLN CA   C  54.741 0.014 1  
      359 40 GLN CB   C  32.600 0.212 1  
      360 40 GLN CG   C  33.735 0.03  1  
      361 40 GLN C    C 175.264 0.03  1  
      362 40 GLN H    H   6.647 0.003 1  
      363 40 GLN HA   H   4.577 0.003 1  
      364 40 GLN HB2  H   1.696 0.002 2  
      365 40 GLN HB3  H   1.845 0.003 2  
      366 40 GLN HG2  H   2.187 0.003 2  
      367 40 GLN N    N 116.234 0.018 1  
      368 41 GLY CA   C  45.085 0.019 1  
      369 41 GLY C    C 175.797 0.03  1  
      370 41 GLY H    H   8.943 0.001 1  
      371 41 GLY HA2  H   4.182 0.003 2  
      372 41 GLY HA3  H   3.906 0.003 2  
      373 41 GLY N    N 109.417 0.006 1  
      374 42 GLY CA   C  43.803 0.002 1  
      375 42 GLY C    C 172.996 0.03  1  
      376 42 GLY H    H   9.292 0.001 1  
      377 42 GLY HA2  H   4.516 0.003 2  
      378 42 GLY HA3  H   3.711 0.003 2  
      379 42 GLY N    N 112.607 0.008 1  
      380 43 ASN CA   C  51.708 0.030 1  
      381 43 ASN CB   C  40.620 0.014 1  
      382 43 ASN C    C 175.253 0.03  1  
      383 43 ASN H    H   9.210 0.001 1  
      384 43 ASN HA   H   4.927 0.003 1  
      385 43 ASN HB2  H   3.185 0.003 2  
      386 43 ASN HB3  H   2.910 0.003 2  
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      387 43 ASN N    N 119.403 0.004 1  
      388 44 GLU CA   C  58.274 0.028 1  
      389 44 GLU CB   C  30.696 0.003 1  
      390 44 GLU CG   C  37.380 0.03  1  
      391 44 GLU C    C 176.940 0.03  1  
      392 44 GLU H    H   8.289 0.003 1  
      393 44 GLU HA   H   4.039 0.003 1  
      394 44 GLU HB2  H   1.750 0.003 2  
      395 44 GLU HB3  H   2.188 0.003 2  
      396 44 GLU HG2  H   2.339 0.001 2  
      397 44 GLU N    N 112.749 0.010 1  
      398 45 ASN CA   C  50.762 0.027 1  
      399 45 ASN CB   C  34.877 0.008 1  
      400 45 ASN C    C 173.938 0.03  1  
      401 45 ASN H    H   8.303 0.002 1  
      402 45 ASN HA   H   4.652 0.003 1  
      403 45 ASN HB2  H   3.159 0.003 2  
      404 45 ASN HB3  H   2.902 0.003 2  
      405 45 ASN N    N 121.075 0.006 1  
      406 46 ASN CA   C  53.459 0.024 1  
      407 46 ASN CB   C  38.976 0.023 1  
      408 46 ASN C    C 173.714 0.03  1  
      409 46 ASN H    H   6.547 0.003 1  
      410 46 ASN HA   H   4.740 0.003 1  
      411 46 ASN HB2  H   2.453 0.003 2  
      412 46 ASN HB3  H   2.578 0.004 2  
      413 46 ASN N    N 118.242 0.008 1  
      414 47 PHE CA   C  55.726 0.021 1  
      415 47 PHE CB   C  42.353 0.006 1  
      416 47 PHE C    C 175.525 0.03  1  
      417 47 PHE H    H  10.039 0.002 1  
      418 47 PHE HA   H   4.947 0.003 1  
      419 47 PHE HB2  H   3.265 0.003 2  
      420 47 PHE HB3  H   2.593 0.003 2  
      421 47 PHE HD1  H   7.265 0.003 3  
      422 47 PHE HE1  H   7.563 0.003 3  
      423 47 PHE N    N 123.588 0.004 1  
      424 48 ARG CA   C  57.622 0.052 1  
      425 48 ARG CB   C  31.162 0.019 1  
      426 48 ARG CD   C  43.185 0.03  1  
      427 48 ARG CG   C  28.627 0.03  1  
      428 48 ARG C    C 176.771 0.03  1  
      429 48 ARG H    H   9.466 0.002 1  
      430 48 ARG HA   H   4.396 0.003 1  
      431 48 ARG HB2  H   2.042 0.003 2  
      432 48 ARG HB3  H   1.819 0.009 2  
      433 48 ARG HD2  H   3.224 0.003 2  
      434 48 ARG HG2  H   1.813 0.005 2  
      435 48 ARG HG3  H   1.590 0.004 2  
      436 48 ARG N    N 119.221 0.004 1  
      437 49 ARG CA   C  53.942 0.024 1  
      438 49 ARG CB   C  33.507 0.021 1  
      439 49 ARG CG   C  26.809 0.03  1  
      440 49 ARG H    H   7.498 0.002 1  
      441 49 ARG HA   H   4.886 0.003 1  
      442 49 ARG HB2  H   2.076 0.003 2  
      443 49 ARG HB3  H   1.910 0.003 2  
      444 49 ARG HD2  H   3.307 0.003 2  
      445 49 ARG HG2  H   1.786 0.003 2  
      446 49 ARG HG3  H   1.600 0.003 2  
      447 49 ARG N    N 113.085 0.005 1  
      448 50 THR H    H   9.263 0.002 1  
      449 50 THR N    N 122.046 0.007 1  
      450 51 TYR CA   C  60.984 0.230 1  
      451 51 TYR CB   C  38.922 0.025 1  
      452 51 TYR C    C 176.579 0.03  1  
      453 51 TYR HA   H   4.280 0.004 1  
      454 51 TYR HB2  H   2.562 0.001 2  
      455 51 TYR HB3  H   3.272 0.003 2  
      456 51 TYR HD1  H   7.134 0.003 3  
      457 51 TYR HE1  H   6.831 0.003 3  
      458 52 ASP CA   C  57.161 0.039 1  
      459 52 ASP CB   C  41.122 0.004 1  
      460 52 ASP C    C 177.257 0.03  1  
      461 52 ASP H    H   6.640 0.004 1  
      462 52 ASP HA   H   4.249 0.003 1  
      463 52 ASP HB2  H   3.106 0.003 2  
      464 52 ASP HB3  H   2.839 0.003 2  
      465 52 ASP N    N 115.867 0.010 1  
      466 53 CYS CA   C  58.631 0.041 1  
      467 53 CYS CB   C  44.619 0.004 1  
      468 53 CYS C    C 175.009 0.03  1  
      469 53 CYS H    H   6.730 0.003 1  
      470 53 CYS HA   H   1.885 0.001 1  
      471 53 CYS HB2  H   2.535 0.003 2  
      472 53 CYS HB3  H   2.962 0.003 2  
      473 53 CYS N    N 120.799 0.002 1  
      474 54 GLN CA   C  58.508 0.005 1  
      475 54 GLN CB   C  27.764 0.035 1  
      476 54 GLN CG   C  34.735 0.03  1  
      477 54 GLN C    C 178.023 0.03  1  
      478 54 GLN H    H   8.355 0.002 1  
      479 54 GLN HA   H   3.565 0.003 1  
      480 54 GLN HB2  H   2.126 0.002 2  
      481 54 GLN HB3  H   1.765 0.001 2  
      482 54 GLN HG2  H   2.042 0.003 2  
      483 54 GLN HG3  H   2.501 0.002 2  
      484 54 GLN N    N 120.571 0.004 1  
      485 55 ARG CA   C  58.106 0.017 1  
      486 55 ARG CB   C  29.495 0.026 1  
      487 55 ARG CD   C  43.064 0.03  1  
      488 55 ARG CG   C  26.660 0.03  1  
      489 55 ARG C    C 176.856 0.03  1  
      490 55 ARG H    H   8.098 0.002 1  
      491 55 ARG HA   H   3.898 0.003 1  
      492 55 ARG HB2  H   1.578 0.003 2  
      493 55 ARG HD2  H   3.019 0.003 2  
      494 55 ARG HD3  H   2.901 0.003 2  
      495 55 ARG HG2  H   1.432 0.003 2  
      496 55 ARG N    N 117.371 0.005 1  
      497 56 THR CA   C  66.062 0.057 1  
      498 56 THR CB   C  69.047 0.055 1  
      499 56 THR CG2  C  22.118 0.03  1  
      500 56 THR C    C 175.235 0.03  1  
      501 56 THR H    H   7.140 0.003 1  
      502 56 THR HA   H   3.992 0.003 1  
      503 56 THR HB   H   3.893 0.003 2  
      504 56 THR HG1  H   1.377 0.001 2  
      505 56 THR N    N 112.797 0.015 1  
      506 57 CYS CA   C  54.328 0.047 1  
      507 57 CYS CB   C  42.393 0.012 1  
      508 57 CYS C    C 173.311 0.03  1  
      509 57 CYS H    H   7.553 0.002 1  
      510 57 CYS HA   H   4.633 0.003 1  
      511 57 CYS HB2  H   1.672 0.003 2  
      512 57 CYS HB3  H   1.363 0.003 2  
      513 57 CYS N    N 112.636 0.006 1  
      514 58 LEU CA   C  56.270 0.03  1  
      515 58 LEU CB   C  44.237 0.006 1  
      516 58 LEU CD1  C  25.252 0.03  1  
      517 58 LEU CG   C  27.320 0.03  1  
      518 58 LEU C    C 176.548 0.03  1  
      519 58 LEU H    H   7.522 0.002 1  
      520 58 LEU HA   H   4.257 0.003 1  
      521 58 LEU HB2  H   1.206 0.003 2  
      522 58 LEU HB3  H   1.525 0.002 2  
      523 58 LEU HD1  H   0.867 0.003 2  
      524 58 LEU HD2  H   0.739 0.003 2  
      525 58 LEU HG   H   1.176 0.003 2  
      526 58 LEU N    N 120.701 0.003 1  
      527 59 TYR CA   C  56.469 0.040 1  
      528 59 TYR CB   C  37.679 0.025 1  
      529 59 TYR C    C 175.127 0.03  1  
      530 59 TYR H    H   7.745 0.002 1  
      531 59 TYR HA   H   4.744 0.003 1  
      532 59 TYR HB2  H   3.167 0.003 2  
      533 59 TYR HB3  H   2.822 0.003 2  
      534 59 TYR HD1  H   6.982 0.003 3  
      535 59 TYR HE1  H   6.745 0.003 3  
      536 59 TYR N    N 120.378 0.006 1  
      537 60 THR CA   C  62.782 0.03  1  
      538 60 THR CB   C  70.624 0.03  1  
      539 60 THR H    H   7.486 0.001 1  




C   NMR restraints of Conk-S1 
C.1 Residual dipolar couplings 
Table 3 HNN-RDCs of Conk-S1 
Residue 1 Atom 1 Residue 2 Atom 2 D [Hz] 
3 N 3 HN 4.382 
5 N 5 HN -3.092 
6 N 6 HN 12.505 
7 N 7 HN -20.229 
11 N 11 HN 4.851 
12 N 12 HN 16.789 
13 N 13 HN 21.371 
15 N 15 HN 10.715 
16 N 16 HN -5.478 
17 N 17 HN 5.788 
18 N 18 HN -20.673 
19 N 19 HN -7.587 
20 N 20 HN 7.302 
21 N 21 HN 6.391 
22 N 22 HN 21.147 
23 N 23 HN 5.649 
25 N 25 HN 2.689 
27 N 27 HN -2.612 
28 N 28 HN -21.061 
29 N 29 HN -6.266 
30 N 30 HN 19.603 
31 N 31 HN 29.311 
32 N 32 HN 21.366 
34 N 34 HN 8.869 
35 N 35 HN 14.104 
36 N 36 HN 16.081 
37 N 37 HN 17.244 
38 N 38 HN 5.068 
39 N 39 HN 0.627 
40 N 40 HN 9.685 
41 N 41 HN 7.842 
43 N 43 HN 11.588 
44 N 44 HN 1.986 
45 N 45 HN 18.790 
46 N 46 HN -4.266 
48 N 48 HN -3.909 
49 N 49 HN -11.954 
53 N 53 HN -17.750 
54 N 54 HN -28.635 
55 N 55 HN -25.261 
56 N 56 HN -30.443 
57 N 57 HN -13.133 
58 N 58 HN -1.008 
59 N 59 HN -11.870 








Table 4 C’N-RDCs of Conk-S1 
Residue 1 Atom 1 Residue 2 Atom 2 D [Hz] 
2 C 3 N -0.158 
4 C 5 N 2.014 
5 C 6 N 0.538 
6 C 7 N -1.098 
7 C 8 N 0.880 
8 C 9 N -1.013 
10 C 11 N -0.485 
11 C 12 N 0.160 
12 C 13 N -1.197 
13 C 14 N 1.339 
14 C 15 N -0.245 
15 C 16 N 2.589 
16 C 17 N -0.826 
17 C 18 N -0.159 
18 C 19 N 1.916 
19 C 20 N -3.296 
20 C 21 N 2.182 
21 C 22 N -1.004 
22 C 23 N -2.734 
23 C 24 N 0.160 
24 C 25 N -2.109 
25 C 26 N 0.415 
26 C 27 N 1.545 
27 C 28 N 0.388 
28 C 29 N -1.466 
29 C 30 N 0.453 
30 C 31 N -3.401 
31 C 32 N 1.453 
32 C 33 N 0.062 
33 C 34 N -2.095 
34 C 35 N 0.262 
35 C 36 N 0.388 
36 C 37 N 0.925 
37 C 38 N 1.596 
38 C 39 N 0.129 
39 C 40 N 2.500 
40 C 41 N -1.435 
41 C 42 N 0.372 
42 C 43 N -0.158 
43 C 44 N -2.353 
44 C 45 N 0.606 
45 C 46 N 1.779 
47 C 48 N 1.645 
48 C 49 N -2.844 
51 C 52 N -1.191 
52 C 53 N 0.150 
53 C 54 N 1.958 
54 C 55 N 0.930 
55 C 56 N 0.566 
56 C 57 N 0.475 
57 C 58 N 2.329 
58 C 59 N 1.123 





Table 5 CAHA-RDCs of Conk-S1 
Residue 1 Atom 1 Residue 2 Atom 2 D [Hz] 
 1 CA  1 HA   0.252 
 2 CA  2 HA  12.392 
 4 CA  4 HA -12.394 
 5 CA  5 HA  -4.727 
 6 CA  6 HA  32.221 
 7 CA  7 HA -32.452 
 8 CA  8 HA  10.480 
10 CA 10 HA   9.266 
11 CA 11 HA  27.490 
12 CA 12 HA  24.486 
13 CA 13 HA  40.151 
15 CA 15 HA  20.952 
17 CA 17 HA  20.754 
18 CA 18 HA -32.378 
19 CA 19 HA  -9.803 
20 CA 20 HA   2.458 
21 CA 21 HA  23.361 
22 CA 22 HA  33.248 
25 CA 25 HA  34.016 
26 CA 26 HA  27.866 
27 CA 27 HA  29.870 
28 CA 28 HA -39.994 
29 CA 29 HA  -1.480 
31 CA 31 HA  26.955 
32 CA 32 HA  24.484 
33 CA 33 HA  22.897 
34 CA 34 HA  11.525 
35 CA 35 HA   5.522 
36 CA 36 HA  38.599 
37 CA 37 HA  24.048 
38 CA 38 HA   4.611 
40 CA 40 HA  15.438 
43 CA 43 HA  11.700 
44 CA 44 HA  -9.919 
45 CA 45 HA   9.769 
47 CA 47 HA   8.926 
48 CA 48 HA  -7.004 
49 CA 49 HA -26.711 
51 CA 51 HA -12.324 
52 CA 52 HA -12.583 
53 CA 53 HA  24.849 
54 CA 54 HA  19.993 
55 CA 55 HA -19.145 
56 CA 56 HA -12.933 
57 CA 57 HA  -8.267 
58 CA 58 HA  26.260 
59 CA 59 HA  -2.156 
 
 
Table 6 CaC’-RDCs of Conk-S1 
Residue 1 Atom 1 Residue 2 Atom 2 D [Hz] 
 1 CA  1 C  1.597  
 2 CA  2 C -4.968  
 4 CA  4 C  2.9125 
 5 CA  5 C -4.209  
 6 CA  6 C  0.527  
 7 CA  7 C  2.895  
 8 CA  8 C -1.292  
10 CA 10 C -1.8185 
11 CA 11 C  0.38   
12 CA 12 C -3.8165 
14 CA 14 C -2.327  
15 CA 15 C -2.948  
16 CA 16 C -3.291  
17 CA 17 C  2.839  
18 CA 18 C -1.199  
19 CA 19 C  2.0015 
20 CA 20 C -3.877  
21 CA 21 C -3.51   
22 CA 22 C -4.806  
26 CA 26 C -4.6885 
27 CA 27 C -0.278  
28 CA 28 C  2.748  
29 CA 29 C  0.6455 
31 CA 31 C -3.3695 
32 CA 32 C -4.058  
33 CA 33 C -1.8915 
34 CA 34 C  2.8385 
35 CA 35 C -2.6045 
36 CA 36 C  0.7975 
37 CA 37 C -4.624  
38 CA 38 C  0.386  
40 CA 40 C -0.7465 
41 CA 41 C -2.520  
42 CA 42 C -3.959  
43 CA 43 C  3.689  
44 CA 44 C  2.176  
45 CA 45 C -3.636  
47 CA 47 C -3.479  
48 CA 48 C  3.147  
49 CA 49 C -3.0025 
51 CA 51 C  1.4185 
52 CA 52 C  1.827  
53 CA 53 C -3.923  
54 CA 54 C -2.5265 
55 CA 55 C  3.372  
56 CA 56 C  1.0275 
57 CA 57 C -1.341  
58 CA 58 C -1.849  











C.2 Dihedral angles 
Table 7 Phi angles of Conk-S1 from Talos 
Residue 1 Atom 1 Residue 2 Atom 2 Residue 3 Atom 3 Residue 4 Atom 4 Phi angle [°] 
3 C 4 N 4 CA 4 C -70.0 
4 C 5 N 5 CA 5 C -76.3 
5 C 6 N 6 CA 6 C -81.2 
7 C 8 N 8 CA 8 C -97.0 
8 C 9 N 9 CA 9 C -77.0 
9 C 10 N 10 CA 10 C -72.0 
10 C 11 N 11 CA 11 C -78.0 
11 C 12 N 12 CA 12 C -100.0 
12 C 13 N 13 CA 13 C -74.0 
14 C 15 N 15 CA 15 C -96.0 
15 C 16 N 16 CA 16 C -84.0 
16 C 17 N 17 CA 17 C -90.0 
17 C 18 N 18 CA 18 C -100.0 
18 C 19 N 19 CA 19 C -97.0 
19 C 20 N 20 CA 20 C -114.0 
20 C 21 N 21 CA 21 C -90.0 
21 C 22 N 22 CA 22 C -138.0 
22 C 23 N 23 CA 23 C -112.0 
23 C 24 N 24 CA 24 C -127.0 
24 C 25 N 25 CA 25 C -100.0 
25 C 26 N 26 CA 26 C -106.0 
26 C 27 N 27 CA 27 C -66.0 
27 C 28 N 28 CA 28 C -71.0 
28 C 29 N 29 CA 29 C -96.0 
29 C 30 N 30 CA 30 C 57.0 
30 C 31 N 31 CA 31 C -126.0 
31 C 32 N 32 CA 32 C -117.0 
32 C 33 N 33 CA 33 C -116.0 
33 C 34 N 34 CA 34 C -103.0 
34 C 35 N 35 CA 35 C -130.0 
35 C 36 N 36 CA 36 C -99.0 
36 C 37 N 37 CA 37 C -114.0 
37 C 38 N 38 CA 38 C -112.0 
38 C 39 N 39 CA 39 C 88.0 
39 C 40 N 40 CA 40 C -121.0 
40 C 41 N 41 CA 41 C 75.0 
41 C 42 N 42 CA 42 C -85.0 
42 C 43 N 43 CA 43 C -110.0 
43 C 44 N 44 CA 44 C -81.0 
44 C 45 N 45 CA 45 C -79.0 
45 C 46 N 46 CA 46 C -83.0 
46 C 47 N 47 CA 47 C -111.0 
47 C 48 N 48 CA 48 C -80.0 
48 C 49 N 49 CA 49 C -129.0 
50 C 51 N 51 CA 51 C -67.0 
51 C 52 N 52 CA 52 C -83.0 
52 C 53 N 53 CA 53 C -68.0 
53 C 54 N 54 CA 54 C -65.0 
54 C 55 N 55 CA 55 C -66.0 
55 C 56 N 56 CA 56 C -80.0 
56 C 57 N 57 CA 57 C -85.0 
57 C 58 N 58 CA 58 C -90.0 









Table 8 Psi angles of Conk-S1 from Talos 
Residue 1 Atom 1 Residue 2 Atom 2 Residue 3 Atom 3 Residue 4 Atom 4 Psi angle [°] 
 4 N  4 CA  4 C  5 N 138.0 
 5 N  5 CA  5 C  6 N -20.7 
 6 N  6 CA  6 C  7 N  -3.2 
 8 N  8 CA  8 C  9 N  -1.0 
 9 N  9 CA  9 C 10 N 147.1 
10 N 10 CA 10 C 11 N 146.0 
11 N 11 CA 11 C 12 N 134.0 
12 N 12 CA 12 C 13 N 141.0 
13 N 13 CA 13 C 14 N -38.0 
15 N 15 CA 15 C 16 N   4.0 
16 N 16 CA 16 C 17 N 167.0 
17 N 17 CA 17 C 18 N -15.0 
18 N 18 CA 18 C 19 N 146.0 
19 N 19 CA 19 C 20 N 126.0 
20 N 20 CA 20 C 21 N 135.0 
21 N 21 CA 21 C 22 N 133.0 
22 N 22 CA 22 C 23 N 153.0 
23 N 23 CA 23 C 24 N 132.0 
24 N 24 CA 24 C 25 N 155.0 
25 N 25 CA 25 C 26 N 117.0 
26 N 26 CA 26 C 27 N 126.0 
27 N 27 CA 27 C 28 N -27.0 
28 N 28 CA 28 C 29 N -32.0 
29 N 29 CA 29 C 30 N   0.0 
30 N 30 CA 30 C 31 N  35.0 
31 N 31 CA 31 C 32 N 154.0 
32 N 32 CA 32 C 33 N 149.0 
33 N 33 CA 33 C 34 N 151.0 
34 N 34 CA 34 C 35 N 139.0 
35 N 35 CA 35 C 36 N 146.0 
36 N 36 CA 36 C 37 N 116.0 
37 N 37 CA 37 C 38 N 140.0 
38 N 38 CA 38 C 39 N   2.0 
39 N 39 CA 39 C 40 N  -2.0 
40 N 40 CA 40 C 41 N 146.0 
41 N 41 CA 41 C 42 N  25.0 
42 N 42 CA 42 C 43 N 137.0 
43 N 43 CA 43 C 44 N 163.0 
44 N 44 CA 44 C 45 N -28.0 
45 N 45 CA 45 C 46 N 124.0 
46 N 46 CA 46 C 47 N 118.0 
47 N 47 CA 47 C 48 N 150.0 
48 N 48 CA 48 C 49 N -20.0 
49 N 49 CA 49 C 50 N 151.0 
51 N 51 CA 51 C 52 N -36.0 
52 N 52 CA 52 C 53 N -17.0 
53 N 53 CA 53 C 54 N -38.0 
54 N 54 CA 54 C 55 N -29.0 
55 N 55 CA 55 C 56 N -37.0 
56 N 56 CA 56 C 57 N -14.0 
57 N 57 CA 57 C 58 N  -8.0 
58 N 58 CA 58 C 59 N -15.0 
59 N 59 CA 59 C 60 N 117.0 
 
Table 9 Chi1 angles (C’ CA CB CG) of Conk-S1 



























C.3 Coupling constants 
Table 10 3JHnHa coupling constants 
Residue 1 Atom 1 Residue 2 Atom 2 3JHnHa [Hz] 
5 H 5 HA 4.0 
7 H 7 HA 5.4 
8 H 8 HA 9.9 
9 H 9 HA 7.5 
11 H 11 HA 6.2 
12 H 12 HA 12.6 
13 H 13 HA 6.4 
15 H 15 HA 11.6 
16 H 16 HA 10.1 
17 H 17 HA 10.1 
18 H 18 HA 11.0 
19 H 19 HA 9.5 
20 H 20 HA 11.2 
21 H 21 HA 9.4 
22 H 22 HA 10.9 
23 H 23 HA 12.4 
24 H 24 HA 10.2 
26 H 26 HA 10.1 
27 H 27 HA 5.4 
28 H 28 HA 7.2 
29 H 29 HA 9.9 
30 H 30 HA 9.7 
31 H 31 HA 10.1 
32 H 32 HA 10.3 
33 H 33 HA 11.2 
34 H 34 HA 7.7 
35 H 35 HA 9.7 
36 H 36 HA 9.6 
37 H 37 HA 10.1 
38 H 38 HA 9.6 
40 H 40 HA 10.2 
43 H 43 HA 9.7 
44 H 44 HA 5.5 
45 H 45 HA 10.1 
46 H 46 HA 9.9 
47 H 47 HA 10.2 
48 H 48 HA 9.5 
49 H 49 HA 10.8 
52 H 52 HA 7.3 
53 H 53 HA 6.1 
54 H 54 HA 4.6 
55 H 55 HA 5.5 
56 H 56 HA 9.5 
57 H 57 HA 11.3 
58 H 58 HA 9.8 
59 H 59 HA 9.7 













C.4 Distance constraints 
Table 11 NOE distance restraints for Conk-S1 
Residue 1 Atom 1 Residue 2 Atom 2 Distance 
[Å] 
4 HG2 4 HA 2.547 
20 HG2 22 HG2 3.550 
10 HG2 44 HN 3.927 
30 HB1 30 HN 3.465 
48 HG1 22 HD2 2.192 
34 HB2 24 HB2 3.535 
18 HB1 17 HG1 3.579 
48 HG1 48 HN 3.105 
48 HB2 52 HB2 3.827 
49 HG1 49 HN 3.145 
49 HG1 23 HG11 4.387 
54 HB2 54 HN 2.618 
29 HB1 29 HB2 2.064 
21 HB1 21 HN 2.050 
21 HB1 22 HG2 3.907 
49 HB2 52 HB1 3.325 
49 HB2 52 HA 3.881 
21 HB1 21 HE2 3.441 
24 HB1 11 HB2 3.564 
24 HB1 11 HB1  
24 HB1 11 HB3  
24 HB2 11 HA 3.746 
24 HB1 33 HB1 3.972 
7 HB2 57 HB2 2.245 
7 HB2 57 HA 3.278 
47 HB2 47 HD1 2.392 
24 HB2 11 HB2 3.291 
24 HB2 11 HB1  
24 HB2 11 HB3  
32 HB2 54 HB2 3.402 
8 HB1 4 HA 4.303 
1 HE2 1 HA 3.844 
8 HB1 5 HA 3.846 
22 HD2 22 HB2 3.467 
52 HB2 53 HA 3.343 
22 HD2 37 HB1 4.900 
55 HD2 55 HA 3.841 
45 HB2 45 HN 2.579 
45 HB2 45 HA 2.870 
51 HB2 55 HD1 3.334 
40 HG2 15 HB2 3.307 
20 HG1 22 HG2 3.736 
4 HB2 7 HN 3.673 
4 HB1 6 HG 2.774 
52 HB2 51 HB2 3.397 
51 HB2 51 HB1 2.028 
44 HG2 43 HB1 3.575 
12 HB2 13 HN 3.621 
58 HB2 58 HB1 2.141 
58 HG 58 HA 3.348 
57 HB2 58 HA 3.682 
31 HB2 31 HG2 3.519 
58 HB2 54 HG2 3.750 
49 HG2 52 HN 3.125 
18 HD2 18 HA 1.955 
48 HG2 48 HN 2.752 
49 HG2 49 HN 2.090 
55 HB2 55 HD1 1.920 
21 HB2 21 HN 2.913 
48 HG2 52 HB2 3.962 
40 HB2 40 HG2 3.413 
21 HD1 21 HE2 2.716 
31 HB1 31 HG2 2.901 
40 HB2 40 HA 2.634 
33 HB1 33 HB2 1.885 
29 HG2 29 HA 2.425 
29 HG2 29 HN 2.422 
Residue 1 Atom 1 Residue 2 Atom 2 Distance 
[Å] 
58 HB1 54 HG2 3.573 
34 HA 33 HA 4.025 
14 HA1 15 HN 3.539 
47 HA 49 HN 2.591 
47 HA 46 HA 3.348 
32 HA 58 HG 3.174 
16 HA1 15 HA 3.200 
48 HA 49 HA 3.538 
7 HA 8 HA 3.619 
35 HA 24 HA 4.020 
35 HA 34 HA 4.812 
8 HA 27 HB2 4.234 
31 HA 31 HB1 1.939 
31 HA 58 HA 4.086 
39 HA1 15 HB2 4.644 
11 HA 45 HB2 3.859 
11 HA 45 HN 3.435 
54 HA 32 HB1 3.874 
11 HA 35 HB1 4.071 
48 HD2 20 HA 4.587 
47 HB1 53 HN 3.274 
47 HB1 47 HB2 2.114 
51 HB1 55 HD1 3.561 
10 HD1 44 HN 3.761 
10 HD1 10 HD2 2.121 
15 HB2 16 HA1 3.870 
30 HE2 57 HA 5.379 
55 HD1 52 HA 4.570 
55 HD1 55 HA 3.713 
34 HD2 34 HN 4.030 
45 HB1 45 HA 2.670 
59 HB1 59 HB2 1.960 
45 HB2 45 HB1 1.932 
45 HB1 47 HE1 3.382 
27 HB2 32 HA 4.578 
6 HA 6 HB2 2.550 
52 HA 56 HN 2.766 
28 HA 30 HE2 3.759 
44 HA 43 HB1 4.058 
2 HB2 2 HA 3.017 
2 HB1 2 HA 2.562 
4 HB2 6 HD22 3.048 
4 HB2 6 HD21  
4 HB2 6 HD23  
4 HA 4 HB2 2.590 
4 HB2 6 HN 3.651 
4 HA 4 HB1 1.864 
4 HD2 4 HB2 3.255 
4 HD1 4 HB2 3.102 
6 HB2 6 HD11 2.491 
6 HB1 6 HA 2.593 
6 HB1 6 HD11 1.729 
7 HB2 7 HN 2.387 
7 HB2 57 HB1 1.981 
7 HB1 7 HN 2.836 
7 HB1 7 HA 2.628 
8 HA 8 HB2 2.411 
8 HB1 8 HN 2.804 
8 HA 8 HB1 2.032 
10 HA 10 HB2 2.461 
10 HB1 10 HD2 2.008 
10 HA 10 HB1 2.566 
10 HB1 10 HD1 2.808 
6 HA 10 HD1 3.672 
10 HD1 10 HG2 2.469 
10 HG2 10 HD2 2.541 
11 HA 11 HB1 2.419 
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Residue 1 Atom 1 Residue 2 Atom 2 Distance 
[Å] 
12 HA 12 HB2 2.721 
12 HB2 12 HB1 2.095 
12 HB1 14 HA1 3.797 
12 HB1 12 HA 2.978 
12 HB1 42 HA2 2.836 
14 HA2 14 HN 1.815 
15 HB2 15 HA 2.669 
15 HB2 15 HB1 2.108 
16 HA2 40 HG2 3.467 
16 HA2 18 HN 3.251 
17 HG1 17 HB 2.325 
17 HG1 15 HB2 4.077 
18 HB2 18 HN 2.779 
18 HB2 18 HA 2.921 
18 HA 18 HB1 2.663 
19 HA 19 HN 3.441 
19 HA 19 HB2 2.425 
20 HB2 20 HA 2.915 
20 HB1 20 HA 2.575 
20 HG2 20 HN 3.247 
20 HG2 20 HA 3.286 
20 HG1 20 HA 3.424 
21 HA 21 HB2 2.417 
21 HA 21 HB1 3.046 
21 HD2 21 HA 3.111 
22 HB2 22 HA 2.974 
22 HB2 22 HG2 2.474 
22 HB2 23 HN 2.854 
22 HB2 37 HB1 2.832 
22 HB1 22 HA 1.985 
22 HB2 22 HB1 2.133 
22 HB1 23 HN 2.555 
22 HB1 47 HN 3.665 
22 HD2 23 HN 3.542 
22 HD2 22 HA 2.763 
22 HB1 22 HD2 1.702 
22 HD2 48 HA 3.011 
22 HD1 48 HB1 3.592 
22 HD1 23 HN 3.883 
22 HD1 22 HA 2.579 
22 HB1 22 HD1 2.867 
22 HD1 22 HG2 2.633 
22 HD1 48 HA 2.844 
22 HG2 22 HA 2.832 
22 HG2 22 HB1 2.291 
22 HD2 22 HG2 2.545 
22 HG2 23 HN 3.207 
22 HG2 37 HB1 2.425 
23 HA 23 HN 3.134 
23 HA 23 HB 2.555 
23 HA 23 HD11 2.464 
23 HA 23 HG11 2.711 
23 HA 23 HG21 2.354 
23 HA 35 HN 3.043 
23 HB 23 HD11 3.024 
23 HB 23 HG12 2.501 
23 HB 23 HG21 2.497 
23 HG12 23 HN 3.429 
23 HA 23 HG12 2.933 
23 HG11 23 HD11 2.585 
23 HG21 32 HA 3.113 
23 HG21 53 HN 3.735 
23 HG21 47 HD1 2.958 
23 HG21 24 HD1 3.878 
24 HA 25 HB1 3.278 
24 HA 47 HE1 3.413 
24 HA 23 HG21 3.362 
24 HA 24 HN 2.863 
24 HA 24 HD1 3.357 
24 HA 34 HN 3.862 
24 HB2 24 HN 4.121 
24 HA 24 HB2 2.183 
24 HB2 24 HE1 3.582 
Residue 1 Atom 1 Residue 2 Atom 2 Distance 
[Å] 
24 HB2 25 HN 3.286 
24 HB1 24 HN 3.274 
24 HB1 24 HA 2.167 
24 HB1 24 HD1 1.968 
24 HB1 24 HE1 3.055 
24 HB1 25 HN 3.387 
24 HD1 23 HA 3.650 
24 HD1 35 HB1 2.825 
24 HD1 24 HN 2.893 
24 HB2 24 HD1 2.546 
24 HD1 25 HN 4.467 
24 HD1 34 HN 3.046 
25 HA 33 HN 3.321 
25 HB2 57 HB1 3.316 
25 HA 25 HB2 1.808 
25 HA 25 HB1 2.449 
25 HB1 26 HN 3.251 
26 HB2 33 HB1 3.946 
26 HB2 33 HB2 3.070 
26 HB2 26 HA 3.627 
26 HB2 29 HB2 2.808 
26 HB2 33 HD11 2.839 
26 HB1 33 HB1 3.876 
26 HB1 26 HN 2.648 
26 HB1 26 HA 2.780 
26 HB2 26 HB1 1.933 
26 HB1 29 HB2 1.779 
26 HB1 33 HD11 2.740 
27 HA 30 HN 3.108 
27 HB2 28 HN 3.161 
27 HB2 30 HE2 3.521 
28 HA 28 HB1 2.223 
29 HA 29 HN 2.709 
29 HA 29 HB1 2.548 
29 HB2 33 HD12 3.334 
29 HB2 31 HG2 3.462 
29 HA 29 HB2 2.436 
29 HB2 29 HD2 2.873 
29 HB1 33 HD12 3.943 
29 HB1 29 HN 2.847 
29 HB1 29 HD2 2.767 
30 CA 30 HN 2.375 
30 HA 30 HB2 2.361 
30 HB1 30 HA 2.336 
30 HA 30 HG2 2.589 
30 HB2 30 HG2 2.585 
31 HA 31 HB2 3.377 
31 HB2 33 HD11 2.851 
31 HG2 33 HD12 3.372 
31 HA 31 HG2 2.308 
32 HA 26 HN 2.796 
32 HA 32 HN 2.991 
32 HA 32 HB2 2.905 
32 HA 32 HB1 2.663 
32 HA 33 HN 2.242 
32 HB2 58 HG 2.985 
32 HB1 32 HN 2.812 
32 HB1 33 HN 3.362 
33 HB2 24 HE1 3.020 
33 HB2 33 HG 2.147 
33 HB2 33 HA 2.903 
33 HB2 33 HD11 2.478 
33 HB1 33 HG 2.827 
33 HB1 24 HE1 3.020 
33 HB1 33 HN 2.976 
33 HB1 33 HA 2.722 
33 HB1 33 HD11 2.433 
33 HD11 34 HN 3.270 
33 HD11 31 HA 3.751 
33 HD11 33 HA 2.554 
33 HD11 29 HD2 4.282 
33 HD11 34 HD2 4.289 
34 HA 33 HB2 3.134 
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Residue 1 Atom 1 Residue 2 Atom 2 Distance 
[Å] 
34 HA 23 HG22 3.981 
34 HA 23 HG21  
34 HA 23 HG23  
34 HA 35 HB1 3.783 
34 HA 23 HD11 2.708 
34 HA 24 HN 3.321 
34 HA 34 HB2 2.112 
34 HB1 34 HN 2.092 
34 HB1 34 HD2 1.922 
34 HG2 34 HN 3.382 
34 HG2 23 HD11 3.446 
34 HG2 34 HA 2.945 
34 HG1 34 HA 3.081 
34 HD2 34 HG1 2.212 
35 HB2 35 HD1 2.354 
35 HB2 11 HB1 3.408 
35 HB2 24 HE1 2.769 
35 HB2 35 HA 1.831 
35 HB1 35 HD1 2.535 
35 HB1 11 HB1 3.517 
36 HB2 36 HN 2.160 
36 HB2 36 HA 1.868 
36 HA 36 HB1 2.356 
37 HA 37 HN 2.725 
37 HB2 22 HB2 3.022 
37 HB2 37 HN 2.899 
37 HB2 37 HA 2.819 
37 HB1 37 HA 2.369 
39 HA2 40 HN 2.618 
42 HA2 42 HN 2.533 
43 HA 43 HB2 2.804 
43 HA 43 HB1 2.577 
43 HB2 44 HN 2.311 
43 HB1 44 HN 2.336 
44 HA 44 HN 2.759 
44 HB2 44 HN 2.231 
44 HA 44 HB2 2.301 
44 HB1 44 HA 2.555 
44 HG2 44 HA 2.636 
44 HG2 44 HB2 2.367 
46 HB2 46 HN 2.952 
46 HB2 46 HA 2.802 
46 HB1 46 HA 2.921 
47 HA 48 HB2 2.847 
47 HA 47 HB1 1.906 
47 HB2 48 HN 2.910 
23 HB 47 HB2 2.891 
47 HB2 47 HA 2.676 
47 HB2 49 HN 2.469 
48 HA 48 HG2 2.666 
48 HA 48 HB2 2.233 
48 HB2 48 HD2 2.767 
48 HB1 48 HN 2.786 
48 HA 48 HB1 2.371 
48 HB1 48 HD2 1.817 
48 HD2 48 HG1 2.790 
48 HG2 48 HD2 2.428 
48 HG1 48 HA 2.348 
49 HA 49 HB2 2.438 
49 HB2 49 HD2 2.781 
49 HB1 52 HN 2.739 
49 HB1 49 HN 3.048 
49 HA 49 HB1 2.453 
49 HB1 49 HD2 2.815 
49 HG2 49 HA 3.372 
49 HG2 49 HB2 2.674 
49 HG1 49 HA 3.116 
51 HA 51 HD1 2.710 
51 HA 51 HB2 2.788 
51 HA 52 HN 2.812 
51 HA 54 HB2 2.623 
51 HA 54 HB1 3.105 
51 HB2 54 HB1 3.330 
Residue 1 Atom 1 Residue 2 Atom 2 Distance 
[Å] 
51 HB2 49 HG1 3.904 
51 HB2 51 HD1 2.374 
51 HB2 51 CA 2.883 
51 HB1 51 HD1 2.760 
51 HB1 49 HB1 3.499 
51 HA 51 HB1 2.228 
52 HA 52 HB2 2.147 
52 HA 55 HB2 2.173 
52 HB1 49 HN 2.798 
52 HA 52 HB1 2.893 
52 HB1 53 HN 2.567 
53 HA 57 HN 3.078 
53 HA 53 HN 2.943 
53 HA 53 HB2 2.538 
53 HA 53 HB1 2.747 
53 HA 54 HN 3.889 
53 HA 56 HB 3.180 
53 HB2 47 HD1 2.711 
53 HB2 53 HN 2.701 
53 HB2 54 HN 3.122 
53 HB1 23 HG21 2.652 
53 HB1 54 HN 2.770 
54 HA 58 HA 3.955 
54 HA 58 HD22 2.857 
54 HA 58 HD21  
54 HA 58 HD23  
54 HA 58 HN 2.822 
53 HB2 54 HA 2.862 
54 HA 54 HB2 2.533 
54 HA 54 HB1 2.362 
54 HA 58 HB2 2.644 
54 HA 58 HB1 2.412 
58 HG 54 HG2 3.078 
54 HG2 54 HA 2.789 
54 HG2 58 HD21 2.981 
54 HG1 58 HG 2.873 
54 HG1 54 HA 2.875 
54 HG1 54 HB1 2.850 
55 HA 55 HB2 2.485 
55 HA 59 HB1 2.726 
55 HG2 56 HN 3.113 
55 HG2 52 HA 2.949 
56 HG1 52 HA 3.584 
56 HG1 59 HB1 4.253 
56 HA 56 HG1 2.265 
56 HG1 57 HN 2.805 
57 HB2 57 HN 2.668 
57 HB2 57 HA 2.954 
7 HB1 57 HB1 2.836 
57 HB1 57 HA 2.691 
58 HA 58 HB2 2.490 
58 HA 58 HD11 2.315 
58 HB2 58 HN 2.740 
58 HB2 58 HD11 2.747 
58 HB1 58 HN 2.579 
58 HB1 58 HA 2.989 
58 HB1 58 HD21 2.690 
58 HB1 59 HN 2.499 
58 HD11 32 HN 4.032 
58 HD11 60 HN 3.896 
58 HD11 31 HA 3.295 
59 HB2 59 HD1 3.170 
59 HB2 59 HA 2.730 
59 HB2 60 HN 3.597 
59 HB1 59 HD1 2.912 
59 HB1 59 HN 2.820 
59 HB1 59 HA 2.917 
57 HN 59 HN 3.779 
57 HN 57 HA 2.876 
8 HN 7 HN 2.817 
57 HN 56 HB 2.689 
57 HB1 57 HN 2.687 
54 HA 57 HN 3.678 
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Residue 1 Atom 1 Residue 2 Atom 2 Distance 
[Å] 
57 HN 56 HA 3.522 
9 HN 7 HN 3.633 
7 HN 6 HA 3.444 
60 HN 59 HA 2.545 
60 HN 59 HN 3.305 
59 HB1 60 HN 3.530 
48 HB2 49 HN 2.676 
49 HN 48 HN 2.528 
58 HN 58 HG 2.620 
58 HN 57 HB1 3.396 
49 HN 49 HA 2.853 
49 HN 52 HB2 3.081 
48 HA 49 HN 3.214 
49 HB2 49 HN 2.845 
48 HB1 49 HN 2.874 
28 HN 30 HN 3.197 
55 HA 55 HN 2.692 
55 HN 52 HA 3.118 
54 HB1 55 HN 2.763 
55 HG2 55 HN 2.725 
55 HB2 55 HN 2.300 
26 HN 33 HD12 3.587 
26 HN 30 HN 3.502 
18 HN 19 HN 3.707 
59 HB2 59 HN 2.641 
58 HB2 59 HN 3.153 
59 HN 59 HD1 3.613 
59 HN 59 HA 2.775 
58 HN 59 HN 2.479 
31 HN 31 HG2 3.381 
31 HN 26 HB1 3.021 
30 HA 31 HN 2.540 
31 HN 31 HB1 3.272 
31 HN 29 HB2 3.094 
31 HB2 31 HN 2.810 
31 HA 31 HN 2.782 
52 HN 53 HN 2.635 
52 HN 51 HD1 3.539 
52 HN 51 HB2 2.791 
52 HN 52 HB1 3.096 
52 HN 52 HA 2.856 
49 HB2 52 HN 2.662 
52 HN 52 HB2 2.531 
52 HN 51 HB1 2.993 
53 HB1 53 HN 2.497 
53 HN 52 HA 3.353 
53 HN 52 HB2 2.807 
53 HN 54 HN 2.590 
57 HN 56 HN 2.610 
56 HN 55 HN 2.754 
56 HN 56 HA 2.809 
56 HN 56 HB 2.472 
55 HB2 56 HN 2.809 
32 HN 31 HB2 2.951 
20 HN 39 HN 4.102 
16 HN 20 HN 4.781 
22 HN 21 HN 3.678 
54 HG1 54 HN 2.456 
54 HB1 54 HN 2.554 
54 HG2 54 HN 3.017 
54 HA 54 HN 2.792 
54 HN 55 HN 2.851 
51 HA 54 HN 3.231 
36 HN 22 HN 3.969 
42 HN 14 HN 3.539 
48 HN 47 HA 2.433 
48 HA 48 HN 2.877 
48 HB2 48 HN 2.332 
47 HB1 48 HN 2.779 
23 HN 47 HB2 3.253 
4 HA 5 HN 2.266 
5 HA 5 HN 2.884 
5 HB2 5 HN 2.540 
Residue 1 Atom 1 Residue 2 Atom 2 Distance 
[Å] 
4 HB1 5 HN 3.194 
5 HN 4 HB2 2.961 
37 HN 20 HN 3.028 
43 HN 44 HN 3.468 
16 HN 41 HN 3.847 
54 HB2 55 HN 3.035 
54 HA 55 HN 3.669 
2 HN 2 HA 2.232 
5 HN 6 HN 2.898 
6 HN 6 HG 2.484 
5 HB2 6 HN 3.171 
6 HN 6 HD22 2.793 
6 HN 6 HD21  
6 HN 6 HD23  
5 HA 6 HN 3.224 
4 HB1 6 HN 2.919 
6 HA 6 HN 2.732 
6 HB2 6 HN 2.433 
6 HB1 6 HN 2.775 
7 HN 4 HB1 3.165 
6 HN 7 HN 2.822 
7 HN 6 HD21 3.046 
7 HN 6 HG 2.562 
7 HN 7 HA 3.081 
8 HN 6 HA 3.406 
8 HN 7 HB2 3.066 
8 HA 8 HN 2.931 
8 HB2 8 HN 2.430 
9 HN 6 HA 3.362 
9 HN 8 HB2 3.339 
9 HN 8 HA 3.150 
10 HB2 11 HN 2.762 
10 HB1 11 HN 3.061 
10 HA 11 HN 2.260 
11 HN 11 HA 2.866 
11 HA 12 HN 2.300 
12 HN 12 HA 3.110 
12 HB2 12 HN 3.083 
12 HB1 12 HN 2.893 
12 HA 13 HN 2.229 
13 HN 13 HA 3.177 
13 HB2 13 HN 2.993 
14 HN 12 HA 3.257 
14 HA2 15 HN 2.397 
15 HN 15 HA 2.856 
15 HB2 15 HN 3.054 
15 HB1 15 HN 2.779 
15 HN 16 HN 2.563 
16 HN 15 HA 2.860 
16 HA2 16 HN 2.495 
16 HA2 17 HN 2.468 
17 HN 17 HA 2.838 
17 HN 18 HN 2.443 
18 HN 18 HA 2.468 
18 HN 18 HB1 2.924 
18 HN 18 HG2 3.265 
18 HA 19 HN 2.232 
19 HN 18 HB2 2.860 
18 HB1 19 HN 2.400 
19 HB2 19 HN 2.401 
19 HN 20 HN 3.914 
19 HA 20 HN 2.152 
19 HB2 20 HN 2.782 
20 HA 20 HN 2.753 
20 HB1 20 HN 2.877 
20 HG1 20 HN 2.794 
20 HB2 20 HN 2.971 
21 HN 21 HD2 2.581 
20 HB1 21 HN 2.772 
20 HA 21 HN 2.229 
21 HN 21 HA 2.863 
22 HN 21 HD2 3.372 
22 HN 21 HB2 2.872 
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Residue 1 Atom 1 Residue 2 Atom 2 Distance 
[Å] 
21 HA 22 HN 2.144 
22 HN 22 HA 2.907 
22 HB2 22 HN 2.879 
22 HN 22 HB1 3.284 
22 HG2 22 HN 3.391 
22 HN 35 HN 2.869 
23 HN 22 HA 2.669 
23 HB 23 HN 2.243 
23 HG11 23 HN 3.004 
23 HN 23 HG21 3.650 
23 HA 24 HN 2.297 
23 HG21 24 HN 2.516 
24 HN 33 HN 2.903 
25 HN 47 HE1 3.593 
24 HA 25 HN 2.640 
25 HA 25 HN 3.522 
25 HB2 25 HN 2.813 
25 HB1 25 HN 2.778 
25 HA 26 HN 2.388 
26 HN 26 HA 3.033 
26 HB2 26 HN 2.619 
26 HN 31 HN 3.177 
26 HA 27 HN 2.229 
27 HA 27 HN 2.888 
27 HB2 27 HN 2.401 
27 HN 28 HN 2.724 
28 HN 27 HA 3.348 
28 HA 28 HN 2.680 
28 HB1 28 HN 2.246 
28 HN 29 HN 2.543 
28 HA 29 HN 3.242 
28 HB1 29 HN 2.304 
29 HB2 29 HN 2.499 
30 HN 30 HG1 3.127 
30 HN 30 HG2 2.991 
30 HN 30 HB2 3.261 
29 HN 30 HN 2.399 
30 HN 29 HA 3.217 
30 HN 29 HB2 3.121 
30 HN 30 HA 2.287 
30 HN 31 HN 2.572 
31 HA 32 HN 2.199 
31 HB1 32 HN 2.797 
32 HB2 32 HN 2.446 
33 HN 33 HD12 3.138 
23 HG21 33 HN 2.865 
33 HN 33 HA 2.933 
33 HB2 33 HN 2.658 
34 HN 33 HA 2.269 
33 HB1 34 HN 2.476 
Residue 1 Atom 1 Residue 2 Atom 2 Distance 
[Å] 
34 HA 34 HN 2.893 
34 HB1 35 HN 3.257 
34 HB2 35 HN 2.765 
35 HN 34 HG2 3.081 
34 HA 35 HN 2.224 
35 HN 35 HA 3.066 
36 HN 35 HA 2.395 
35 HB2 36 HN 2.908 
36 HN 35 HD1 3.228 
36 HN 36 HA 2.981 
36 HB1 36 HN 2.880 
36 HA 37 HN 2.209 
37 HB1 37 HN 2.579 
38 HN 37 HB2 3.765 
38 HN 13 HA 3.412 
38 HN 37 HA 2.324 
40 HN 38 HN 3.367 
40 HN 40 HG2 3.438 
16 HN 40 HN 2.977 
16 HA2 40 HN 3.042 
40 HN 40 HA 2.809 
40 HN 40 HB2 2.975 
40 HB1 40 HN 3.187 
40 HA 41 HN 2.324 
41 HN 40 HB2 3.228 
41 HN 40 HB1 3.012 
41 HN 40 HG2 3.091 
41 HA2 41 HN 2.465 
41 HA2 42 HN 2.473 
12 HB1 43 HN 3.099 
43 HN 42 HA2 2.417 
43 HN 43 HA 2.951 
43 HA 44 HN 2.586 
44 HB1 44 HN 2.857 
44 HG2 44 HN 2.630 
45 HN 45 HA 2.769 
45 HB1 45 HN 2.638 
46 HN 45 HN 3.555 
46 HN 45 HA 2.395 
46 HN 46 HA 3.214 
46 HN 46 HB1 2.839 
23 HB 47 HN 3.091 
23 HN 47 HN 2.946 
47 HN 46 HA 2.428 
47 HA 47 HN 3.422 
47 HN 47 HB2 3.433 
47 HN 47 HB1 2.817 
58 HA 58 HN 2.866 
58 HA 59 HN 2.789 
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D   Pulse-programs and parameters used for HVDAC 
 




;2D H-1/X correlation via TROSY 
;   using sensitivity improvement 
;phase sensitive using Echo/Antiecho gradient selection 
;using f3 - channel 
;(use parameterset TROSYETF3GPSI) 
; 
;M. Czisch & R. Boelens, J. Magn. Reson. 134, 158-160 (1998) 
;K. Pervushin, G. Wider & K. Wuethrich, J. Biomol. NMR 12, 
;   345-348 (1998) 
;A. Meissner, T. Schulte-Herbrueggen, J. Briand & O.W. Sorensen, Mol. Phys. 96, 
;   1137-1142 (1998) 
;J. Weigelt, J. Am. Chem. Soc. 120, 10778-10779 (1998) 
;M. Rance, J.P. Loria & A.G. Palmer III, J. Magn. Reson. 136, 91-101 (1999) 
























1 ze  
2 d11 
3 d1 pl1:f1 
  50u UNBLKGRAD 
  (p1 ph1) 
  4u 
  p16:gp1 
  d16 
  DELTA1 
  (center (p2 ph2) (p22 ph1):f3 ) 
  4u 
  DELTA1 
  p16:gp1 
  d16 
  (p1 ph3)  
 
  p16:gp6 
 
 
  if "l0 %2 == 1" 
     { 
     (p21 ph4):f3 
     } 
  else 
     { 
     (p21 ph5):f3 
     } 
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  d0 gron0 
  d0 gron0*-1 
  10u groff 
 
  p19:gp2*EA 
  d16 
  (p22 ph1):f3 
 
  DELTA 
 
  p19:gp2*-1*EA 
  d16 
 
  (p1 ph6) 
  4u 
  p16:gp3 
  d16 
  DELTA2 pl1:f1 
  (center (p2 ph1) (p22 ph1):f3 ) 
  4u 
  DELTA1 
  p16:gp3 
  d16 
  (center (p1 ph1) (p21 ph2):f3 ) 
 
  4u 
  p16:gp4 
  d16 
  DELTA1 
  (center (p2 ph1) (p22 ph1):f3 ) 
  DELTA1 
  p16:gp4 
  d16 
  4u 
  (p21 ph7):f3 
 
  DELTA3 
  (p2 ph1) 
  4u 
  p19:gp5 
  d16 
  4u BLKGRAD 
 
  go=2 ph31 
  d11 mc #0 to 2  
     F1EA(igrad EA & ip6*2 & ip7*2 & iu0, id0 & ip4*2 & ip5*2 & ip31*2) 
exit  





ph4=1 3 2 0 
ph5=3 1 2 0 
ph6=1 
ph7=0 
ph31=0 2 3 1 
 
 
;pl1 : f1 channel - power level for pulse (default) 
;pl3 : f3 channel - power level for pulse (default) 
;p1 : f1 channel -  90 degree high power pulse 
;p2 : f1 channel - 180 degree high power pulse 
;p16: homospoil/gradient pulse                       [1 msec] 
;p19: gradient pulse 2                               [500 usec] 
;p21: f3 channel -  90 degree high power pulse 
;p22: f3 channel - 180 degree high power pulse 
;d0 : incremented delay (2D)                         [6 usec] 
;d1 : relaxation delay; 1-5 * T1 
;d11: delay for disk I/O                             [30 msec] 
;d16: delay for homospoil/gradient recovery 
;d26 : 1/(4J)YH 
;cnst4: = J(YH) 
;in0: 1/(2 * SW(X)) = DW(X) 
;nd0: 2 
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;NS: 4 * n 
;DS: 16 




;use gradient ratio:    gp 0 : gp 1 : gp 2 : gp 3 : gp 4 : gp 5 
;                                   3 :    30 :     80 :    45 :    50 :   16.2 
 

















;$Id: trosyetf3gpsi,v 1.4 2002/06/12 09:05:18 ber Exp $ 
 
 
D.1.2 TROSY-HSQC parameters 
 
##TITLE= Parameter file, XWIN-NMR 
 Version 3.5 
##JCAMPDX= 5.0 
##DATATYPE= Parameter Values 
##ORIGIN= UXNMR, Bruker Analytische Messtechnik 
GmbH 
##OWNER= demo 




100 100 100 100 100 100 100 100 100 100 100 100 100 
100 100 100 100 100 100 100 100 100 100 100 100 100 


















1 1 140 1 90 1 1 1 1 1 1 1 1 1 1 1 1 1 4.755 8.5 3.5 176 54 













6e-06 1 0.0036 0 0 0 0 0 0.12 0 0 0.03 2e-05 5e-06 0 0 
3.48e-05 0 0 5e-05 0 0 0 0 0 0 0.00175 0 0 0 0 0  
##$DATE= 1169116837 
##$DBL= (0..7) 
120 120 120 120 120 120 120 120  
##$DBP= (0..7) 











0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5  
##$DBPOFFS= (0..7) 









10 120 120 120 120 120 120 120  
##$DP= (0..7) 












0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5  
##$DPOFFS= (0..7) 


































































0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
0  
##$GPY= (0..31) 
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
0  
##$GPZ= (0..31) 
3 30 80 45 50 16.2 15 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 












0 0 0 0 0 0 0 0  
##$HPPRGN= 0 
##$IN= (0..31) 
0.0001813625 0.001 0.001 0.001 0.001 0.001 0.001 0.001 
0.001 0.001 0.001 0.001 0.001 0.001 0.001 0.001 0.001 
0.001 0.001 0.001 0.001 0.001 0.001 0.001 0.001 0.001 
0.001 0.001 0.001 0.001 0.001 0.001  
##$INP= (0..31) 









































0 0 0 0 0 0 0 0 0 0  
##$OVERFLW= 0 
##$P= (0..31) 
11 13.3 26.6 0.1 0 0 0 0 0 0 0 0 0 0 0 0 1000 0 0 500 26 34 




100 100 100 100 100 100 100 100 100 100  
##$PHCOR= (0..31) 






120 -1 -6 -6 120 120 120 120 120 56 120 120 120 120 120 
120 120 120 -3 120 120 120 120 120 120 120 120 120 120 




-1 1 0 -1 -1 2 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1  
##$PRGAIN= 0 






##$QS= (0..7)83 83 83 83 83 83 83 22  
##$QSB= (0..7)83 83 83 83 83 83 83 83  
##$RD= 0 
##$RECCHAN= (0..15) 





0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0  
##$ROUTWD2= (0..23) 
0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 1 0 1 1 0 0  
##$RPUUSED= (0..8) 
0 0 0 0 0 0 0 0 0  
##$RSEL= (0..9) 
0 2 1 5 0 0 0 0 0 0  
##$S= (0..7) 












1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 150 150 150 150 150 150 




































0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 
0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 
0.5 0.5  
##$SPOFFS= (0..31) 























10 120 120 120 120 120 120 120  
##$TP= (0..7) 











0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5  
##$TPOFFS= (0..7) 


















##$WS= (0..7)83 83 83 83 83 83 83 83  
##$XGAIN= (0..3) 


















;2D H-1/X correlation via TROSY and inept transfer 
;   using sensitivity improvement 
;for measuring H1-N15 NOEs 
;phase sensitive using Echo/Antiecho-TPPI gradient selection 
;using f3 - channel 
;recording NOE and NONOE interleaved 
;(use parameterset TRNOEF3GPSI) 
; 
;G. Zhu, Y. Xia, L.K. Nicholson & K.H. Sze, 























;#   ifdef LABEL_CN 
;"DELTA=d0*2+p8-p21*4/3.1416" 
;"DELTA2=d26-p11-p19-d16-8u" 
;#   else 
"DELTA2=d26+d0*2-p11-p19-d16-8u" 





   
1  ze 
2  d11 
   d12 
3  d12*4 
4  d12*4 
5  d12 
6  d12 pl16:f3 
   d31 cpd3:f3 
   4u  do:f3 
 
  if "l1==2" goto 7  
 
   d1 
   
  4u pl0:f1         ;flip back like in the hsqc version of hetnoe 
  (p11:sp1 ph2):f1 
  4u  
  4u pl1:f1 
 
    goto 8      
7    (p0 ph1) 
 160 
     5m 
     lo to 7 times l4 
     4u 
;     goto 8 
;10  d1 
8  50u  
   100u UNBLKGRAD 
 
  p16:gp1   ;instead of gradient flip back pulse 
  d16 
 
  (p1 ph1) 
  4u 
  p16:gp2 
  d16 pl3:f3 
 
  if "l0 %2 == 1" 
     { 
     (p21 ph4):f3 
     } 
  else 
     { 
     (p21 ph5):f3 
     } 
 
;#   ifdef LABEL_CN 
;  DELTA 
;  (p22 ph1):f3 
;  d0 
;  (p8:sp13 ph1):f2 
;  d0 
;#   else 
  d0 
  d0 
;#   endif /*LABEL_CN*/ 
 
  (p1 ph6) 
  4u pl0:f1 
  (p11:sp1 ph6):f1 
  p19:gp3 
  d16 
  DELTA1 pl1:f1 
  (center (p2 ph1) (p22 ph1):f3 ) 
  DELTA2 
  p19:gp3 
  d16 pl0:f1 
  (p11:sp1 ph9):f1 
  4u 
  4u pl1:f1 
 
  (center (p1 ph1) (p21 ph2):f3 ) 
 
  4u 
  p19:gp4 
  d16 
  DELTA3 pl0:f1 
  (p11:sp1 ph3:r):f1 
  4u 
  4u pl1:f1 
  (center (p2 ph1) (p22 ph1):f3 ) 
  4u pl0:f1 
  (p11:sp1 ph3:r):f1 
  DELTA4 
  p19:gp4 
  d16 pl1:f1 
  4u 
  4u BLKGRAD 
  (p21 ph7):f3 
 
  go=2 ph31 
  d11 wr #0 if #0 zd 
   
     ;d11 mc #0 to 2  
     ;F1I(iu0, 2) 
     ;F1EA(ip6*2 & ip7*2, id0 & ip4*2 & ip5*2 & ip31*2) 
 161 
 
   d12 iu1 
lo to 3 times 2 
   d12 ru1 
   d12 iu0 
   d12 ip6*2 
   d12 ip7*2 
lo to 4 times 2 
   d12 id0 
   d12 ip4*2 
   d12 ip5*2 
   d12 ip31*2  







;#   ifdef LABEL_CN 
;ph4=3 1 2 0 
;ph5=1 3 2 0 
;#   else 
ph4=1 3 2 0 
ph5=3 1 2 0 




ph31=0 2 3 1 
 
;pl0 : 120dB 
;pl1 : f1 channel - power level for pulse (default) 
;pl3 : f3 channel - power level for pulse (default) 
;pl16: f3 channel - power level for CPD/BB decoupling 
;sp1: f1 channel - shaped pulse  90 degree 
;sp13: f2 channel - shaped pulse 180 degree  (adiabatic) 
;p0 : f1 channel - 120 degree high power pulse 
;p1 : f1 channel -  90 degree high power pulse 
;p2 : f1 channel - 180 degree high power pulse 
;p8 : f2 channel - 180 degree shaped pulse for inversion (adiabatic) 
;p11: f1 channel -  90 degree shaped pulse 
;p16: homospoil/gradient pulse                       [1 msec] 
;p19: gradient pulse 2                               [500 usec] 
;p21: f3 channel -  90 degree high power pulse 
;p22: f3 channel - 180 degree high power pulse 
;d0 : incremented delay (2D)                         [3 usec] 
;d1 : relaxation delay; 1-5 * T1 
;d11: delay for disk I/O                             [30 msec] 
;d12: delay for power switching                      [20 usec] 
;d16: delay for homospoil/gradient recovery 
;d26: 1/(4J(YH)) 
;d31: = aq 
;cnst4: = J(YH) 
;l0: flag to switch between NOE and NONOE 
;in0: 1/(2 * SW(X)) = DW(X) 
;nd0: 2 
;NS: 4 * n 
;DS: >= 32 
;td1: total number of experiments 
;        = number of experiments for each 2D * 2 
;FnMODE: echo-antiecho 
;cpd3: decoupling according to sequence defined by cpdprg3 
;pcpd3: f3 channel - 90 degree pulse for decoupling sequence 
 
 
;use gradient ratio: gp 1 : gp 2 : gp 3 : gp 4 
;    11 :    7 :   10 :   25 
 














                                          ;preprocessor-flags-start 
;LABEL_CN: for C-13 and N-15 labeled samples start experiment with  
;             option -DLABEL_CN (eda: ZGOPTNS) 




;use AU-program splitinvnoe to separate NOE and NONOE data into 




;$Id: trnoef3gpsi,v 1.3 2002/07/16 12:41:09 ber Exp $ 
 
 
D.2.2 HetNOE parameters 
 
##TITLE= Parameter file, XWIN-NMR 
 Version 3.5 
##JCAMPDX= 5.0 
##DATATYPE= Parameter Values 
##ORIGIN= UXNMR, Bruker Analytische Messtechnik 
GmbH 
##OWNER= demo 




100 100 100 100 100 100 100 100 100 100 100 100 100 
100 100 100 100 100 100 100 100 100 100 100 100 100 


















1 1 140 1 90 1 1 1 1 1 1 1 1 1 1 1 1 1 4.755 8.5 3.5 176 54 













3e-06 5 0.0036 0 0 0 0 0 0.12 0 0 0.07 5e-05 5e-06 0 0 
3.48e-05 0 0 5e-05 0 0 0 0 0 0 0.002777778 0 0 0 0 0.0472  
##$DATE= 1167648929 
##$DBL= (0..7) 
120 120 120 120 120 120 120 120  
##$DBP= (0..7) 











0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5  
##$DBPOFFS= (0..7) 









10 120 120 120 120 120 120 120  
##$DP= (0..7) 











0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5  
##$DPOFFS= (0..7) 



































































0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
0  
##$GPY= (0..31) 
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
0  
##$GPZ= (0..31) 
3 50 7 10 25 16.2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 












0 1 1 0 0 0 0 0  
##$HPPRGN= 0 
##$IN= (0..31) 
0.0001523 0.001 0.001 0.001 0.001 0.001 0.001 0.001 
0.001 0.001 0.001 0.001 0.001 0.001 0.001 0.001 0.001 
0.001 0.001 0.001 0.001 0.001 0.001 0.001 0.001 0.001 
0.001 0.001 0.001 0.001 0.001 0.001  
##$INP= (0..31) 




1 1 1 101 996 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 




































0 0 0 0 0 0 0 0 0 0  
##$OVERFLW= 0 
##$P= (0..31) 
15.46667 11.6 23.2 0.1 15.6 0 0 0 0 0 0 1000 0 0 0 0 1000 




100 100 100 160 100 100 100 100 100 100  
##$PHCOR= (0..31) 





120 -1 120 -3 -0.5 120 120 120 120 56 120 120 120 120 
120 120 9.6 120 -3 120 120 120 120 120 120 120 120 120 




-1 2 -1 -1 0 1 -1 -1 -1 -1 4 -1 -1 -1 -1 -1  
##$PRGAIN= 0 







##$QS= (0..7)83 83 83 83 83 83 83 22  
##$QSB= (0..7)83 83 83 83 83 83 83 83  
##$RD= 0 
##$RECCHAN= (0..15) 





0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0  
##$ROUTWD2= (0..23) 
0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 1 0 1 1 0 0  
##$RPUUSED= (0..8) 
0 0 0 0 0 0 0 0 0  
##$RSEL= (0..9) 
0 1 2 5 0 0 0 0 0 0  
##$S= (0..7) 












1 35.17 0 0 0 0 0 0 0 0 0 0 0 0 0 0 150 150 150 150 150 




































0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 
0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 
0.5 0.5  
##$SPOFFS= (0..31) 























10 120 120 120 120 120 120 120  
##$TP= (0..7) 











0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5  
##$TPOFFS= (0..7) 


















##$WS= (0..7)83 83 83 83 83 83 83 83  
##$XGAIN= (0..3) 






















;1 hn, 15n edited n15 t2 measurement according to linda 
;history 
;written by sg 2/23/93 
;put in water flip_back 6/1/93 
;change to waternh 7/29/93 






;p1 proton 90 at pl1, 9u 





;p7 high power n15 90 on N pl7:N 
;p31 low power n15 90 (160ms) on N at pl31:N 





























;"p11=4.25m"  ;gp1 = +50% 
;"p12=1.75m"  ;gp1 = +50% 
;"p13=0.70m"  ;gp1 = +50% 
;"p14=2.35m"  ;gp0 = -50% 







2 d11 BLKGRAD 





26 10u do:C1 
 10u  
 166 
 10u pl7:N 
#ifdef ON 
 d1 
 1m UNBLKGRAD 
 10u fq1:H 
 10u pl1:f1 
;***** start 90-degree on h-n ***** 
 (p1 ph0) 
 2u 
 d4 
 (p7*2 ph6):N (d26 p1*2 ph4) 
 d4 
 2u 
;***** hsqc to nitrogen ***** 








 (p7*2 ph0):N (d25 p1 ph4 2u p1*2.22 ph0 2u p1 ph4) 
 2u 
 p12:gp0 
 928u pl8:N   ; SL power 2.5KHz 
 d7 
 100u 
;***** n15 relaxation delay ******* 
;70 (p18 ph8):N 
; (p17*1.5 ph8):N (p1*1.5 ph4) 
; (p18 ph8):N 
; lo to 70 times 2  
 (p9 ph8):N 
;***** n15 evolution delay ******* 
        d0 pl5:C1 
#ifdef CARB 
        2u 
        d28*2.0 
        4u 
        2u fq2:C1 
        d28*2.0 pl7:N 
#else 
        d17 pl7:N 
#endif 
        (p7*2 ph20):N 
        d9  
#ifdef CARB 
        2u pl5:C1 
        (p5*2 ph10):C1 (p1*2 ph0) 
        4u 
        2u fq2:C1 
        (p5*2 ph10):C1 
#else 
        (p1*2 ph0) 
#endif 
        d10 
;***** end n15 evolution delay ******* 
 (p7 ph7):N 
 2u 
 p14:gp1 
 10u fq1:H 
 2m 
 (p1 ph0) 
 2u 
 p15:gp1 
 950u pl2:f1 
 (p2 ph14) 
 2u 
 5u pl1:f1 
 (p1*2 ph15) 
 2u 
 5u pl2:f1 




 (2u ph0) 
 950u pl31:N 
#endif 
#ifdef ONE_D 
go=2 ph31 cpd2:N 
1m do:N 
1m BLKGRAD 
d11 wr #0 
#endif 
#ifdef TWO_D 
 go=2 ph31 cpd2:N 
 1m BLKGRAD 




lo to 3 times 1 
d12 ip7 






















d12 rf #0 
d12 ip8 
d12 ip8 

















ph20=0 0 0 0 1 1 1 1 2 2 2 2 3 3 3 3 




D.3.2 T1rho parameters 
 
##TITLE= Parameter file, XWIN-NMR 
 Version 3.5 
##JCAMPDX= 5.0 
##DATATYPE= Parameter Values 
##ORIGIN= Bruker Analytik GmbH 
##OWNER= guest 






100 100 100 100 100 100 100 100 100 100 100 100 100 
100 100 100 100 100 100 100 100 100 100 100 100 100 


















1 1 147 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 













0.002727569 1 0 0 0.00225 0 0 2.3569e-05 0 4e-06 0.0027 
0.05 0.01 3e-06 0 0 1e-04 2.076e-05 0 0 0 0 0 0 0 




120 120 120 120 120 120 120 120  
##$DBP= (0..7) 











0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5  
##$DBPOFFS= (0..7) 









120 120 120 120 120 120 120 120  
##$DP= (0..7) 











0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5  
##$DPOFFS= (0..7) 






































































0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
0  
##$GPZ= (0..31) 
50 25 37 8.1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -50 30 33 41     












0 1 1 0 0 0 0 0  
##$HPPRGN= 0 
##$IN= (0..31) 
0.0001827125 0.001 0.001 0.001 0.001 0.001 0.001 0.001 
0.001 0.001 0.001 0.001 0.001 0.001 0.001 0.001 0.001 
0.001 0.001 0.001 0.001 0.001 0.001 0.001 0.001 0.001 
0.001 0.001 0.001 0.001 0.001 0.001  
##$INP= (0..31) 




1 1 1 256 1 28 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 




































0 0 0 0 0 0 0 0 0 0  
##$OVERFLW= 0 
##$P= (0..31) 
11 10.38 1030 13.65 15.8 15.6 25 37 9 2000 10 4250 1750 
0 2350 400 1000 10.38 1300000 1300000 2000 1100 1000 




0 0 1500 160 0 0 0 0 100 100  
##$PHCOR= (0..31) 





120 -1 41 120 -1.2 120 120 -2 6.64 54 120 120 11.7 120 
120 120 12.6 120 120 120 120 120 120 120 120 120 120 




-1 2 -1 -1 0 1 -1 -1 -1 -1 4 -1 -1 -1 -1 -1  
##$PRGAIN= 0 














0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0  
##$ROUTWD2= (0..23) 
0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 1 0 1 1 0 0  
##$RPUUSED= (0..8) 
0 0 0 0 0 0 0 0 0  
##$RSEL= (0..9) 
0 1 2 5 0 0 0 0 0 0  
##$S= (0..7) 












1 0 0 2.8 0 0 0 0 0 0 0 0 0 0 0 0 150 150 150 150 150 150 





































0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 
0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 
0.5 0.5  
##$SPOFFS= (0..31) 























120 120 120 120 120 120 120 120  
##$TP= (0..7) 











0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5  
##$TPOFFS= (0..7) 





































;3D sequence with 
;   homonuclear correlation via dipolar coupling 
;   dipolar coupling may be due to noe or chemical exchange 
;   H-1/X correlation via TROSY 
;      using sensitivity improvement 
;phase sensitive (t1) 
;phase sensitive using Echo/Antiecho-TPPI gradient selection (t2) 
;using f3 - channel 
;(use parameterset NOESYTRETF3GP3D) 
; 
;G. Zhu, X.M. Kong & K.H. Sze, J. Biomol. NMR 13, 77-81 (1999) 
;M. Czisch & R. Boelens, J. Magn. Reson. 134, 158-160 (1998) 
;K. Pervushin, G. Wider & K. Wuethrich, J. Biomol. NMR 12, 
;   345-348 (1998) 
;A. Meissner, T. Schulte-Herbrueggen, J. Briand & O.W. Sorensen, Mol. Phys. 96, 
;   1137-1142 (1998) 
;J. Weigelt, J. Am. Chem. Soc. 120, 10778-10779 (1998) 























#   ifdef LABEL_CN 
"DELTA=d10*2+p4*4+8u+p21*4/3.1416+12u" 
"DELTA4=d0*2+p4*4+p22+8u+4u" 
#   else 
"DELTA=d10*2+p21*4/3.1416+12u" 
"DELTA4=d0*2+p22+4u" 








1 ze  
2 d11 
3 d1 pl1:f1 
  50u UNBLKGRAD 
  (p1 ph3) 
  DELTA4 
  (p2 ph9) 
  d0 gron0 
  2u groff 
 
#   ifdef LABEL_CN 
  ;(center (p14:sp3 ph1):f2 (p22 ph1):f3 ) 
 
       (p22 ph1):f3 
       2u pl4:f2 
       2u fq4:f2 
       (p4*2 ph1):f2 
       2u pl4:f2 
       2u fq4:f2 
       (p4*2 ph1):f2      
 
#   else 
  (p22 ph1):f3 
#   endif /*LABEL_CN*/ 
 
  d0 gron0*-1 
  2u groff 
 
  (p1 ph1) 
  TAU 
  p16:gp6 
  d16 
  (p1 ph1) 
  4u 
  p16:gp1 
  d16 
  DELTA1 
  (center (p2 ph2) (p22 ph1):f3 ) 
  4u 
  DELTA1 
  p16:gp1 
  d16 
  (p1 ph4)  
 
   ;p16:gp7 
 
  if "l0 %2 == 1" 
 172 
     { 
     (p21 ph5):f3 
     } 
  else 
     { 
     (p21 ph6):f3 
     } 
 
  d10 gron0 
  6u groff 
 
#   ifdef LABEL_CN 
  ;(p14:sp3 ph1):f2 
 
       2u pl4:f2 
       2u fq4:f2 
       (p4*2 ph1):f2 
       2u pl4:f2 
       2u fq4:f2 
       (p4*2 ph1):f2      
 
#   else 
#   endif /*LABEL_CN*/ 
 
  d10 gron0*-1 
  6u groff 
 
  p19:gp2*EA 
  d16 
  (p22 ph1):f3 
 
  DELTA 
 
  p19:gp2*-1*EA 
  d16 
 
  (p1 ph7) 
  4u 
  p16:gp3 
  d16 
  DELTA2 pl1:f1 
  (center (p2 ph1) (p22 ph1):f3 ) 
  4u 
  DELTA1 
  p16:gp3 
  d16 
  (center (p1 ph1) (p21 ph2):f3 ) 
 
  4u 
  p16:gp4 
  d16 
  DELTA1 
  (center (p2 ph1) (p22 ph1):f3 ) 
  DELTA1 
  p16:gp4 
  d16 
  4u 
  (p21 ph8):f3 
 
  DELTA3 
  (p2 ph1) 
  4u 
  p19:gp5 
  d16 
  4u BLKGRAD 
 
  go=2 ph31 
  d11 mc #0 to 2  
     F1PH(rd10 & ip3 & ip9, id0)  
     F2EA(igrad EA & ip7*2 & ip8*2 & iu0, id10 & ip5*2 & ip6*2 & ip31*2) 
exit  





ph3=0 0 0 0 2 2 2 2 
ph4=3 
ph5=1 3 2 0 




ph31=0 2 3 1 2 0 1 3 
 
;pl1 : f1 channel - power level for pulse (default) 
;pl3 : f3 channel - power level for pulse (default) 
;sp3: f2 channel - shaped pulse 180 degree 
;p1 : f1 channel -  90 degree high power pulse 
;p2 : f1 channel - 180 degree high power pulse 
;p14: f2 channel - 180 degree shaped pulse for inversion 
;p16: homospoil/gradient pulse                         [1 msec] 
;p19: gradient pulse 2                                 [500 usec] 
;p21: f3 channel -  90 degree high power pulse 
;p22: f3 channel - 180 degree high power pulse 
;d0 : incremented delay (F1 in 3D)                     [6 usec] 
;d1 : relaxation delay; 1-5 * T1 
;d8 : mixing time 
;d10: incremented delay (F2 in 3D)                     [6 usec] 
;d11: delay for disk I/O                               [30 msec] 
;d16: delay for homospoil/gradient recovery 
;d26 : 1/(4J)YH 
;cnst4: = J(YH) 
;in0: 1/(2 * SW(H)) = DW(H) 
;nd0: 2 
;in10: 1/(2 * SW(X)) = DW(X) 
;nd10: 2 
;NS: 8 * n 
;DS: 16 
;td1: number of experiments 
;td2: number of experiments in F2 
;FnMODE: States-TPPI (or TPPI) in F1 
;FnMODE: echo-antiecho in F2 
 
;use gradient ratio:    gp 0 : gp 1 : gp 2 : gp 3 : gp 4 : gp 5 : gp 6 
;                          3 :   30 :   80 :   45 :   50 : 16.2 :   19 
 


















                                          ;preprocessor-flags-start 
;LABEL_CN: for C-13 and N-15 labeled samples start experiment with  
;             option -DLABEL_CN (eda: ZGOPTNS) 
                                          ;preprocessor-flags-end 
 
;$Id: noesytretf3gp3d,v 1.8.2.2 2002/09/24 09:43:30 ber Exp $ 
 
D.4.2 NOESY-TROSY-HSQC parameters 
 
##TITLE= Parameter file, XWIN-NMR 
 Version 3.5 
##JCAMPDX= 5.0 
##DATATYPE= Parameter Values 
##ORIGIN= Bruker Analytik GmbH 
##OWNER= guest 





100 100 100 100 100 100 100 100 100 100 100 100 100 
100 100 100 100 100 100 100 100 100 100 100 100 100 


















1 1 140 1 90 1 1 1 1 1 1 1 1 1 1 1 1 1 4.755 8.5 3.5 176 54 













6e-06 1 0.001 0.001 0.0018 0 0 0 0.16 0.06 6e-06 0.03   
2e-05 4e-06 0 0 0.0005 0 0 0 1e-05 1e-05 0 0 0.00275 0 
0.002777778 0 0 0 0 0  
##$DATE= 1141936943 
##$DBL= (0..7) 
120 120 120 120 120 120 120 120  
##$DBP= (0..7) 











0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5  
##$DBPOFFS= (0..7) 









120 120 120 120 120 120 120 120  
##$DP= (0..7) 











0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5  
##$DPOFFS= (0..7) 


































































0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
0  
##$GPY= (0..31) 




3 30 80 45 50 16.2 19 15 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 













0 0 0 0 0 0 0 0  
##$HPPRGN= 0 
##$IN= (0..31) 
6.2e-05 0.001 0.001 0.001 0.001 0.001 0.001 0.001 0.001 
0.001 0.00022 0.001 0.001 0.001 0.001 0.001 0.001 0.001 
0.001 0.001 0.000232 0.001 0.001 0.001 0.001 0.001 
0.001 0.001 0.001 2e-05 0.0002 0.001  
##$INP= (0..31) 




1 20 1 64 1 1 1 1 1 1 1 1 1 64 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 




































0 0 0 0 0 0 0 0 0 0  
##$OVERFLW= 0 
##$P= (0..31) 
10.5 12.14 24.28 11.8 18.5 23.1 35 70 0 35 70 0 0 256 500 
200000 1000 1000 0 500 0 48.5 97 0 2000 0 70 10.5 200 




100 100 100 100 100 100 100 100 100 100  
##$PHCOR= (0..31) 





120 -1 120 -3 -3 120 120 120 120 59.06 15.96 120 13.46 
120 120 7.36 17.8 120 5.5 19.88 120 120 120 120 120 120 




-1 2 0 -1 -1 3 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1  
##$PRGAIN= 0 














0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0  
##$ROUTWD2= (0..23) 
0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0  
##$RPUUSED= (0..8) 
0 0 0 0 0 0 0 0 0  
##$RSEL= (0..9) 
0 2 1 5 0 0 0 0 0 0  
##$S= (0..7) 












1 120 120 4 0 3.1 120 4 1 12.8 0 0 0 0 0 12.8 150 150 150 





































0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 
0.5 0.5 0.5  
0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5  
##$SPOFFS= (0..31) 
0 0 0 0 0 32005.68 0 -32005.68 0 0 0 0 0 0 0 -20000 0 0 0 
0 0 0 0 0 0  






















120 120 120 120 120 120 120 120  
##$TP= (0..7) 











0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5  
##$TPOFFS= (0..7) 




































;Written by Jinfa Ying, 5/11/06 
;H-N Parallel evolution MQ 
;NOESY transfer to the neightboring HN's 
;1H detection 
 
;modified from pareMQ_NOE_gsMQ2B.jfy 
 
;p1 = 90 deg (10us) 1H pulse @pl1 
;p7 = 90 deg (50us) 15N pulse @pl7 
;p4 = selective 180 deg (23.7*2us) 13CA  


















;---  p1*4.22+4u+d0==d6+p7*2+d9 for identical N/H durations 
;---  d10*2+d6==d9 for zero 15N evolution to get 0/0 phase correction 
"d9=p1*2.11+2u+d0*0.5+d10-p7"  ;initial d0 set to 70u to keep d6 & d9 >0 
"d6=p1*2.11+2u+d0*0.5-d10-p7" 
 
"d3=d2*2-d0-p7*4.44-d28*2-4u"  ;compensate the cs evolution for 1H 0/0 phase correction 
 
"d7=d8-p27-310u"   ;d8=noe mixing time 








1       ze 
        1m RESET 
2       d11 do:f3 do:f2 
        d12 LOCK_ON 
3       d12 DEUT_OFF 
4       d12 LOCK_ON 
5       d12 do:f2 do:f3 
6       d12 do:f3 
        d12 do:f2 
7       d12 do:f2 do:f3 
8       d12 do:f2 do:f3 
        1m DEUT_OFF 
        d1 LOCK_ON 
        1m LOCK_OFF 
        10u pl1:f1 
        10u pl7:f3 
 
       (p7 ph0):f3  ;kill Boltzman 




;WURST 13C dec on if 13C labeled 
#ifdef CARBON_LABEL 
        10u pl30:f2 
        10u cpds4:f2 
#endif 
;---start 90-degree on hn ----------------------- 
       (p1 ph5):f1 
        d28 
       (d25 p1 ph0 2u p1*2.22 ph1 2u p1 ph0 d25):f1 (p7 ph0 2u p7*2.44 ph1 2u p7 ph0):f3 
        d29 
       (p7 ph6):f3 
 
;---MQ and Parallel Evolution start 
       (d10 p1 ph0 2u p1*2.22 ph1 2u p1 ph0 d10 d0):f1 (d10 d10 d6 p7*2 d9):f3 
       (p7 ph0):f3 
 
;---refocusing 1J(N-H) 
        d3 
       (p1 ph2):f1 
 
;--------HN-HN NOE mixing---------- 
        10u do:f2   ;turn off the WURST 13C (ie CA and CO) decoupling 
        d7 
        p27:gp0 
        300u pl11:f1 
;-------HN readout----- 
       (p11:sp11 ph0):f1   ;eburp2 
        5u 
        p20:gp3            
        100u pl2:f1 
       (p12:sp12 ph0):f1   ;reburp 
        5u 
        p20:gp3 
        100u pl31:f3 
       go=2 ph31 cpd2:f3 
        d12*0.25 do:f3 do:f2 
 178 
        d12*0.25 LOCK_ON 
        d11 wr #0 if #0 zd 
 
#ifdef NITROGEN 
        d12*0.5 ip6 
     lo to 3 times 2 
        d12*0.5 ip31*2 
        if "d9 > in9" 
           { 
            d12*0.25 dd9 
            d12*0.25 id6 
           } 
        else 
           { 
            d12*0.5 id10 
           } 
 
     lo to 4 times l3 
        d12*0.5 rd10        ;must appear before d6 & d9 are re-evaluated 
       "d9=p1*2.11+2u+d0*0.5+d10-p7" 




        d12*0.5 ip5 
     lo to 5 times 2 
        d12*0.5 ip31*2 
        if "d29 > in29" 
           { 
            d12*0.25 dd29 
            d12*0.25 id28 
           } 
        else 
           { 
            d12*0.25 id0 
            d12*0.25 id0    ;id0 twice to make nd0=2 
           } 
       "d9=p1*2.11+2u+d0*0.5+d10-p7"  ;d6 & d9 must appear after id0 
       "d6=p1*2.11+2u+d0*0.5-d10-p7" 
 
     lo to 6 times l4 
        ;d12*0.25 rd28 
        ;d12*0.25 rd29 
        ;d12*0.5  rd0                  ;must appear before d6 & d9 are re-calculated 
       ;"d9=p1*2.11+2u+d0*0.5+d10-p7" 
















D.5.2 HMQC-NOESY parameters 
 
##TITLE= Parameter file, XWIN-NMR 
 Version 3.5 
##JCAMPDX= 5.0 
##DATATYPE= Parameter Values 
##ORIGIN= Bruker Analytik GmbH 
##OWNER= guest 




100 100 100 100 100 100 100 100 100 100 100 100 100 
100 100 100 100 100 100 100 100 100 100 100 100 100 



















1 1 140 1 90 1 1 1 1 1 1 1 1 1 1 1 1 1 4.755 8.5 3.5 176 54 













7e-05 1 0.0021 0.00396904 0.0018 0 2.26275e-05 0.11869 
0.12 2.66275e-05 2e-06 0.05 0.001 4e-06 0 0 0.0005 0 0 0 
1e-05 1e-05 0 0 0.00275 5.38525e-05  
0.00275 0 3e-06 0.00404204 0 0  
##$DATE= 1161607586 
##$DBL= (0..7) 
120 120 120 120 120 120 120 120  
##$DBP= (0..7) 











0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5  
##$DBPOFFS= (0..7) 









120 120 120 120 120 120 120 120  
##$DP= (0..7) 











0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5  
##$DPOFFS= (0..7) 


































































0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
0  
##$GPY= (0..31) 
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
0  
##$GPZ= (0..31) 
60 30 80 55 50 16.2 19 15 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
0 0 0 0 0  













0 0 0 0 0 0 0 0  
##$HPPRGN= 0 
##$IN= (0..31) 
4.9e-05 0.001 0.001 0.001 0.001 0.001 0.000212 0.001 
0.001 0.000212 0.000212 0.001 0.001 0.001 0.001 0.001 
0.001 0.001 0.001 0.001 0.000232 0.001 0.001 0.001 
0.001 0.001 0.001 0.001 4.9e-05 4.9e-05 0.0002 0.001  
##$INP= (0..31) 




1 20 1 25 91 1 1 1 1 1 1 1 1 64 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 




































0 0 0 0 0 0 0 0 0 0  
##$OVERFLW= 0 
##$P= (0..31) 
10.5 10.25 21 11.8 18.5 23.1 35 34 0 35 70 2000 2000 256 
500 200000 1000 1000 0 500 1000 48.5 84 0 2000 0 70 




100 100 100 142 100 100 100 100 100 100  
##$PHCOR= (0..31) 





120 -1 120 120 -3 120 120 -6 120 59.06 15.96 120 13.46 
120 120 7.36 17.8 120 5.5 19.88 120 120 120 120 120 120 




-1 1 0 -1 -1 2 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1  
##$PRGAIN= 0 














0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0  
##$ROUTWD2= (0..23) 
0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0  
##$RPUUSED= (0..8) 
0 0 0 0 0 0 0 0 0  
##$RSEL= (0..9) 
0 2 1 5 0 0 0 0 0 0  
##$S= (0..7) 












1 120 120 4 0 3.1 120 4 1 12.8 0 20.52 16.83 0 0 12.8 150 
150 150 150 150 150 150 150 150 150 150 150 150 150 





































0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 
0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 
0.5 0.5  
##$SPOFFS= (0..31) 
0 0 0 0 0 32005.68 0 -32005.68 0 0 0 2360 2360 0 0 -






















120 120 120 120 120 120 120 120  
##$TP= (0..7) 











0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5  
##$TPOFFS= (0..7) 




































;3D sequence with 
;   inverse correlation for triple resonance 
;      via TROSY and inept transfer steps 
; 
;      F1(H) -> F3(N) -> F2(Caliph.,t1) -> F3(N,t2) -> F1(H,t3) 
; 
;on/off resonance Ca and C=O pulses using shaped pulse 
;phase sensitive (t1) 
;phase sensitive using Echo/Antiecho gradient selection (t2) 
;using constant time in t2 
;with H-1 180degree pulses in t1 
;uncompensated version d25=d26 
;(use parameterset TRHNCACBETGP3D) 
; 
;T. Schulte-Herbrueggen & O.W. Sorensen, J. Magn. Reson. 144, 
;   123 - 128 (2000) 
;A. Eletsky, A. Kienhoefer & K. Pervushin, 
;   J. Biomol. NMR 20, 188-180 (2001) 
;(M. Salzmann, G. Wider, K. Pervushin, H. Senn & K. Wuethrich, 









define list<gradient> EA5 = { 0.8750 1.0000} 
define list<gradient> EA7 = { 1.0000 0.6667} 



































1 d11 ze 
  d11 LOCKDEC_ON 
2 d11 
3 d11 H2_LOCK 
  6m LOCKH_OFF 
  d1 pl1:f1 
  50u LOCKH_ON 
  d12 H2_PULSE 
  50u UNBLKGRAMP 
 
  4u pl0:f1 
  (p11:sp1 ph2:r):f1 
  4u 
  4u pl1:f1 
 
  (p1 ph3):f1 
  p16:gp1 
  d16 
  DELTA1 
  (center (p2 ph2) (p22 ph1):f3 ) 
  DELTA1 
  p16:gp1 
  d16 
  (p1 ph2):f1 
 
  (p21 ph1):f3 
  d16 
  DELTA2 
  (center (p14:sp3 ph1):f2 (p22 ph1):f3 ) 
  DELTA2 
  d16 
  (p21 ph2):f3 
  4u 
  4u pl4:f4 
  20u cpd4:f4 
 
  (p13:sp2 ph6):f2 
   d0 
  (p2 ph1):f1 
  d0 
  (center (p14:sp5 ph1):f2 (p22 ph1):f3 ) 
  d0 
 183 
  (p2 ph1):f1 
  d0 
  (p14:sp3 ph1):f2 
  DELTA 
  (p14:sp5 ph1):f2 
  4u 
  (p13:sp8 ph9):f2 
 
  4u do:f4 
 
  20u 
  (p21 ph5):f3 
  d30 
  (p14:sp5 ph1):f2 
  d30 
  (center (p14:sp3 ph1):f2 (p22 ph1):f3 ) 
  DELTA4 
  d10 
  (p14:sp5 ph1):f2 
  d10 
  DELTA5 
  p16:gp5*EA5 
  d16 pl0:f1 
  (p11:sp1 ph3:r):f1 
  4u 
  4u pl1:f1 
 
  (p1 ph7) 
  p16:gp6 
  d16 
  DELTA6 
  (center (p2 ph2) (p22 ph2):f3 ) 
  DELTA6 
  p16:gp6 
  d16 
  (p1 ph1) 
 
  p16:gp7*EA7 
  d16 
  4u 
 
  (p21 ph1):f3 
  p16:gp8 
  d16 
  DELTA7 pl0:f1 
  (p11:sp1 ph4:r):f1 
  4u 
  4u pl1:f1 
  (center (p2 ph2) (p22 ph2):f3 ) 
  4u pl0:f1 
  (p11:sp1 ph4:r):f1 
  4u 
  DELTA7 
  p16:gp8 
  d16 pl1:f1 
  (p21 ph8:r):f3 
 
  p16:gp9*EA9 
  d16 
  4u BLKGRAMP 
 
  go=2 ph31 
  d11 mc #0 to 2 
    ; F1PH(rd10 & rd30 & ip9 & ip10, id0) 
       F1PH(rd10 & rd30 & ip9, id0) 
       F2EA(igrad EA5 & igrad EA7 & igrad EA9 & ip7*2 & ip8*2, id10 & dd30 & ip5*2 & ip31*2) 
    ; F1EA(igrad EA5 & igrad EA7 & igrad EA9 & ip7*2 & ip8*2, id10 & dd30 & ip5*2 & ip31*2) 
  d11 H2_LOCK 
  d11 LOCKH_OFF 
















ph31=0 2 2 0 
 
;pl0 : 120dB 
;pl1 : f1 channel - power level for pulse (default) 
;pl3 : f3 channel - power level for pulse (default) 
;sp1: f1 channel - shaped pulse  90 degree  (H2O on resonance) 
;sp2: f2 channel - shaped pulse  90 degree  (Cali on resonance) 
;sp3: f2 channel - shaped pulse 180 degree  (Cali on resonance) 
;sp5: f2 channel - shaped pulse 180 degree  (C=O off resonance) 
;sp8: f2 channel - shaped pulse  90 degree  (Cali on resonance) 
;                  for time reversed pulse 
;p1 : f1 channel -  90 degree high power pulse 
;p2 : f1 channel - 180 degree high power pulse 
;p11: f1 channel -  90 degree shaped pulse             [1 msec] 
;p13: f2 channel -  90 degree shaped pulse 
;p14: f2 channel - 180 degree shaped pulse 
;p16: homospoil/gradient pulse                         [1 msec] 
;p21: f3 channel -  90 degree high power pulse 
;p22: f3 channel - 180 degree high power pulse 
;d0 : incremented delay (F1 in 3D)                     [3 usec] 
;d1 : relaxation delay; 1-5 * T1 
;d10: incremented delay (F2 in 3D)                     [3 usec] 
;d11: delay for disk I/O                               [30 msec] 
;d16: delay for homospoil/gradient recovery 
;d23: 1/(4J(NCa)                                       [11 msec] 
;d25: 1/(4J'(NH)                                       [2.3 msec] 
;d26: 1/(4J(NH)                                        [2.3 msec] 
;d28: 1/(8J(CaCb)                                      [3.6 msec] 
;d30: decremented delay (F2 in 3D) = d23/2-d25/2-p14/2-p16/2-d16/2-2u 
;cnst21: CO chemical shift (offset, in ppm) 
;cnst23: Caliphatic chemical shift (offset, in ppm) 
;o2p: Caliphatic chemical shift (cnst23) 
;in0: 1/(4 * SW(Cali)) =  (1/2) DW(Cali) 
;nd0: 4 
;in10: 1/(4 * SW(N)) = (1/2) DW(N) 
;nd10: 4 
;in30: = in10 
;NS: 8 * n 
;DS: >= 16 
;td1: number of experiments in F1 
;td2: number of experiments in F2       td2 max = 2 * d30 / in30 
;FnMODE: States-TPPI (or TPPI) in F1 
;FnMODE: echo-antiecho in F2 
 
;use gradient ratio:  gp 1:gp 2:gp 3:gp 4:gp 5:gp 6:gp 7:gp 8: gp 9 
;                        2:   2:   2:   2: -80:   2:  30:  45:30.13 
 




























;F1 reverse: true 
 
;$Id: trhncacbetgp3d,v 1.2 2004/01/22 14:59:03 ber Exp $} 
 
D.6.2 TROSY-HNCA parameters 
 
##TITLE= Parameter file, XWIN-NMR 
 Version 3.5 
##JCAMPDX= 5.0 
##DATATYPE= Parameter Values 
##ORIGIN= UXNMR, Bruker Analytische Messtechnik 
GmbH 
##OWNER= demo 




100 100 100 100 100 100 100 100 100 100 100 100 100 
100 100 100 100 100 100 100 100 100 100 100 100 100 


















1 1 140 1 90 1 1 1 1 1 1 1 1 1 1 1 1 1 4.755 8.5 3.5 176 54 













3e-06 1 0.0036 0 0 0 0 0 0.12 0.06 3e-06 0.03 2e-05 5e-06 
0 0 0.00015  
0 0 5e-05 0 0 0 0.011 0 0.0023 0.0023 0 0.0036 0 
0.003645 0  
##$DATE= 1114699439 
##$DBL= (0..7) 
120 120 120 120 120 120 120 120  
##$DBP= (0..7) 











0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5  
##$DBPOFFS= (0..7) 









10 120 120 120 120 120 120 120  
##$DP= (0..7) 











0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5  
##$DPOFFS= (0..7) 



































































0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
0  
##$GPY= (0..31) 
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
0  
##$GPZ= (0..31) 
3 2 18 44 50 -80 2 30 45 30.13 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 












0 0 0 0 0 0 0 0  
##$HPPRGN= 0 
##$IN= (0..31) 
3.945e-05 0.001 0.001 0.001 0.001 0.001 0.001 0.001 
0.001 0.001 9.5175e-05 0.001 0.001 0.001 0.001 0.001 
0.001 0.001 0.001 0.001 9.7e-05 0.001 0.001 0.001 0.001 
0.001 0.001 0.001 9.7e-05 0.001 9.5175e-05 0.001  
##$INP= (0..31) 









































0 0 0 0 0 0 0 0 0 0  
##$OVERFLW= 0 
##$P= (0..31) 
10.5 10.75 21.5 11.8 23.6 23.1 35 70 2000 35 70 1000 
2000 400 256 200000 1000 0 0 500 26 34.2 68.4 500 500 




100 100 100 100 260 100 100 100 100 100  
##$PHCOR= (0..31) 





120 -1 -2 -4 -6 120 120 120 120 59.06 15.96 120 13.46 
120 120 7.36 17.8 -6 5.5 19.88 120 120 120 120 120 120 




-1 -1 -1 -1 0 -1 1 -1 -1 -1 4 -1 -1 -1 -1 -1  
##$PRGAIN= 0 







##$QS= (0..7)83 83 83 83 83 83 83 22  
##$QSB= (0..7)83 83 83 83 83 83 83 83  
##$RD= 0 
##$RECCHAN= (0..15) 





0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0  
##$ROUTWD2= (0..23) 
0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 1 0 1 1 0 0  
##$RPUUSED= (0..8) 
 187 
0 0 0 0 0 0 0 0 0  
##$RSEL= (0..9) 
0 1 2 5 0 10 0 0 0 0  
##$S= (0..7) 












120 35 2.6 1.6 3.8 1.6 120 2.8 2.6 8.6 6 120 6 4 120 12.4 
150 150 150 150 150 150 150 150 150 150 150 150 150 




































0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 
0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 
0.5 0.5  
##$SPOFFS= (0..31) 
0 0 0 0 0 27835.54 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 






















10 120 120 120 120 120 120 120  
##$TP= (0..7) 











0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5  
##$TPOFFS= (0..7) 


















##$WS= (0..7)83 83 83 83 83 83 83 83  
##$XGAIN= (0..3) 













D.7.1 TROSY-MQ-HNCOCA pulse-program 
 
This pulse-program was modified from the standard Bruker trhncocaetgp3d pulse-
program with a multiple quantum carbon evolution time kindly provided by Roland 






;3D sequence with 
;   inverse correlation for triple resonance 
;      via TROSY and inept transfer steps 
; 
;      F1(H) -> F3(N) -> F2(Ca) -> F2(C=O,t1) 
;            -> F2(Ca) -> F3(N,t2) -> F1(H,t3) 
; 
;on/off resonance Ca and C=O pulses using shaped pulse 
;phase sensitive (t1) 
;phase sensitive using Echo/Antiecho gradient selection (t2) 
;using constant time in t2 
;with H-1 180degree pulses in t1 
;uncompensated version d25=d26 
;(use parameterset TRHNCOCAETGP3D) 
; 
;T. Schulte-Herbrueggen & O.W. Sorensen, J. Magn. Reson. 144,  
;   123 - 128 (2000) 
;A. Eletsky, A. Kienhoefer & K. Pervushin, 
;   J. Biomol. NMR 20, 188-180 (2001) 
;(M. Salzmann, G. Wider, K. Pervushin, H. Senn & K. Wuethrich, 








define list<gradient> EA3 = { 0.8750 1.0000} 
define list<gradient> EA5 = { 1.0000 0.6667} 
define list<gradient> EA7 = { 0.6595 1.0000} 
 
#define GRADIENT3  10u p23:gp8 190u pl2:f2 
 
























































1 d11 ze 
  d11 LOCKDEC_ON 
  d11 pl17:f4 
2 d11 
3 d11 H2_LOCK 
  9m LOCKH_OFF 
  d1 pl1:f1 ;fq=cnst21(bf ppm):f2 
  50u UNBLKGRAD 
  d12 H2_PULSE 
 
  4u pl0:f1 
  (p11:sp1 ph2:r):f1 
  4u 
  4u pl1:f1 
 
  (p1 ph3):f1 
  p16:gp1 
  d16 
  DELTA1 
  (center (p2 ph2) (p22 ph1):f3 ) 
  DELTA1 
  p16:gp1 
  d16 
  (p1 ph2):f1  
 
  (p21 ph1):f3 
  p16:gp2 
  d16 
  DELTA2 
  (center (p14:sp6 ph1):f2 (p22 ph1):f3 ) ;sp3 to sp6, CO 180 with offset 
  DELTA2 
  p16:gp2 
  d16 pl2:f2 
  (p21 ph2):f3 
 
  ;;(p13:sp9 ph6):f2  ;sp2 to sp9, CO 
  ;;4u 
  ;;(p14:sp7 ph1):f2   ;sp5 to sp7, CA toCO !!! 
  ;;p16:gp1 
  ;;d16 
  ;;DELTA3 
  ;;(p14:sp5 ph1):f2   ;sp3 to sp5, Co to Ca !!! 
  ;;4u 
  ;;(p14:sp7 ph1):f2    ;sp5 to sp7, Ca to Co !!! 
  ;;;DELTA3 
  ;;d8  
  ;;p16:gp1 
  ;;d16 
  ;;;(p13:sp8 ph2):f2 
 
  4u 
  30u fq=cnst22(bf ppm):f2 
  10u cpd4:f4 
   
         (p5 ph6):f2  ;co hard power 
         GRADIENT3 
         (d14 p13:sp2 ph7 d0 p15:sp5 d0 p13:sp8 ph1 d14):f2 ;(d15 d0 5u p15:sp5):f2  ;ca co 
         GRADIENT3 
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         (p5 ph1):f2  ;co hard power 
 
         ;(p5 ph6):f2  ;co hard power 
         ;GRADIENT3 
         ;(d14 p13:sp2 ph7 d0 d0 10u  p13:sp8 ph1 d14):f2 (d15 d0 5u p15:sp5):f2  ;ca co 
         ;GRADIENT3 
         ;(p5 ph1):f2  ;co hard power 
   
         ;;(p5 ph6):f2  ;co hard power 
         ;(p13:sp10 ph6):f2 ;co shaped pulse 
         ;GRADIENT3 
         ;(d14 p5 ph7 d0 d0 10u  p5 ph1 d14):f2 (d15 d0 5u p14:sp7 pl2):f2  ;ca co 
         ;GRADIENT3 
         ;(p13:sp11 ph1):f2 ;co shaped pulse 
         ;;(p5 ph1):f2  ;co hard power 
 
  ;;10u ;pl2:f2  
 
  ;;(p13:sp2 ph7):f2   ;ca 
  ;;;(p15 ph7):f2   ;ca hard power 
  ;;d6 
  ;;d9 
  ;;(p14:sp3 ph1):f2 ;ca 
    ;;d7 
  ;;d0 
  ;;(center (p2 ph1):f1 (p22 ph1):f3 ) 
  ;;;(p22 ph1):f3 
  ;;d0 
  ;;;(center (p2 ph1):f1 (p14:sp7 ph1):f2 )  ;co 
  ;;(p14:sp7 ph1):f2     ;co 
  ;;d0 
  ;;(center (p2 ph1):f1 (p22 ph1):f3 )  
  ;;;(p22 ph1):f3 
  ;;d0 
  ;;4u 
  ;;d7 
  ;;(p14:sp3 ph1):f2 ;ca 
  ;;d6 
  ;;d9 
  ;;;DELTA 
  ;;(p14:sp7 ph1):f2 ;co 
  ;;2u  
  ;;2u ;pl2:f2 
  ;;;(p15 ph1):f2   ; ca hard power 
  ;;(p13:sp8 ph1):f2 ;ca 
 
  4u do:f4 
  30u fq=cnst21(bf ppm):f2 
  20u 
 
  ;;(p13:sp2 ph2):f2 
  ;4u 
  ;(p14:sp7 ph1):f2   ;sp5 to sp7, Ca to Co !!! 
  ;p16:gp1 
  ;d16 
  ;;d8 
  ;DELTA3 
  ;(p14:sp5 ph1):f2  ;sp3 to sp5, Co to Ca  !!! 
  ;4u 
  ;(p14:sp7 ph1):f2  ;sp5 to sp7, Ca to Co  !!! 
  ;;DELTA3 
  ;d8 
  ;p16:gp1 
  ;d16 
  ;(p13:sp10 ph1):f2  ;sp8 to sp10, CO 
 
  (p21 ph5):f3 
  d30 
  (p14:sp7 ph1):f2 ;ca without offset 
  d30 
  (center (p14:sp6 ph1):f2 (p22 ph1):f3 ) ;co 180 
  DELTA4 
  d10 
  (p14:sp7 ph1):f2 
  d10 
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  DELTA5 
  p16:gp3*EA3 
  d16 pl0:f1 
  (p11:sp1 ph3:r):f1 
;(p11:sp1 ph1:r):f1 
  4u 
  4u pl1:f1 
 
  (p1 ph8) 
  p16:gp4 
  d16 
  DELTA6 
  (center (p2 ph2) (p22 ph2):f3 ) 
  DELTA6 
  p16:gp4 
  d16 
  (p1 ph1)  
 
  p16:gp5*EA5 
  d16 
  4u 
 
  (p21 ph1):f3 
  p16:gp6 
  d16 
  DELTA7 pl0:f1 
  (p11:sp1 ph4:r):f1 
  4u 
  4u pl1:f1 
  (center (p2 ph2) (p22 ph2):f3 ) 
  4u pl0:f1 
  (p11:sp1 ph4:r):f1 
  4u 
  DELTA7 
  p16:gp6 
  d16 pl1:f1 
  (p21 ph9:r):f3 
 
  p16:gp7*EA7 
  d16 
  4u BLKGRAMP 
 
  go=2 ph31 
  d11 mc #0 to 2  
     F1PH(rd10 & rd30 & ip7, id0)  
     F2EA(igrad EA3 & igrad EA5 & igrad EA7 & ip8*2 & ip9*2, id10 & dd30 & ip5*2 & ip31*2) 
 
  d11 H2_LOCK 
  d11 LOCKH_OFF 












;ph6=0 0 0 0 2 2 2 2 
;ph7=0 
ph7=0 0 2 2 
ph8=3 
ph9=3 
ph31=0 2 2 0 ;2 0 0 2 
;ph31=2 0 0 2 0 2 2 0 
 
 
;pl0 : 120dB 
;pl1 : f1 channel - power level for pulse (default) 
;pl3 : f3 channel - power level for pulse (default) 
;sp1: f1 channel - shaped pulse  90 degree  (H2O on resonance) 
;sp2: f2 channel - shaped pulse  90 degree  (on resonance) 
 192 
;sp3: f2 channel - shaped pulse 180 degree  (on resonance) 
;sp5: f2 channel - shaped pulse 180 degree  (Ca off resonance) 
;sp7: f2 channel - shaped pulse 180 degree  (C=O off resonance) 
;sp8: f2 channel - shaped pulse  90 degree  (on resonance) 
;                  for time reversed pulse 
;p1 : f1 channel -  90 degree high power pulse 
;p2 : f1 channel - 180 degree high power pulse 
;p11: f1 channel -  90 degree shaped pulse             [1 msec] 
;p13: f2 channel -  90 degree shaped pulse 
;p14: f2 channel - 180 degree shaped pulse 
;p16: homospoil/gradient pulse                         [1 msec] 
;p21: f3 channel -  90 degree high power pulse 
;p22: f3 channel - 180 degree high power pulse 
;d0 : incremented delay (F1 in 3D)                     [3 usec] 
;d1 : relaxation delay; 1-5 * T1 
;d10: incremented delay (F2 in 3D)                     [3 usec] 
;d11: delay for disk I/O                               [30 msec] 
;d16: delay for homospoil/gradient recovery 
;d22: 1/(4J(COCa)                                      [4 msec] 
;d23: 1/(4J(NCO)                                       [12 msec] 
;d25: 1/(4J'(NH)                                       [2.3 msec] 
;d26: 1/(4J(NH)                                        [2.3 msec] 
;d30: decremented delay (F2 in 3D) = d23/2-d25/2-p14/2-p16/2-d16/2-2u 
;cnst21: CO chemical shift (offset, in ppm) 
;cnst22: Calpha chemical shift (offset, in ppm) 
;o2p: Calpha chemical shift (cnst22) 
;in0: 1/(4 * SW(Ca)) =  (1/2) DW(Ca)  ;now in0=1/(2 *SW(Ca)) 
;nd0: 4                               ;now 2 
;in10: 1/(4 * SW(N)) = (1/2) DW(N) 
;nd10: 4 
;in30: = in10 
;NS: 8 * n 
;DS: >= 16 
;td1: number of experiments in F1 
;td2: number of experiments in F2       td2 max = 2 * d30 / in30 
;FnMODE: States-TPPI (or TPPI) in F1 
;FnMODE: echo-antiecho in F2 
 
 
;use gradient ratio:  gp 1 : gp 2 : gp 3 : gp 4 : gp 5 : gp 6 :  gp 7 
;                        2 :    2 :  -80 :    2 :   30 :   45 : 30.13 
 






















;$Id: trhncocaetgp3d,v 1.2 2004/01/22 14:59:05 ber Exp $ 
 
D.7.2 TROSY-MQ-HNCOCA parameters 
 
##TITLE= Parameter file, TOPSPIN 
 Version 1.3 
##JCAMPDX= 5.0 
##DATATYPE= Parameter Values 
##ORIGIN= UXNMR, Bruker Analytische Messtechnik 
GmbH 
##OWNER= demo 




100 100 100 100 100 100 100 100 100 100 100 100 100 
100 100 100 100 100 100 100 100 100 100 100 100 100 



















1 1 140 1 90 1 1 1 1 1 1 1 1 1 1 1 1 1 4.755 8.5 3.5 54 172 
39 120 1 70 15 6.5 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
1 1 1 1 1 1 1 1 1 1 1  













6.360437e-06 1 0.0036 0 0 0 1.6e-05 4e-06 0.002842 
0.000111 4e-06 0.03 2e-05 5e-06 0.0047445 0.06 0.0002 0 
0 5e-05 0 0 0.0045 0.012 0 0.0023 0.0023 0 0 0 0.004098 
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0  
0 0 0 0 0 0 0 0 0 
##$DATE= 1137694485 
##$DBL= (0..7) 
120 120 120 120 120 120 120 120 
##$DBP= (0..7) 











0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 
##$DBPOFFS= (0..7) 









10 120 120 120 120 120 120 120 
##$DP= (0..7) 











0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 
##$DPOFFS= (0..7) 





































































0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
0 
##$GPY= (0..31) 
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
0 
##$GPZ= (0..31) 
3 20 20 -80 2 30 45 30.13 45 0 0 0 0 45 50 70 0 0 0 0 0 0 0 













0 0 0 0 0 0 0 0 
##$HPPRGN= 0 
##$IN= (0..31) 
0.000137 0.001 0.001 0.001 0.001 0.001 0.001 0.001 
0.001 0.001 0.00014685 0.001 0.001 0.001 0.001 0.001 
0.001 0.001 0.001 0.001 9.7e-05 0.001 0.001 0.001 0.001 
0.001 0.001 0.001 9.7e-05 0.001 0.00014685 0.001 
##$INP= (0..31) 










































0 0 0 0 0 0 0 0 0 0 
##$OVERFLW= 0 
##$P= (0..63) 
12.45 9.12 18.24 15 30 21 25 50 500 25 50 1000 2000 400 
300 300 1000 1500 0 500 26 55.5 111 700 620 1000 55 
12.45 0.1 0 0 768 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 




100 55 80 280 150 100 100 100 100 100 
##$PHCOR= (0..31) 





120 -3 -4.5 -4.5 120 120 120 120 120 60.15 13.05541 
25.09661 15.9 120 120 5.9 19.2 -1 7 19.90387 120 120 
120 120 120 120 120 120 13.5 120 120 120 120 120 120 
120 120 120 120 120 120 120 120 120 120 120 120 120 
120 120 120 120 120 120 120 120 120 120 120 120 120 




-1 2 -1 -1 0 3 4 -1 -1 -1 -1 -1 -1 -1 -1 -1 
##$PRGAIN= 0 








##$QS= (0..7)83 83 83 83 83 83 83 22 
##$QSB= (0..7)83 83 83 83 83 83 83 83 
##$RD= 0 
##$RECCHAN= (0..15) 





0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 
##$ROUTWD2= (0..23) 
0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 1 0 1 1 0 0 
##$RPUUSED= (0..8) 
0 0 0 0 0 0 0 0 0 
##$RSEL= (0..9) 
0 1 2 5 6 0 0 0 0 0 
##$S= (0..7) 












13.2 34 -4.1 -3.73 5.3 -3.73 -3.73 -3.73 -4.1 -4.1 -4.1 120 
13.2 5.9 13.2  
13.5 150 150 150 150 150 150 150 150 150 150 150 150 





































0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 
0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 
0.5 0.5 
##$SPOFFS= (0..31) 
0 0 -17850 0 0 0 17850 0 -17850 0 17850 17850 0 0 0 0 0 






















10 120 120 120 120 120 120 120 
##$TP= (0..7) 











0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 
##$TPOFFS= (0..7) 


















##$WS= (0..7)83 83 83 83 83 83 83 83 
##$XGAIN= (0..3) 
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